Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 1103 articles:
HTML format



Single Articles


    July 2021
  1. ROHRICH M, Leitz D, Glatting FM, Wefers AK, et al
    Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.261925. doi: 10.2967/jnumed.121.261925.
    PubMed     Abstract available


  2. SANCHEZ-CATASUS C, Bohnen NI, D'Cruz N, Muller M, et al
    Striatal acetylcholine-dopamine imbalance in Parkinson's disease: in vivo neuroimaging study with dual-tracer PET and dopaminergic PET-informed correlational tractography.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.261939. doi: 10.2967/jnumed.121.261939.
    PubMed     Abstract available


  3. IMPERIALE A, Boursier C, Sahakian N, Ouvrard E, et al
    Values of (68)Ga-DOTATOC and Carbidopa-assisted (18)F-DOPA PET/CT for insulinoma localization.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.262401. doi: 10.2967/jnumed.121.262401.
    PubMed     Abstract available


  4. THORNTON A, Fraioli F, Wan S, Garthwaite HS, et al
    Evolution of (18)F-FDG-PET/CT findings in patients following COVID-19 pneumonia: An Initial Investigation.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.262296. doi: 10.2967/jnumed.121.262296.
    PubMed     Abstract available


  5. BENZ MR, Armstrong WR, Ceci F, Polverari G, et al
    (18)F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.261952. doi: 10.2967/jnumed.121.261952.
    PubMed     Abstract available


  6. NIEMEIJER AN, Oprea Lager DE, Huisman MC, Hoekstra OS, et al
    First-in-human study of (89)Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
    J Nucl Med. 2021 Jul 16. pii: jnumed.121.261926. doi: 10.2967/jnumed.121.261926.
    PubMed     Abstract available


  7. READER AJ, Schramm G
    AI for PET image reconstruction.
    J Nucl Med. 2021 Jul 8. pii: jnumed.121.262303. doi: 10.2967/jnumed.121.262303.
    PubMed    


  8. IM C, Kim H, Zaheer J, Kim JY, et al
    PET tracing of biodistribution for orally administered (64)Cu-labeled polystyrene in mice.
    J Nucl Med. 2021 Jul 2. pii: jnumed.120.256982. doi: 10.2967/jnumed.120.256982.
    PubMed     Abstract available


  9. BOSS M, Rottenburger C, Brenner W, Blankenstein O, et al
    (68)Ga-NODAGA-exendin-4 PET improves the detection of focal congenital hyperinsulinism.
    J Nucl Med. 2021 Jul 2. pii: jnumed.121.262327. doi: 10.2967/jnumed.121.262327.
    PubMed     Abstract available


  10. STATES LJ, Davis JC, Hamel SM, Becker SA, et al
    (18)F-6-Fluoro-l-Dopa PET/CT Imaging of Congenital Hyperinsulinism.
    J Nucl Med. 2021;62.
    PubMed     Abstract available


  11. WAHL R
    Nuclear Medicine Innovations: Providing Access for All.
    J Nucl Med. 2021;62:16N.
    PubMed    


  12. MARZELLA L, Czernin J, Hope T
    Perspectives on Radiopharmaceutical Agents from the FDA: A Conversation between Lou Marzella, Johannes Czernin, and Thomas Hope.
    J Nucl Med. 2021;62:881-883.
    PubMed    


  13. BLAZHENETS G, Schroeter N, Bormann T, Thurow J, et al
    Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients.
    J Nucl Med. 2021;62:910-915.
    PubMed     Abstract available


    June 2021
  14. BARCA C, Kiliaan AJ, Foray C, Wachsmuth L, et al
    A longitudinal PET/MR imaging study of colony stimulating factor-1 receptor-mediated microglia depletion in experimental stroke.
    J Nucl Med. 2021 Jun 24. pii: jnumed.121.262279. doi: 10.2967/jnumed.121.262279.
    PubMed     Abstract available


  15. CZERNIN J, Calais J
    (177)Lu-PSMA617 and the VISION Trial: One of the Greatest Success Stories in the History of Nuclear Medicine.
    J Nucl Med. 2021 Jun 24. pii: jnumed.121.262710. doi: 10.2967/jnumed.121.262710.
    PubMed    


  16. MEIER SR, Sehlin D, Roshanbin S, Lim Falk V, et al
    (11)C-PIB and (124)I-antibody PET provide differing estimates of brain amyloid-beta after therapeutic intervention.
    J Nucl Med. 2021 Jun 4. pii: jnumed.121.262083. doi: 10.2967/jnumed.121.262083.
    PubMed     Abstract available


  17. WAKFIE-CORIEH CG, Ferrando-Castagnetto F, Blanes Garcia AM, Garcia-Esquinas MG, et al
    Incidental findings suggestive of COVID-19 pneumonia in oncological patients undergoing 18F-FDG PET/CT studies: association between metabolic and structural lung changes.
    J Nucl Med. 2021 Jun 4. pii: jnumed.121.261915. doi: 10.2967/jnumed.121.261915.
    PubMed     Abstract available


  18. ZHANG X, Landgraf L, Bailis N, Unger M, et al
    Image-guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
    J Nucl Med. 2021 Jun 4. pii: jnumed.120.256230. doi: 10.2967/jnumed.120.256230.
    PubMed     Abstract available


  19. DASHORA HR, Rosenblum JS, Quinn KA, Alessi H, et al
    Comparing Semi-quantitative and Qualitative Methods of Vascular FDG-PET Activity Measurement in Large-Vessel Vasculitis.
    J Nucl Med. 2021 Jun 4. pii: jnumed.121.262326. doi: 10.2967/jnumed.121.262326.
    PubMed     Abstract available


  20. ORELLANA P, Mut F, Estrada E, Lette MM, et al
    Status of Nuclear Medicine in Latin America and the Caribbean: IAEA Analysis of Development in the Past 6 Years.
    J Nucl Med. 2021;62:23N-29N.
    PubMed    


  21. ALLIS J, Mankoff D
    Industry Perspective on the Changing Nuclear Medicine Landscape: A Conversation Between Jonathan Allis and David Mankoff.
    J Nucl Med. 2021;62:749-751.
    PubMed    


    May 2021
  22. GAFITA A, Wang H, Robertson A, Armstrong WR, et al
    Tumor sink effect in (68)Ga-PSMA-11 PET: Myth or Reality?
    J Nucl Med. 2021 May 28. pii: jnumed.121.261906. doi: 10.2967/jnumed.121.261906.
    PubMed     Abstract available


  23. RAMAN F, Fang YD, Grandhi S, Murchison CF, et al
    Dynamic Amyloid PET: Relationships to Flortaucipir Tau PET Measures.
    J Nucl Med. 2021 May 28. pii: jnumed.120.254490. doi: 10.2967/jnumed.120.254490.
    PubMed     Abstract available


  24. JIN X, Wei M, Wang S, Wang G, et al
    Detecting fibroblast activation proteins in lymphoma using (68)Ga-FAPI PET/CT.
    J Nucl Med. 2021 May 28. pii: jnumed.121.262134. doi: 10.2967/jnumed.121.262134.
    PubMed     Abstract available


  25. JACENE HA, Liu M, Cheng SC, Abbott A, et al
    Imaging Androgen Receptors in Breast Cancer with (18)F-fluoro-5alpha-dihydrotestosterone-PET: A Pilot Study.
    J Nucl Med. 2021 May 28. pii: jnumed.121.262068. doi: 10.2967/jnumed.121.262068.
    PubMed     Abstract available


  26. SEBAN RD, Champion L, Muneer I, Synn S, et al
    Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma.
    J Nucl Med. 2021 May 28. pii: jnumed.121.262361. doi: 10.2967/jnumed.121.262361.
    PubMed    


  27. KRAUS S, Dierks A, Rasche L, Kertels O, et al
    (68)Ga-Pentixafor-PET/CT imaging represents a novel approach to detect chemokine receptor CXCR4 expression in myeloproliferative neoplasms.
    J Nucl Med. 2021 May 28. pii: jnumed.121.262206. doi: 10.2967/jnumed.121.262206.
    PubMed     Abstract available


  28. MUNOZ C, Ellis S, Nekolla SG, Kunze KP, et al
    MR-guided motion-corrected PET image reconstruction for cardiac PET-MR.
    J Nucl Med. 2021 May 28. pii: jnumed.120.254235. doi: 10.2967/jnumed.120.254235.
    PubMed     Abstract available


  29. BIECHELE G, Sebastian Monasor L, Wind K, Blume T, et al
    Glitter in the Darkness? Non-fibrillar beta-amyloid Plaque Components Significantly Impact the beta-amyloid PET Signal in Mouse Models of Alzheimer's Disease.
    J Nucl Med. 2021 May 20. pii: jnumed.120.261858. doi: 10.2967/jnumed.120.261858.
    PubMed     Abstract available


  30. ZARAGORI T, Oster J, Roch V, Hossu G, et al
    (18)F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.
    J Nucl Med. 2021 May 20. pii: jnumed.120.261545. doi: 10.2967/jnumed.120.261545.
    PubMed     Abstract available


  31. GUBERINA M, Poettgen C, Metzenmacher M, Wiesweg M, et al
    PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY.
    J Nucl Med. 2021 May 20. pii: jnumed.120.260646. doi: 10.2967/jnumed.120.260646.
    PubMed     Abstract available


  32. MORAWITZ J, Bruckmann NM, Dietzel F, Ullrich T, et al
    Determining the axillary nodal status with four current imaging modalities including (18)F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard.
    J Nucl Med. 2021 May 20. pii: jnumed.121.262009. doi: 10.2967/jnumed.121.262009.
    PubMed     Abstract available


  33. COLLET S, Guillamo JS, Berro DH, Chakhoyan A, et al
    Simultaneous mapping of vasculature, hypoxia and proliferation using DSC-MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.
    J Nucl Med. 2021 May 20. pii: jnumed.120.249524. doi: 10.2967/jnumed.120.249524.
    PubMed     Abstract available


  34. BARBATO F, Fendler WP, Rauscher I, Herrmann K, et al
    PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease.
    J Nucl Med. 2021 May 14. pii: jnumed.121.262120. doi: 10.2967/jnumed.121.262120.
    PubMed     Abstract available


  35. EL-ATOUM B, Ebert M, Bucher B, Afify Z, et al
    Is (18)F-FDG PET/CT effective in identifying true residual disease after treatment of pediatric PTLD?
    J Nucl Med. 2021 May 14. pii: jnumed.121.262414. doi: 10.2967/jnumed.121.262414.
    PubMed    


  36. BOERS J, Loudini N, Brunsch CL, Koza SA, et al
    Value of (18)F-FES-PET to solve clinical dilemmas in breast cancer patients: a retrospective study.
    J Nucl Med. 2021 May 14. pii: jnumed.120.256826. doi: 10.2967/jnumed.120.256826.
    PubMed     Abstract available


  37. HENDERSON TA, DeBruin S, Briandet P
    (18)F-FDG PET National Coverage Determination for Infection/Inflammation Retired.
    J Nucl Med. 2021;62:18N-22N.
    PubMed    


  38. WAHL RL, Ahuja S, Clarke B
    Current Landscape of Radiopharmaceutical Therapies: SNMMI Therapy Task Force Survey.
    J Nucl Med. 2021;62:11N-16N.
    PubMed    



  39. Challenges and Promise for Nuclear Medicine in Africa: A Conversation Between Mike Sathekge and Johannes Czernin.
    J Nucl Med. 2021;62:593-595.
    PubMed    


  40. SCHAEFER WM, Knollmann D, Meyer PT
    Q/V-SPECT CT in times of COVID-19: Changing the order to improve safety without sacrificing accuracy.
    J Nucl Med. 2021 May 7. pii: jnumed.120.261263. doi: 10.2967/jnumed.120.261263.
    PubMed    


    April 2021
  41. KESSLER L, Ferdinandus J, Hirmas N, Bauer S, et al
    Ga-68-FAPI as diagnostic tool in sarcoma: Data from the FAPI-PET prospective observational trial.
    J Nucl Med. 2021 Apr 30. pii: jnumed.121.262096. doi: 10.2967/jnumed.121.262096.
    PubMed     Abstract available


  42. COHEN AS, Grudzinski J, Smith GT, Peterson TE, et al
    First-in-human PET imaging and estimated radiation dosimetry of L-[5-(11)C]-glutamine in patients with metastatic colorectal cancer.
    J Nucl Med. 2021 Apr 30. pii: jnumed.120.261594. doi: 10.2967/jnumed.120.261594.
    PubMed     Abstract available


  43. CHENG JL, Dibble EH, Baird GL, Gordon LL, et al
    Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors.
    J Nucl Med. 2021 Apr 23. pii: jnumed.120.260711. doi: 10.2967/jnumed.120.260711.
    PubMed     Abstract available


  44. KWIECINSKI J, Tzolos E, Meah M, Cadet S, et al
    Machine-learning with (18)F-sodium fluoride PET and quantitative plaque analysis on CT angiography for the future risk of myocardial infarction.
    J Nucl Med. 2021 Apr 23. pii: jnumed.121.262283. doi: 10.2967/jnumed.121.262283.
    PubMed     Abstract available


  45. FENDLER WP, Herrmann K, Eiber M
    Nuclear Medicine beyond VISION.
    J Nucl Med. 2021 Apr 23. pii: jnumed.121.262441. doi: 10.2967/jnumed.121.262441.
    PubMed    


  46. CHEN R, Wang Y, Zhu Y, Shi Y, et al
    The added value of (18)F-FDG PET/CT compared to (68)Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
    J Nucl Med. 2021 Apr 23. pii: jnumed.121.262250. doi: 10.2967/jnumed.121.262250.
    PubMed     Abstract available


  47. EIFER M, Tau N, Alhoubani Y, Kanana N, et al
    Covid-19 mRNA Vaccination: Age and Immune Status and its Association with Axillary Lymph Node PET/CT Uptake.
    J Nucl Med. 2021 Apr 23. pii: jnumed.121.262194. doi: 10.2967/jnumed.121.262194.
    PubMed     Abstract available


  48. GHZALLY Y, Imanli H, Smith M, Mahat J, et al
    Metabolic Scar Assessment with (18)F-FDG -PET: Correlation to Ischemic VT Substrate and Successful Ablation Sites.
    J Nucl Med. 2021 Apr 23. pii: jnumed.120.246413. doi: 10.2967/jnumed.120.246413.
    PubMed     Abstract available


  49. GOGOLA A, Minhas DS, Villemagne VL, Cohen AD, et al
    Direct comparison of the tau PET tracers [(18)F]flortaucipir and [(18)F]MK-6240 in human subjects.
    J Nucl Med. 2021 Apr 16. pii: jnumed.120.254961. doi: 10.2967/jnumed.120.254961.
    PubMed     Abstract available


  50. YOUNG AJ, Pantel AR, Viswanath V, Dominguez TL, et al
    Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted (18)F-FluorThanatrace ((18)F-FTT) PET images of ovarian cancer.
    J Nucl Med. 2021 Apr 16. pii: jnumed.121.261894. doi: 10.2967/jnumed.121.261894.
    PubMed     Abstract available


  51. QIN C, Shao F, Gai Y, Liu Q, et al
    (68)Ga-DOTA-FAPI-04 PET/MR in the evaluation of gastric carcinomas: comparison with (18)F-FDG PET/CT.
    J Nucl Med. 2021 Apr 16. pii: jnumed.120.258467. doi: 10.2967/jnumed.120.258467.
    PubMed     Abstract available


  52. LUKEY PT, Wilson FJ
    Quantification of the alphavbeta6 Integrin by PET/CT Imaging in the Lungs of Patients after SARS-CoV2 Infection and Comparison to Fibrotic Lungs.
    J Nucl Med. 2021 Apr 9. pii: jnumed.121.262342. doi: 10.2967/jnumed.121.262342.
    PubMed    


  53. GUGLIELMETTI C, Levi J, Huynh TL, Tiret B, et al
    Longitudinal imaging of T-cells and inflammatory demyelination in a preclinical model of multiple sclerosis using (18)F-FAraG PET and MRI.
    J Nucl Med. 2021 Apr 9. pii: jnumed.120.259325. doi: 10.2967/jnumed.120.259325.
    PubMed     Abstract available


  54. KUO HT, Lin KS, Zhang Z, Uribe CF, et al
    (177)Lu-Labeled Albumin-Binder-Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio.
    J Nucl Med. 2021;62:521-527.
    PubMed     Abstract available


    March 2021
  55. BATEMAN TM, Heller GV, Beanlands R, Calnon DA, et al
    Practical guide for interpreting and reporting cardiac PET measurements of myocardial blood flow: an Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2021 Mar 31. pii: jnumed.121.261989. doi: 10.2967/jnumed.121.261989.
    PubMed    


  56. BAKKER IL, Froberg AC, Busstra MB, Verzijlbergen JF, et al
    GRPr antagonist (68)Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients.
    J Nucl Med. 2021 Mar 31. pii: jnumed.120.258814. doi: 10.2967/jnumed.120.258814.
    PubMed     Abstract available


  57. MICHALSKI K, Klein C, Brueggemann T, Meyer PT, et al
    Assessing Response to [(177)Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria.
    J Nucl Med. 2021 Mar 31. pii: jnumed.120.260836. doi: 10.2967/jnumed.120.260836.
    PubMed     Abstract available


  58. VEAL M, Dias G, Kersemans V, Sneddon D, et al
    A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes.
    J Nucl Med. 2021 Mar 31. pii: jnumed.120.251173. doi: 10.2967/jnumed.120.251173.
    PubMed     Abstract available


  59. IMPERIALE A, Meuter L, Pacak K, Taieb D, et al
    Imaging of small intestine neuroendocrine neoplasms: Is SSTR PET the holy grail?
    J Nucl Med. 2021 Mar 26. pii: jnumed.121.262140. doi: 10.2967/jnumed.121.262140.
    PubMed    


  60. BUVAT I, Orlhac F
    The T.R.U.E. checklist for identifying impactful AI-based findings in nuclear medicine: is it True? Is it Reproducible? Is it Useful? Is it Explainable?
    J Nucl Med. 2021 Mar 26. pii: jnumed.120.261586. doi: 10.2967/jnumed.120.261586.
    PubMed    


  61. OZUTEMIZ C, Koksel Y, Froelich JW, Rubin N, et al
    COMPARISON OF THE EFFECT OF THREE DIFFERENT DIETARY MODIFICATIONS ON MYOCARDIAL SUPPRESSION IN (18)F-FDG PET/CT EVALUATION OF PATIENTS FOR SUSPECTED CARDIAC SARCOIDOSIS.
    J Nucl Med. 2021 Mar 26. pii: jnumed.121.261981. doi: 10.2967/jnumed.121.261981.
    PubMed     Abstract available


  62. PENG S, Tang C, Schindlbeck K, Rydzinski Y, et al
    Dynamic (18)F-FPCIT PET: Quantification of Parkinson's disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session.
    J Nucl Med. 2021 Mar 19. pii: jnumed.120.257345. doi: 10.2967/jnumed.120.257345.
    PubMed     Abstract available


  63. AFAQ A, Payne H, Davda R, Hines J, et al
    A Phase II, Open-label study to assess safety and management change using (68)Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
    J Nucl Med. 2021 Mar 19. pii: jnumed.120.257527. doi: 10.2967/jnumed.120.257527.
    PubMed     Abstract available


  64. NARCISO L, Ssali T, Liu L, Biernaski H, et al
    A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model.
    J Nucl Med. 2021 Mar 19. pii: jnumed.120.260521. doi: 10.2967/jnumed.120.260521.
    PubMed     Abstract available


  65. BUCKNOR MD, Hope T
    Reply: "Disparities in PET imaging for prostate cancer at a tertiary academic medical center".
    J Nucl Med. 2021 Mar 19. pii: jnumed.121.262332. doi: 10.2967/jnumed.121.262332.
    PubMed    


  66. VELLEMAN T, Kwee TC, Noordzij W, Ongena Y, et al
    The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
    J Nucl Med. 2021 Mar 12. pii: jnumed.120.261503. doi: 10.2967/jnumed.120.261503.
    PubMed     Abstract available


  67. CZERNIN J, Herrmann K
    The disappearance act of Nuclear Medicine in the Netherlands: Just a new trick by the great Harry Houdini?
    J Nucl Med. 2021 Mar 12. pii: jnumed.121.262190. doi: 10.2967/jnumed.121.262190.
    PubMed    


  68. FAROLFI A, Calderoni L, Mattana F, Mei R, et al
    Current and emerging clinical applications of PSMA-PET diagnostic imaging for prostate cancer.
    J Nucl Med. 2021 Mar 12. pii: jnumed.120.257238. doi: 10.2967/jnumed.120.257238.
    PubMed     Abstract available


  69. MARCHETTI L, Perrucci L, Pellegrino F, Baroni L, et al
    Diagnostic contribution of contrast-enhanced CT as compared to unenhanced low-dose CT in PET/CT staging and treatment response assessment of 18FDG-avid lymphomas: a prospective study.
    J Nucl Med. 2021 Mar 12. pii: jnumed.120.259242. doi: 10.2967/jnumed.120.259242.
    PubMed     Abstract available


  70. UPRIMNY C, Bayerschmidt S, Kroiss AS, Fritz J, et al
    Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for (68)Ga-PSMA-11 PET/CT.
    J Nucl Med. 2021 Mar 12. pii: jnumed.120.261866. doi: 10.2967/jnumed.120.261866.
    PubMed     Abstract available


  71. RAUSCHER I, Karimzadeh A, Schiller K, Horn T, et al
    Detection efficacy of (18)F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.
    J Nucl Med. 2021 Mar 12. pii: jnumed.120.260091. doi: 10.2967/jnumed.120.260091.
    PubMed     Abstract available


  72. ZWEZERIJNEN GJ, Eertink JJ, Burggraaff CN, Wiegers SE, et al
    Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim (18)F-FDG PET in DLBCL.
    J Nucl Med. 2021 Mar 5. pii: jnumed.120.258673. doi: 10.2967/jnumed.120.258673.
    PubMed     Abstract available


  73. HOPE TA, Graces C, Calais J, Ehman E, et al
    Accuracy of (18)F-fluorocholine PET for the detection of parathyroid adenomas: prospective single center study.
    J Nucl Med. 2021 Mar 5. pii: jnumed.120.256735. doi: 10.2967/jnumed.120.256735.
    PubMed     Abstract available


  74. BARATTO L, Song H, Duan H, Hatami N, et al
    PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2021 Mar 5. pii: jnumed.120.259630. doi: 10.2967/jnumed.120.259630.
    PubMed     Abstract available


  75. WU H, Czernin J
    A Conversation Between Hong Wu and Johannes Czernin.
    J Nucl Med. 2021;62:293-295.
    PubMed    


  76. LODGE MA
    Phantom Preparation Using a Dilution Technique.
    J Nucl Med. 2021;62:303.
    PubMed    


  77. ALBRECHT J, Exner S, Grotzinger C, Prasad S, et al
    Multimodal Imaging of 2-Cycle PRRT with (177)Lu-DOTA-JR11 and (177)Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model.
    J Nucl Med. 2021;62:393-398.
    PubMed     Abstract available


  78. BARRINGTON SF, Zwezerijnen BGJC, de Vet HCW, Heymans MW, et al
    Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.
    J Nucl Med. 2021;62:332-337.
    PubMed     Abstract available


  79. PEREIRA PMR, Norfleet J, Lewis JS, Escorcia FE, et al
    Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition.
    J Nucl Med. 2021;62:366-371.
    PubMed     Abstract available


    February 2021
  80. CARLSEN EA, Johnbeck CB, Loft M, Pfeifer A, et al
    Semi-automatic tumor delineation for evaluation of (64)Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.
    J Nucl Med. 2021 Feb 26. pii: jnumed.120.258392. doi: 10.2967/jnumed.120.258392.
    PubMed     Abstract available


  81. LAFFON E, Marthan R
    Specific and Non-Specific Uptake in Quantitative (89)Zr-Immuno-PET.
    J Nucl Med. 2021 Feb 26. pii: jnumed.121.262065. doi: 10.2967/jnumed.121.262065.
    PubMed    


  82. YANG J, Shi L, Wang R, Miller EJ, et al
    Direct Attenuation Correction Using Deep Learning for Cardiac SPECT: A Feasibility Study.
    J Nucl Med. 2021 Feb 26. pii: jnumed.120.256396. doi: 10.2967/jnumed.120.256396.
    PubMed     Abstract available


  83. DI CARLI MF
    Hot Topic, Why will PET be the future of nuclear cardiology?
    J Nucl Med. 2021 Feb 19. pii: jnumed.120.254979. doi: 10.2967/jnumed.120.254979.
    PubMed    


  84. VERHAGEN MV, Menezes LJ, Neriman D, Watson TA, et al
    (18)F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with (18)F-FDG PET/CT as reference standard.
    J Nucl Med. 2021 Feb 19. pii: jnumed.120.260059. doi: 10.2967/jnumed.120.260059.
    PubMed     Abstract available


  85. ZUKOTYNSKI KA, Emmenegger U, Hotte S, Kapoor A, et al
    Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted (18)F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
    J Nucl Med. 2021 Feb 19. pii: jnumed.120.259069. doi: 10.2967/jnumed.120.259069.
    PubMed     Abstract available


  86. CHAN DL, Ulaner GA, Pattison DA, Wyld D, et al
    Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
    J Nucl Med. 2021 Feb 12. pii: jnumed.120.257659. doi: 10.2967/jnumed.120.257659.
    PubMed     Abstract available


  87. BARRET O, Zhang L, Alagille D, Constantinescu CC, et al
    Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Non-Human Primates.
    J Nucl Med. 2021 Feb 12. pii: jnumed.120.256008. doi: 10.2967/jnumed.120.256008.
    PubMed     Abstract available


  88. ORTEGA C, Wong RK, Schaefferkoetter J, Veit-Haibach P, et al
    Quantitative (68)Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with (177)Lu-DOTATATE.
    J Nucl Med. 2021 Feb 12. pii: jnumed.120.256727. doi: 10.2967/jnumed.120.256727.
    PubMed     Abstract available


  89. DUELL J, Krummenast F, Schirbel A, Klassen P, et al
    Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT.
    J Nucl Med. 2021 Feb 12. pii: jnumed.120.257279. doi: 10.2967/jnumed.120.257279.
    PubMed     Abstract available


  90. MARIANI G, Tonaccehra M, Grosso M, Fiore E, et al
    The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders. Part 2. Nodular Goiter, Hypothyroidism, and Subacute Thyroiditis.
    J Nucl Med. 2021 Feb 12. pii: jnumed.120.251504. doi: 10.2967/jnumed.120.251504.
    PubMed     Abstract available


  91. ALBERTS I, Huenermund JN, Sachpekidis C, Zacho HD, et al
    Combination of forced diuresis with additional late imaging in (68)Ga-PSMA-11 PET/CT - effects on lesion visibility and radiotracer uptake.
    J Nucl Med. 2021 Feb 5. pii: jnumed.120.257741. doi: 10.2967/jnumed.120.257741.
    PubMed     Abstract available


  92. BODET-MILIN C, Faivre-Chauvet A, Carlier T, Ansquer C, et al
    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
    J Nucl Med. 2021 Feb 5. pii: jnumed.120.252791. doi: 10.2967/jnumed.120.252791.
    PubMed     Abstract available


  93. WONDERGEM M, van der Zant FM, Broos WA, Knol RJ, et al
    Matched-pair comparison of (18)F-DCFPyL PET/CT and (18)F-PSMA-1007 PET/CT in 240 prostate cancer patients; inter-reader agreement and lesion detection rate of suspected lesions.
    J Nucl Med. 2021 Feb 5. pii: jnumed.120.258574. doi: 10.2967/jnumed.120.258574.
    PubMed     Abstract available


  94. NAKAMOTO R, Zaba LC, Liang T, Reddy SA, et al
    Prognostic value of bone marrow metabolism on pretreatment (18)F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy.
    J Nucl Med. 2021 Feb 5. pii: jnumed.120.254482. doi: 10.2967/jnumed.120.254482.
    PubMed     Abstract available


  95. WAHL RL
    SNMMI Leadership Update: Advancing Radiopharmaceutical Therapy.
    J Nucl Med. 2021;62:20N.
    PubMed    



  96. FDA Approves First PSMA-Targeted PET Drug.
    J Nucl Med. 2021;62:11N.
    PubMed    


  97. SARTOR O, Hope TA, Calais J, Fendler WP, et al
    Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA.
    J Nucl Med. 2021;62:146-148.
    PubMed    


  98. CARLUCCI G, Ippisch R, Slavik R, Mishoe A, et al
    (68)Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.
    J Nucl Med. 2021;62:149-155.
    PubMed     Abstract available


  99. ZANOTTI-FREGONARA P, Lammertsma AA, Innis RB
    (11)C Dosimetry Scans Should Be Abandoned.
    J Nucl Med. 2021;62:158-159.
    PubMed    


  100. ALTMANN A, Haberkorn U, Siveke J
    The Latest Developments in Imaging of Fibroblast Activation Protein.
    J Nucl Med. 2021;62:160-167.
    PubMed     Abstract available


  101. SLOMKA PJ, Moody JB, Miller RJH, Renaud JM, et al
    Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.
    J Nucl Med. 2021;62:168-176.
    PubMed     Abstract available


  102. AHMED H, Wallimann R, Haider A, Hosseini V, et al
    Preclinical Development of (18)F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis.
    J Nucl Med. 2021;62:259-265.
    PubMed     Abstract available


  103. HADDAD J, Latoche JD, Nigam S, Bellavia MC, et al
    Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury.
    J Nucl Med. 2021;62:280-286.
    PubMed     Abstract available


    January 2021
  104. SCHILHAM MG, Zamecnik P, Prive BM, Israel B, et al
    Head-to-head comparison of (68)Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10 enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients.
    J Nucl Med. 2021 Jan 30. pii: jnumed.120.258541. doi: 10.2967/jnumed.120.258541.
    PubMed     Abstract available


  105. WHITTINGTON A, Gunn R
    TauIQ - A canonical image based algorithm to quantify tau PET scans.
    J Nucl Med. 2021 Jan 30. pii: jnumed.120.258962. doi: 10.2967/jnumed.120.258962.
    PubMed     Abstract available


  106. F ANTUNES I, Dost R, Hoving HD, Waarde AV, et al
    Synthesis and evaluation of (18)F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16beta-(18)F-fluoro-5alpha-dihydrotestosterone.
    J Nucl Med. 2021 Jan 30. pii: jnumed.120.253641. doi: 10.2967/jnumed.120.253641.
    PubMed     Abstract available


  107. ROBU S, Richter A, Gosmann D, Seidl C, et al
    Synthesis and Preclinical Evaluation of (68)Ga-labeled Adnectin, (68)Ga-BMS-986192 as a PET Agent for Imaging PD-L1 Expression.
    J Nucl Med. 2021 Jan 30. pii: jnumed.120.258384. doi: 10.2967/jnumed.120.258384.
    PubMed     Abstract available


  108. ABIODUN-OJO OA, Jani AB, Akintayo AA, Akin-Akintayo OO, et al
    Salvage Radiotherapy Management Decision in Post-prostatectomy Patients with Recurrent Prostate Cancer Based on (18)F-Fluciclovine PET/CT Guidance.
    J Nucl Med. 2021 Jan 30. pii: jnumed.120.256784. doi: 10.2967/jnumed.120.256784.
    PubMed     Abstract available


  109. WEISSINGER M, Taran FA, Gatidis S, Kommoss S, et al
    Lymph node staging with a combined protocol of (18)F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma.
    J Nucl Med. 2021 Jan 28. pii: jnumed.120.255919. doi: 10.2967/jnumed.120.255919.
    PubMed     Abstract available


  110. HIRMAS N, Leyh C, Sraieb M, Barbato F, et al
    [(68)Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma (HCC).
    J Nucl Med. 2021 Jan 28. pii: jnumed.120.257915. doi: 10.2967/jnumed.120.257915.
    PubMed     Abstract available


  111. KESNER AL
    The Evolution of PET/MR is Hindered by our Field's Reluctance to Provide Critical Evaluation.
    J Nucl Med. 2021 Jan 15. pii: jnumed.120.260950. doi: 10.2967/jnumed.120.260950.
    PubMed    


  112. GUZIK P, Fang HY, Deberle LM, Benesova M, et al
    Identification of a PET Radiotracer for Imaging of the Folate Receptor-alpha - A Potential Tool to Select Patients for Targeted Tumor Therapy.
    J Nucl Med. 2021 Jan 15. pii: jnumed.120.255760. doi: 10.2967/jnumed.120.255760.
    PubMed     Abstract available


  113. CHUGANI HT
    HYPERMETABOLISM ON PEDIATRIC POSITRON EMISSION TOMOGRAPHY SCANS OF BRAIN GLUCOSE METABOLISM: What does it signify?
    J Nucl Med. 2021 Jan 15. pii: jnumed.120.256081. doi: 10.2967/jnumed.120.256081.
    PubMed     Abstract available


  114. WHITMAN J, Allen IE, Bergsland EK, Suh IA, et al
    Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis.
    J Nucl Med. 2021 Jan 15. pii: jnumed.120.257303. doi: 10.2967/jnumed.120.257303.
    PubMed     Abstract available


  115. MARKOWSKI MC, Velho PI, Eisenberger MA, Pomper MG, et al
    Detection of Early Progression with (18)F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
    J Nucl Med. 2021 Jan 15. pii: jnumed.120.259226. doi: 10.2967/jnumed.120.259226.
    PubMed     Abstract available


  116. WIBMER AG, Morris MJ, Gonen M, Zheng J, et al
    QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY.
    J Nucl Med. 2021 Jan 8. pii: jnumed.120.256602. doi: 10.2967/jnumed.120.256602.
    PubMed     Abstract available



  117. Humana Decision to Deny PET/CT Coverage.
    J Nucl Med. 2021;62:20N.
    PubMed    


  118. VALI R, Alessio A, Balza R, Borgwardt L, et al
    SNMMI Procedure Standard/EANM Practice Guideline on Pediatric (18)F-FDG PET/CT for Oncology 1.0.
    J Nucl Med. 2021;62:99-110.
    PubMed     Abstract available


  119. WAHL RL, Chareonthaitawee P, Clarke B, Drzezga A, et al
    Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.
    J Nucl Med. 2021;62:6-14.
    PubMed     Abstract available


  120. CZERNIN J, Iagaru A
    Humana and (18)F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others.
    J Nucl Med. 2021;62:1-2.
    PubMed    


  121. LAFFON E, Marthan R
    Distribution Volume of (18)F-BMS-986192 in NSCLC Patients.
    J Nucl Med. 2021;62:144.
    PubMed    


  122. BUVAT I, Herrmann K, Stremitzer A, Tobia K, et al
    Irene Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen Nielsen.
    J Nucl Med. 2021;62:3-5.
    PubMed    


  123. PRICE WN 2ND, Gerke S, Cohen IG
    How Much Can Potential Jurors Tell Us About Liability for Medical Artificial Intelligence?
    J Nucl Med. 2021;62:15-16.
    PubMed    


  124. TOBIA K, Nielsen A, Stremitzer A
    When Does Physician Use of AI Increase Liability?
    J Nucl Med. 2021;62:17-21.
    PubMed     Abstract available


  125. CAPOBIANCO N, Meignan M, Cottereau AS, Vercellino L, et al
    Deep-Learning (18)F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2021;62:30-36.
    PubMed     Abstract available


  126. ZIESSMAN HA, Jeyasingam M, Khan AU, McMahan Z, et al
    Experience with Esophagogastrointestinal Transit Scintigraphy in the Initial 229 Patients: Multiple Regions of Dysmotility Are Common.
    J Nucl Med. 2021;62:115-122.
    PubMed     Abstract available


    December 2020
  127. FRANCIS R, Bailey D, Hofman MS, Scott A, et al
    The Australasian Radiopharmaceutical Trials Network (ARTnet) - Clinical Trials, Evidence and Opportunity.
    J Nucl Med. 2020 Dec 31. pii: jnumed.120.258152. doi: 10.2967/jnumed.120.258152.
    PubMed    


  128. CERCI JJ, Bogoni M, Cerci RJ, Masukawa M, et al
    PET/CT guided biopsy of suspected lung lesions requires less rebiopsy than CT guided biopsy due to inconclusive results.
    J Nucl Med. 2020 Dec 31. pii: jnumed.120.252403. doi: 10.2967/jnumed.120.252403.
    PubMed     Abstract available


  129. WALKER MD, Bradley KM, McGowan DR
    Data-Driven Respiratory Motion Correction in Clinical PET - A Turning Point.
    J Nucl Med. 2020 Dec 18. pii: jnumed.120.257022. doi: 10.2967/jnumed.120.257022.
    PubMed    


  130. GOTO T, Kikuchi S, Mori K, Nakayama T, et al
    Cardiac Beta-Adrenergic Receptor Downregulation, Evaluated by Cardiac Positron Emission Tomography, in Chronotropic Incompetence.
    J Nucl Med. 2020 Dec 18. pii: jnumed.120.253419. doi: 10.2967/jnumed.120.253419.
    PubMed     Abstract available


  131. DEVASIA T, Dewaraja YK, Frey KA, Wong KK, et al
    A novel time-activity information sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: application in SPECT/CT imaging post-(177)Lu-DOTATATE.
    J Nucl Med. 2020 Dec 18. pii: jnumed.120.256255. doi: 10.2967/jnumed.120.256255.
    PubMed     Abstract available


  132. WANG C, Leach BI, Lister D, Adams SR, et al
    Metallo-Fluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI.
    J Nucl Med. 2020 Dec 4. pii: jnumed.120.255273. doi: 10.2967/jnumed.120.255273.
    PubMed     Abstract available


  133. HICKS RJ, Roselt PJ, Kallur KG, Tothill RW, et al
    State-of-the-Art: FAPI PET/CT-Will it end the hegemony of FDG in oncology?
    J Nucl Med. 2020 Dec 4. pii: jnumed.120.256271. doi: 10.2967/jnumed.120.256271.
    PubMed     Abstract available


  134. RONCALI E, Capala J, Benedict SH, Akabani G, et al
    Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT).
    J Nucl Med. 2020 Dec 4. pii: jnumed.120.255547. doi: 10.2967/jnumed.120.255547.
    PubMed     Abstract available


  135. VAN DONGEN GAMS, Beaino W, Windhorst AD, Zwezerijnen GJC, et al
    The navigating and de-risking role of (89)Zr-immuno-PET in the development of biopharmaceuticals.
    J Nucl Med. 2020 Dec 4. pii: jnumed.119.239558. doi: 10.2967/jnumed.119.239558.
    PubMed     Abstract available


  136. KROENKE M, Mirzoyan L, Horn T, Peeken JC, et al
    Matched-pair comparison of (68)Ga-PSMA-11 and (18)F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrence of prostate cancer: frequency of non-tumor related uptake and tumor positivity.
    J Nucl Med. 2020 Dec 4. pii: jnumed.120.251447. doi: 10.2967/jnumed.120.251447.
    PubMed     Abstract available


  137. TANNER JA, Rabinovici GD
    Relationship Between Tau and Cognition in the Evolution of Alzheimer's Disease: New Insights from Tau PET.
    J Nucl Med. 2020 Dec 4. pii: jnumed.120.257824. doi: 10.2967/jnumed.120.257824.
    PubMed    


  138. HOPE TA
    Updates to the Appropriate-Use Criteria for Somatostatin Receptor PET.
    J Nucl Med. 2020;61:1764.
    PubMed    


  139. CARSON RE
    Quantitative Cerebral Blood Flow with PET in the 1980s: Going with the Flow.
    J Nucl Med. 2020;61.
    PubMed    


  140. WEBER WA, Czernin J, Anderson CJ, Badawi RD, et al
    The Future of Nuclear Medicine, Molecular Imaging, and Theranostics.
    J Nucl Med. 2020;61.
    PubMed    


  141. CATANA C
    A Stepping-Stone to Fully Integrated Whole-Body PET/MRI.
    J Nucl Med. 2020;61.
    PubMed    


  142. BARTHEL H
    Switching on Brain PET to Light Up Amyloid Pathology In Vivo.
    J Nucl Med. 2020;61.
    PubMed    



  143. The 60th Anniversary Issue of The Journal of Nuclear Medicine.
    J Nucl Med. 2020;61.
    PubMed    


  144. PAGANELLI G, Matteucci F
    Importance of PET with (68)Ga-Labeled Somatostatin Analogs.
    J Nucl Med. 2020;61.
    PubMed    


  145. STUSCHKE M, Pottgen C
    (18)F-FDG PET/CT for Target Volume Contouring in Lung Cancer Radiotherapy.
    J Nucl Med. 2020;61.
    PubMed    


  146. TAI YC
    Small-Animal PET: A Technology That Changed Our Field.
    J Nucl Med. 2020;61.
    PubMed    


  147. FOWLER JS
    (18)F-FDG Radiosynthesis: A Landmark in the History of PET.
    J Nucl Med. 2020;61.
    PubMed    


  148. POLVOY I, Flavell RR, Rosenberg OS, Ohliger MA, et al
    Nuclear Imaging of Bacterial Infection: The State of the Art and Future Directions.
    J Nucl Med. 2020;61:1708-1716.
    PubMed     Abstract available



  149. A Conversation Between Frans van Houten and Ken Herrmann.
    J Nucl Med. 2020;61:1697-1700.
    PubMed    


  150. CULLINANE C, Jeffery CM, Roselt PD, van Dam EM, et al
    Peptide Receptor Radionuclide Therapy with (67)Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model.
    J Nucl Med. 2020;61:1800-1805.
    PubMed     Abstract available


  151. SACHER C, Blume T, Beyer L, Biechele G, et al
    Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models.
    J Nucl Med. 2020;61:1825-1831.
    PubMed     Abstract available


  152. TOMS J, Kogler J, Maschauer S, Daniel C, et al
    Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an (18)F-Labeled FAP Inhibitor.
    J Nucl Med. 2020;61:1806-1813.
    PubMed     Abstract available


  153. BERMAN DS, Rozanski A
    Pharmacologic Stress Testing: Its Roots, Its Impact, and Its Future.
    J Nucl Med. 2020;61.
    PubMed    


  154. HOFMAN MS
    Prostate-Specific Membrane Antigen: The Target of the Decade, from Biochemical Recurrence to Widespread Adoption.
    J Nucl Med. 2020;61.
    PubMed    


  155. STRAUSS HW
    Establishing a Clinical Role for Bone Scans.
    J Nucl Med. 2020;61.
    PubMed    


  156. HICKS RJ, Hoekstra OS
    PERCISTence: Strength or Stubbornness?
    J Nucl Med. 2020;61.
    PubMed    


  157. LAMMERTSMA AA
    On the Origin of Hybrid Imaging.
    J Nucl Med. 2020;61.
    PubMed    


  158. BODEI L
    Somatostatin Receptor Scintigraphy: Blazing in Indium and Quenching in Gallium.
    J Nucl Med. 2020;61.
    PubMed    


  159. SCHWAIGER M
    From (201)Tl to (99m)Tc-Sestamibi.
    J Nucl Med. 2020;61.
    PubMed    


    November 2020
  160. SHIYAM SUNDAR LK, Iommi D, Muzik O, Chalampalakis Z, et al
    Conditional Generative Adversarial Networks (cGANs) aided motion correction of dynamic (18)F-FDG PET brain studies.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.248856. doi: 10.2967/jnumed.120.248856.
    PubMed     Abstract available


  161. ZHAO N, Huang Y, Wang YH, Muir RK, et al
    Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.252460. doi: 10.2967/jnumed.120.252460.
    PubMed     Abstract available


  162. PACKARD RRS, Lazewatsky JL, Orlandi C, Maddahi J, et al
    Diagnostic Performance of PET vs. SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: a Substudy of the (18)F-Flurpiridaz Phase-III Clinical Trial.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.252007. doi: 10.2967/jnumed.120.252007.
    PubMed     Abstract available


  163. BOURLA AB, Herrmann K
    Real-World Data as an Evidence Source in Nuclear Medicine.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.258665. doi: 10.2967/jnumed.120.258665.
    PubMed    


  164. RAY S, Lisok A, Minn IL, Josefsson A, et al
    Preclinical evaluation of (213)Bi-/(225)Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.256388. doi: 10.2967/jnumed.120.256388.
    PubMed     Abstract available


  165. KURCH L, Andreas H, Georgi TW, Rekowski J, et al
    Interim positron emission tomography in diffuse large B-cell lymphoma.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.255034. doi: 10.2967/jnumed.120.255034.
    PubMed     Abstract available


  166. CZERNIN J, Iagaru A
    Humana and (18)F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others.
    J Nucl Med. 2020 Nov 13. pii: jnumed.120.260208. doi: 10.2967/jnumed.120.260208.
    PubMed    


  167. CHANTADISAI M, Buschner G, Kronke M, Rauscher I, et al
    Positive predictive value and correct detection rate of (18)F-rhPSMA-7 PET in biochemically recurrent prostate cancer validated by composite reference standard.
    J Nucl Med. 2020 Nov 13. pii: jnumed.120.255661. doi: 10.2967/jnumed.120.255661.
    PubMed     Abstract available


  168. CECCON G, Lohmann P, Werner JM, Tscherpel C, et al
    Early treatment response assessment using (18)F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
    J Nucl Med. 2020 Nov 6. pii: jnumed.120.254243. doi: 10.2967/jnumed.120.254243.
    PubMed     Abstract available


  169. LEVI J, Goth S, Huynh L, Lam T, et al
    (18)F-FAraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy.
    J Nucl Med. 2020 Nov 6. pii: jnumed.120.249078. doi: 10.2967/jnumed.120.249078.
    PubMed     Abstract available


  170. MEIJER D, Donswijk ML, Bodar YJL, van Leeuwen PJ, et al
    Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging.
    J Nucl Med. 2020 Nov 6. pii: jnumed.120.252528. doi: 10.2967/jnumed.120.252528.
    PubMed     Abstract available


  171. TOWNSEND D, Beyer T, Czernin J
    20 Years of PET/CT: A Conversation with David Townsend and Thomas Beyer.
    J Nucl Med. 2020;61:1541-1543.
    PubMed    


  172. CARTER LM, Henry KE, Platzman A, Lewis JS, et al
    3D-Printable Platform for High-Throughput Small-Animal Imaging.
    J Nucl Med. 2020;61:1691-1692.
    PubMed    


  173. MAIRINGER S, Sake JA, Hernandez Lozano I, Filip T, et al
    Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
    J Nucl Med. 2020;61:1650-1657.
    PubMed     Abstract available


  174. SUURS FV, Lorenczewski G, Stienen S, Friedrich M, et al
    The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm.
    J Nucl Med. 2020;61:1594-1601.
    PubMed     Abstract available


    October 2020
  175. HOU X, Brosch J, Uribe C, Desy A, et al
    Feasibility of single-time-point dosimetry for radiopharmaceutical therapies.
    J Nucl Med. 2020 Oct 30. pii: jnumed.120.254656. doi: 10.2967/jnumed.120.254656.
    PubMed     Abstract available


  176. KOSTYSZYN D, Fechter T, Bartl N, Grosu AL, et al
    Intraprostatic Tumour Segmentation on PSMA-PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
    J Nucl Med. 2020 Oct 30. pii: jnumed.120.254623. doi: 10.2967/jnumed.120.254623.
    PubMed     Abstract available


  177. FRANC BL, Iagaru A
    Letter to the Editor: "Disparities in PET imaging for prostate cancer at a tertiary academic medical center".
    J Nucl Med. 2020 Oct 30. pii: jnumed.120.258160. doi: 10.2967/jnumed.120.258160.
    PubMed    


  178. ALUICIO-SARDUY E, Barnhart TE, Weichert J, Hernandez R, et al
    Cyclotron produced (132)La as a PET imaging surrogate of therapeutic (225)Ac.
    J Nucl Med. 2020 Oct 30. pii: jnumed.120.255794. doi: 10.2967/jnumed.120.255794.
    PubMed     Abstract available


  179. MAMMATAS LH, Yaqub M, Hendrikse NH, Hoekstra OS, et al
    (11)C-sorafenib and (15)O-H2O PET for early evaluation of sorafenib therapy.
    J Nucl Med. 2020 Oct 30. pii: jnumed.120.251611. doi: 10.2967/jnumed.120.251611.
    PubMed     Abstract available


  180. ROHRICH M, Naumann P, Giesel FL, Choyke P, et al
    Impact of (68)Ga-FAPI-PET/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas.
    J Nucl Med. 2020 Oct 23. pii: jnumed.120.253062. doi: 10.2967/jnumed.120.253062.
    PubMed     Abstract available


  181. BLAZHENETS G, Frings L, Sorensen A, Meyer PT, et al
    Principal components analysis based measures of PET data closely reflect neuropathological staging schemes.
    J Nucl Med. 2020 Oct 23. pii: jnumed.120.252783. doi: 10.2967/jnumed.120.252783.
    PubMed     Abstract available


  182. GOLAN S, Aviv T, Groshar D, Yakimov M, et al
    Dynamic (68)Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study.
    J Nucl Med. 2020 Oct 23. pii: jnumed.120.251272. doi: 10.2967/jnumed.120.251272.
    PubMed     Abstract available


  183. BINDERUP T, Knigge U, Johnbeck CB, Loft A, et al
    (18)F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients.
    J Nucl Med. 2020 Oct 16. pii: jnumed.120.244798. doi: 10.2967/jnumed.120.244798.
    PubMed     Abstract available


  184. GERARD SK
    PET/MRI versus PET/CT for Whole-Body Staging.
    J Nucl Med. 2020 Oct 9. pii: jnumed.120.256453. doi: 10.2967/jnumed.120.256453.
    PubMed    


  185. CHRISTENSEN TN, Langer SW, Persson GF, Larsen KR, et al
    (18)F-FLT-PET/CT adds value to (18)F-FDG-PET/CT for diagnosing relapse after definitive radiotherapy in patients with lung cancer. Results of a prospective clinical trial.
    J Nucl Med. 2020 Oct 9. pii: jnumed.120.247742. doi: 10.2967/jnumed.120.247742.
    PubMed     Abstract available


  186. LODGE MA, Lesniak W, Gorin MA, Pienta KJ, et al
    Measurement of PET Quantitative Bias In Vivo.
    J Nucl Med. 2020 Oct 9. pii: jnumed.120.251397. doi: 10.2967/jnumed.120.251397.
    PubMed     Abstract available


  187. PRIOR JO, Mirzaei S, Gnesin S, Nicod Lalonde M, et al
    Dose optimization in pediatric studies: Why this is important and can benefit every nuclear medicine department.
    J Nucl Med. 2020 Oct 9. pii: jnumed.120.254193. doi: 10.2967/jnumed.120.254193.
    PubMed    


  188. SPENCER BA, Berg E, Schmall JP, Omidvari N, et al
    Performance evaluation of the uEXPLORER Total-body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize long axial field-of-view PET scanners.
    J Nucl Med. 2020 Oct 2. pii: jnumed.120.250597. doi: 10.2967/jnumed.120.250597.
    PubMed     Abstract available


  189. CRANDALL JP, Fraum TJ, Lee M, Jiang L, et al
    Repeatability of (18)F-FDG PET Radiomic Features in Cervical Cancer.
    J Nucl Med. 2020 Oct 2. pii: jnumed.120.247999. doi: 10.2967/jnumed.120.247999.
    PubMed     Abstract available


  190. YAMADA S, Tsuyoshi H, Yamamoto M, Tsujikawa T, et al
    Prognostic value of 16alpha-[(18)F]-fluoro-17beta-estradiol positron emission tomography as a predictor of disease outcome in endometrial cancer: A prospective study.
    J Nucl Med. 2020 Oct 2. pii: jnumed.120.244319. doi: 10.2967/jnumed.120.244319.
    PubMed     Abstract available


  191. MARIANI G, Tonacchera M, Grosso M, Orsolini F, et al
    The role of nuclear medicine in the clinical management of benign thyroid disorders. Part 1. Hyperthyroidism.
    J Nucl Med. 2020 Oct 2. pii: jnumed.120.243170. doi: 10.2967/jnumed.120.243170.
    PubMed     Abstract available


  192. JACENE HA
    2020 SNMMI Highlights Lecture: General Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2020;61:17N-23N.
    PubMed    


  193. BARTHEL H
    First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease.
    J Nucl Med. 2020;61:1409-1410.
    PubMed    


  194. SKALI H, Murthy VL, Paez D, Choi EM, et al
    Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI.
    J Nucl Med. 2020;61:1534-1539.
    PubMed    


  195. KOYCHEV I, Hofer M, Friedman N
    Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
    J Nucl Med. 2020;61:1413-1418.
    PubMed     Abstract available


  196. MATTAY VS, Fotenos AF, Ganley CJ, Marzella L, et al
    Brain Tau Imaging: Food and Drug Administration Approval of (18)F-Flortaucipir Injection.
    J Nucl Med. 2020;61:1411-1412.
    PubMed    


  197. DARR C, Harke NN, Radtke JP, Yirga L, et al
    Intraoperative (68)Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study.
    J Nucl Med. 2020;61:1500-1506.
    PubMed     Abstract available


    September 2020
  198. ZUKOTYNSKI K, Gaudet V, Uribe CF, Mathotaarachchi S, et al
    Machine Learning in Nuclear Medicine: Part 2-Neural Networks and Clinical Aspects.
    J Nucl Med. 2020 Sep 25. pii: jnumed.119.231837. doi: 10.2967/jnumed.119.231837.
    PubMed     Abstract available


  199. BOYLE AJ, Tong J, Zoghbi S, Pike VW, et al
    Repurposing [(11)C]PS13 for PET imaging of cyclooxygenase-1 (COX-1) in ovarian cancer xenograft mouse models.
    J Nucl Med. 2020 Sep 25. pii: jnumed.120.249367. doi: 10.2967/jnumed.120.249367.
    PubMed     Abstract available


  200. BUCKNOR MD, Lichtensztajn DY, Lin TK, Borno HT, et al
    Disparities in PET imaging for prostate cancer at a tertiary academic medical center.
    J Nucl Med. 2020 Sep 25. pii: jnumed.120.251751. doi: 10.2967/jnumed.120.251751.
    PubMed     Abstract available


  201. FOSTER CC, Davis RA, Hausner SH, Sutcliffe JL, et al
    alphalphavbeta6 targeted molecular PET/CT imaging of lung post SARS-CoV-2 infection.
    J Nucl Med. 2020 Sep 18. pii: jnumed.120.255364. doi: 10.2967/jnumed.120.255364.
    PubMed     Abstract available


  202. DAS JP, Vargas HA, Ghafoor S, Goh AC, et al
    Clinical utility of (18)F-FDG PET/CT in staging and treatment planning of urachal adenocarcinoma.
    J Nucl Med. 2020 Sep 18. pii: jnumed.120.251561. doi: 10.2967/jnumed.120.251561.
    PubMed     Abstract available


  203. CHEN DL, Ballout S, Chen L, Cheriyan J, et al
    Consensus recommendations on the use of (18)F-FDG PET/CT in lung disease.
    J Nucl Med. 2020 Sep 18. pii: jnumed.120.244780. doi: 10.2967/jnumed.120.244780.
    PubMed     Abstract available


  204. FAROLFI A, Hirmas N, Gafita A, Weber M, et al
    PSMA-PET identifies PCWG3 target populations with superior accuracy and reproducibility when compared to conventional imaging: a multicenter retrospective study.
    J Nucl Med. 2020 Sep 11. pii: jnumed.120.246603. doi: 10.2967/jnumed.120.246603.
    PubMed     Abstract available


  205. STEPHENS DM, Li H, Schoder H, Friedberg J, et al
    Reply to: Interim PET assessment of advanced Hodgkin Lymphoma: is it sufficient?
    J Nucl Med. 2020 Sep 11. pii: jnumed.120.242685. doi: 10.2967/jnumed.120.242685.
    PubMed    


  206. JUNG KH, Park JW, Lee JH, Lee EJ, et al
    (89)Zr Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression.
    J Nucl Med. 2020 Sep 11. pii: jnumed.120.250720. doi: 10.2967/jnumed.120.250720.
    PubMed     Abstract available


  207. VALKEMA MJ, van der Wilk BJ, Eyck BM, Wijnhoven BPL, et al
    Surveillance of clinically complete responders using serial (18)F-FDG PET/CT scans in patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    J Nucl Med. 2020 Sep 4. pii: jnumed.120.247981. doi: 10.2967/jnumed.120.247981.
    PubMed     Abstract available


  208. HUANG Y, Zhao N, Wang YH, Truillet C, et al
    The synthesis and structural requirements for measuring glucocorticoid receptor expression in vivo with (+/-)-(11)C-YJH08 PET.
    J Nucl Med. 2020 Sep 4. pii: jnumed.120.249755. doi: 10.2967/jnumed.120.249755.
    PubMed     Abstract available


  209. GALLDIKS N, Abdulla DS, Scheffler M, Wolpert F, et al
    Treatment Monitoring of Immunotherapy and Targeted Therapy using (18)F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences.
    J Nucl Med. 2020 Sep 4. pii: jnumed.120.248278. doi: 10.2967/jnumed.120.248278.
    PubMed     Abstract available


  210. DORBALA S, Park MA, Cuddy S, Singh V, et al
    Absolute Quantitation of Cardiac (99m)Tc-pyrophophate Using Cadmium Zinc Telluride-based SPECT/CT.
    J Nucl Med. 2020 Sep 4. pii: jnumed.120.247312. doi: 10.2967/jnumed.120.247312.
    PubMed     Abstract available


  211. IRAVANI A, Hicks RJ
    Imaging the cancer immune environment and its response to pharmacological intervention- Part 2- The Role of Novel PET Agents.
    J Nucl Med. 2020 Sep 4. pii: jnumed.120.248823. doi: 10.2967/jnumed.120.248823.
    PubMed     Abstract available


  212. LI YR, Roach M 3rd
    The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging.
    J Nucl Med. 2020;61:1292-1293.
    PubMed    


  213. CASTELLO A, Lopci E
    Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using (18)F-FDG PET/CT.
    J Nucl Med. 2020;61:1405.
    PubMed    


  214. OSBORNE JR, Hope TA
    A Conversation Between Joseph Osborne and Thomas Hope.
    J Nucl Med. 2020;61:1275-1277.
    PubMed    


  215. HENRY KE, Chaney AM, Nagle VL, Cropper HC, et al
    Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide.
    J Nucl Med. 2020;61:1361-1368.
    PubMed     Abstract available


    August 2020
  216. POLI GL, Coca MA, Torres LA, Fahey FH, et al
    Developing and implementing an imaging optimization study in pediatric nuclear medicine: Experience and recommendations from an IAEA Coordinated Research Project.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.244616. doi: 10.2967/jnumed.120.244616.
    PubMed     Abstract available


  217. NAGANAWA M, Nabulsi NB, Henry S, Matuskey D, et al
    First in Human Assessment of the Novel M1 Muscarinic Acetylcholine Receptor PET Radiotracer (11)C-LSN3172176.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.246967. doi: 10.2967/jnumed.120.246967.
    PubMed     Abstract available


  218. RYDEN T, van Essen M, Marin I, Svensson J, et al
    Deep learning generation of synthetic intermediate projections improves (177)Lu SPECT images reconstructed with sparsely acquired projections.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.245548. doi: 10.2967/jnumed.120.245548.
    PubMed     Abstract available


  219. KESSLER L, Schlitter AM, Kroenke M, von Werder A, et al
    First experience using F-18-flubrobenguane PET imaging in patients with the suspicion of pheochromocytoma or paraganglioma.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.248021. doi: 10.2967/jnumed.120.248021.
    PubMed     Abstract available


  220. SANCHEZ-CATASUS CA, Bohnen NI, Yeh FC, D'Cruz N, et al
    Dopaminergic nigrostriatal connectivity in early Parkinson disease: in vivo neuroimaging study of (11)C-DTBZ PET combined with correlational tractography.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.248500. doi: 10.2967/jnumed.120.248500.
    PubMed     Abstract available


  221. WERNER RA, Derlin T, Rowe SP, Bundschuh L, et al
    High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.245464. doi: 10.2967/jnumed.120.245464.
    PubMed     Abstract available


  222. NAGANAWA M, Li S, Nabulsi NB, Henry S, et al
    First-in-human evaluation of (18)F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.249144. doi: 10.2967/jnumed.120.249144.
    PubMed     Abstract available


  223. FILSS CP, Stegmayr C, Lohmann P, Galldiks N, et al
    Reply to: Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.251819. doi: 10.2967/jnumed.120.251819.
    PubMed    


  224. MACASKILL MG, Stadulyte A, Williams L, Morgan TEF, et al
    Quantification of macrophage-driven inflammation during myocardial infarction with (18)F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.243600. doi: 10.2967/jnumed.120.243600.
    PubMed     Abstract available


  225. KUMAR M, Salem K, Jeffery JJ, Yan Y, et al
    Longitudinal molecular imaging of progesterone receptor reveals early differential response to endocrine therapy in breast cancer with an activating ESR1 mutation.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.249508. doi: 10.2967/jnumed.120.249508.
    PubMed     Abstract available


  226. NICOLAY NH, Ruhle A, Wiedenmann N, Niedermann G, et al
    Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer - Results from a Prospective Imaging Trial.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.248633. doi: 10.2967/jnumed.120.248633.
    PubMed     Abstract available


  227. SIITONEN R, Moisio OA, Lankinen P, Li XG, et al
    First-in-Human Study of (68)Ga-DOTA-Siglec-9, PET Ligand Targeting Vascular Adhesion Protein 1.
    J Nucl Med. 2020 Aug 17. pii: jnumed.120.250696. doi: 10.2967/jnumed.120.250696.
    PubMed     Abstract available


  228. SPRUTE K, Kramer V, Koerber S, Meneses M, et al
    Diagnostic accuracy of (18)F-PSMA-1007-PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence.
    J Nucl Med. 2020 Aug 17. pii: jnumed.120.246363. doi: 10.2967/jnumed.120.246363.
    PubMed     Abstract available


  229. VAN ES SC, Velleman T, Elias SG, Bensch F, et al
    Assessment of Bone Lesions with (18)F-FDG-PET Compared to (99m)Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
    J Nucl Med. 2020 Aug 17. pii: jnumed.120.244640. doi: 10.2967/jnumed.120.244640.
    PubMed     Abstract available


  230. BRAGINA O, von Witting E, Garousi J, Zelchan R, et al
    Phase I study of (99m)Tc-ADAPT6, a scaffold protein-based probe for visualization of HER2 expression in breast cancer.
    J Nucl Med. 2020 Aug 17. pii: jnumed.120.248799. doi: 10.2967/jnumed.120.248799.
    PubMed     Abstract available


  231. KOHLI P, Kelly VJ, Hibbert K, Corleis B, et al
    PET Imaging Reveals Early Pulmonary Perfusion Abnormalities in HIV Infection Similar to Smoking.
    J Nucl Med. 2020 Aug 6. pii: jnumed.120.245977. doi: 10.2967/jnumed.120.245977.
    PubMed     Abstract available


  232. REGINE K, Wittig T, Georgi TW, Kurch L, et al
    Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma - contribution to the development of response criteria for relapsed or progressive disease.
    J Nucl Med. 2020 Aug 6. pii: jnumed.120.247924. doi: 10.2967/jnumed.120.247924.
    PubMed     Abstract available


  233. FOSBOL MO, Kurbegovic S, Johannesen HH, Roder MA, et al
    Urokinase Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Non-invasive Evaluation of Aggressiveness: a Prospective Phase II Clinical Trial Comparing with Gleason Score.
    J Nucl Med. 2020 Aug 6. pii: jnumed.120.248120. doi: 10.2967/jnumed.120.248120.
    PubMed     Abstract available


  234. SCHINDLER TH, Bateman TM, Berman DS, Chareonthaitawee P, et al
    Appropriate Use Criteria for PET Myocardial Perfusion Imaging.
    J Nucl Med. 2020;61:1221-1265.
    PubMed    


  235. CZERNIN J
    The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year.
    J Nucl Med. 2020;61:1087.
    PubMed    


  236. BODEI L, Bergsland E, de Herder WW, Ferone D, et al
    Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
    J Nucl Med. 2020;61:1094-1095.
    PubMed    


  237. MARTIN KC, Czernin J
    A Conversation Between Kelsey Martin and Johannes Czernin.
    J Nucl Med. 2020;61:1091-1093.
    PubMed    


  238. ZINDEL C, Herrmann K
    A Conversation Between Christoph Zindel and Ken Herrmann.
    J Nucl Med. 2020;61:1088-1090.
    PubMed    


  239. MUELLER JJ, Dauer LT, Murali R, Iasonos A, et al
    Positron Lymphography via Intracervical (18)F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies.
    J Nucl Med. 2020;61:1123-1130.
    PubMed     Abstract available


  240. TRAN-GIA J, Salas-Ramirez M, Lassmann M
    What You See Is Not What You Get: On the Accuracy of Voxel-Based Dosimetry in Molecular Radiotherapy.
    J Nucl Med. 2020;61:1178-1186.
    PubMed     Abstract available


  241. CISTARO A, Quartuccio N, Piccardo A, Fania P, et al
    (18)F-FDG PET Identifies Altered Brain Metabolism in Patients with Cri du Chat Syndrome.
    J Nucl Med. 2020;61:1195-1199.
    PubMed     Abstract available


  242. POLLARD JH, Raman C, Zakharia Y, Tracy CR, et al
    Quantitative Test-Retest Measurement of (68)Ga-PSMA-HBED-CC in Tumor and Normal Tissue.
    J Nucl Med. 2020;61:1145-1152.
    PubMed     Abstract available


    July 2020
  243. CHODYLA M, Demircioglu A, Schaarschmidt BM, Bertram S, et al
    Evaluation of (18)F-FDG PET and DWI datasets for the prediction of therapy response of soft tissues sarcomas under neoadjuvant isolated limb perfusion.
    J Nucl Med. 2020 Jul 31. pii: jnumed.120.248260. doi: 10.2967/jnumed.120.248260.
    PubMed     Abstract available


  244. THERRIAULT J, Benedet A, Pascoal TA, Savard M, et al
    Determining Amyloid-beta positivity using [(18)F]AZD4694 PET imaging.
    J Nucl Med. 2020 Jul 31. pii: jnumed.120.245209. doi: 10.2967/jnumed.120.245209.
    PubMed     Abstract available


  245. GRIMALDI S, Lagarde S, Harle JR, Boucraut J, et al
    Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from (18)F-FDG PET imaging and neuronal autoantibodies.
    J Nucl Med. 2020 Jul 24. pii: jnumed.120.249292. doi: 10.2967/jnumed.120.249292.
    PubMed     Abstract available


  246. FREUDENBERG LS, Paez D, Giammarile F, Cerci JJ, et al
    Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020.
    J Nucl Med. 2020 Jul 24. pii: jnumed.120.249821. doi: 10.2967/jnumed.120.249821.
    PubMed     Abstract available


  247. LAURELL GL, Plaven-Sigray P, Jucaite A, Varrone A, et al
    Non-displaceable binding is a potential confounding factor in (11)CPBR28 TSPO PET studies.
    J Nucl Med. 2020 Jul 17. pii: jnumed.120.243717. doi: 10.2967/jnumed.120.243717.
    PubMed     Abstract available


  248. KULTERER OC, Pfaff S, Wadsak W, Garstka N, et al
    A microdosing study with (99m)Tc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients.
    J Nucl Med. 2020 Jul 17. pii: jnumed.120.245530. doi: 10.2967/jnumed.120.245530.
    PubMed     Abstract available


  249. ULANER GA, Jhaveri K, Chardarlapaty S, Hatzoglou V, et al
    Head-to-head evaluation of (18)F-FES and (18)F-FDG PET/CT in metastatic invasive lobular breast cancer.
    J Nucl Med. 2020 Jul 17. pii: jnumed.120.247882. doi: 10.2967/jnumed.120.247882.
    PubMed     Abstract available


  250. NABAVIZADEH SA, Nasrallah IM, Pryma DA
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.251116. doi: 10.2967/jnumed.120.251116.
    PubMed    


  251. CUTLER CS, Bailey EA, Kumar V, Schwarz SW, et al
    Global Issues of Radiopharmaceutical Access and Availability: a Nuclear Medicine Global Initiative Project.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.247197. doi: 10.2967/jnumed.120.247197.
    PubMed     Abstract available


  252. HARADA R, Hayakawa Y, Ezura M, Lerdsirisuk P, et al
    (18)F-SMBT-1: A Selective and Reversible Positron-Emission Tomography Tracer for Monoamine Oxidase-B Imaging.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.244400. doi: 10.2967/jnumed.120.244400.
    PubMed     Abstract available


  253. TATEKAWA H, Hagiwara A, Yao J, Oughourlian TC, et al
    Voxel-Wise and Patient-Wise Correlation of (18)F-FDOPA PET, rCBV, and ADC in Treatment-Naive Diffuse Gliomas with Different Molecular Subtypes.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.247411. doi: 10.2967/jnumed.120.247411.
    PubMed     Abstract available


  254. NAGANAWA M, Gallezot JD, Finnema S, Matuskey D, et al
    Simplified Quantification of (11)C-UCB-J PET Evaluated in a Large Human Cohort.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.243949. doi: 10.2967/jnumed.120.243949.
    PubMed     Abstract available


  255. RUSSELL J, Grkovski M, O'Donoghue IJ, Kalidindi TM, et al
    Predicting gemcitabine delivery by (18)F-FAC PET in murine models of pancreatic cancer.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.246926. doi: 10.2967/jnumed.120.246926.
    PubMed     Abstract available


  256. SPANGLER-BICKELL MG, Deller TW, Bettinardi V, Jansen F, et al
    Ultra-Fast List-Mode Reconstruction of Short PET Frames and Example Applications.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.245597. doi: 10.2967/jnumed.120.245597.
    PubMed     Abstract available


  257. JAIN P, Chaney A, Carlson ML, Jackson IM, et al
    Neuroinflammation PET imaging: Current opinion and future directions.
    J Nucl Med. 2020 Jul 3. pii: jnumed.119.229443. doi: 10.2967/jnumed.119.229443.
    PubMed     Abstract available


  258. HAMMES J, Bischof GN, Bohn KP, Onur O, et al
    One stop shop: Flortaucipir PET differentiates amyloid positive and negative forms of neurodegenerative diseases.
    J Nucl Med. 2020 Jul 3. pii: jnumed.120.244061. doi: 10.2967/jnumed.120.244061.
    PubMed     Abstract available


  259. BINI J, Carson RE, Cline GW
    Reply to LTE: (11)C-(+)-PHNO Trapping Reversibility for Quantitative PET Imaging of Beta-Cell-Mass in Patients with Type-1 Diabetes.
    J Nucl Med. 2020 Jul 3. pii: jnumed.120.250985. doi: 10.2967/jnumed.120.250985.
    PubMed    


  260. VAN DEN WYNGAERT T, Elvas F, De Schepper S, Kennedy JA, et al
    SPECT/CT - standing on the shoulders of giants, it is time to reach for the sky!
    J Nucl Med. 2020 Jul 3. pii: jnumed.119.236943. doi: 10.2967/jnumed.119.236943.
    PubMed     Abstract available


  261. ZUBAL IG
    Time for a Next-Generation Nuclear Medicine Gamma Camera?
    J Nucl Med. 2020;61:16N.
    PubMed    


  262. MURTHY VL, Bateman TM, Chen W, Malhotra S, et al
    Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging.
    J Nucl Med. 2020;61:962-964.
    PubMed    


  263. BODINI B, Poirion E, Tonietto M, Benoit C, et al
    Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
    J Nucl Med. 2020;61:1043-1049.
    PubMed     Abstract available


  264. KLINGLER S, Fay R, Holland JP
    Light-Induced Radiosynthesis of (89)Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor.
    J Nucl Med. 2020;61:1072-1078.
    PubMed     Abstract available


  265. KNIGHT JC, Torres JB, Goldin R, Mosley M, et al
    Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling.
    J Nucl Med. 2020;61:1006-1013.
    PubMed     Abstract available


  266. QUELVEN I, Monteil J, Sage M, Saidi A, et al
    (212)Pb alpha-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study.
    J Nucl Med. 2020;61:1058-1065.
    PubMed     Abstract available


  267. YU Q, Huang S, Wu Z, Zheng J, et al
    Label-Free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-Guided Surgery by Photoacoustic Imaging.
    J Nucl Med. 2020;61:1079-1085.
    PubMed     Abstract available


    June 2020
  268. GIESEL F, Adeberg S, Syed M, Lindner T, et al
    FAPI-74 PET/CT Using Either (18)F-AlF or Cold-kit (68)Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients.
    J Nucl Med. 2020 Jun 26. pii: jnumed.120.245084. doi: 10.2967/jnumed.120.245084.
    PubMed     Abstract available


  269. PETERSON LM, Kurland BF, Yan F, Novakova-Jiresova A, et al
    (18)F-Fluoroestradiol ((18)F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
    J Nucl Med. 2020 Jun 26. pii: jnumed.120.244459. doi: 10.2967/jnumed.120.244459.
    PubMed     Abstract available


  270. VAN ROEKEL C, Bastiaannet R, Smits MLJ, Bruijnen RC, et al
    Dose-effect relationships of holmium-166 radioembolization in colorectal cancer.
    J Nucl Med. 2020 Jun 26. pii: jnumed.120.243832. doi: 10.2967/jnumed.120.243832.
    PubMed     Abstract available


  271. NOTO RB
    Diversity, not Divisiveness, is the Future of Nuclear Medicine.
    J Nucl Med. 2020 Jun 23. pii: jnumed.120.250035. doi: 10.2967/jnumed.120.250035.
    PubMed    


  272. CZERNIN J
    Reply to: Diversity, not Divisiveness, is the Future of Nuclear Medicine.
    J Nucl Med. 2020 Jun 23. pii: jnumed.120.250415. doi: 10.2967/jnumed.120.250415.
    PubMed    


  273. SHAFFER T, Gambhir SS, Aalipour A, Schurch C, et al
    PET imaging of the natural killer cell activation receptor NKp30.
    J Nucl Med. 2020 Jun 12. pii: jnumed.119.233163. doi: 10.2967/jnumed.119.233163.
    PubMed     Abstract available


  274. FERDINANDUS J, Barbato F, Chodyla M, Fendler WP, et al
    Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.
    J Nucl Med. 2020 Jun 12. pii: jnumed.120.245803. doi: 10.2967/jnumed.120.245803.
    PubMed     Abstract available


  275. SHARMA R, Inglese M, Dubash S, Lu H, et al
    Monitoring response to transarterial chemoembolization in hepatocellular carcinoma using (18)F-Fluorothymidine Positron Emission Tomography.
    J Nucl Med. 2020 Jun 8. pii: jnumed.119.240598. doi: 10.2967/jnumed.119.240598.
    PubMed     Abstract available


  276. LUO Y, Pan Q, Yang H, Peng L, et al
    Fibroblast activation protein targeted PET/CT with (68)Ga-FAPI for imaging IgG4-related disease: comparison to (18)F-FDG PET/CT.
    J Nucl Med. 2020 Jun 8. pii: jnumed.120.244723. doi: 10.2967/jnumed.120.244723.
    PubMed     Abstract available


  277. KESNER AL
    Data-driven motion correction in clinical PET - a joint accomplishment of creative academia and industry.
    J Nucl Med. 2020 Jun 8. pii: jnumed.120.248187. doi: 10.2967/jnumed.120.248187.
    PubMed    


  278. SCHMALL JP, Surti S, Otero H, Servaes S, et al
    Investigating low-dose image quality in whole-body pediatric (18)F-FDG scans using TOF-PET/MRI.
    J Nucl Med. 2020 Jun 1. pii: jnumed.119.240127. doi: 10.2967/jnumed.119.240127.
    PubMed     Abstract available



  279. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI.
    J Nucl Med. 2020;61:784-791.
    PubMed    


  280. COOK GJR, Goh V
    Molecular Imaging of Bone Metastases and Their Response to Therapy.
    J Nucl Med. 2020;61:799-806.
    PubMed     Abstract available


    May 2020
  281. PRATT EC, Isaac E, Stater E, Yang G, et al
    Synthesis of novel PET tracer (124)I-trametinib for MAPK/ERK kinase distribution and resistance monitoring.
    J Nucl Med. 2020 May 22. pii: jnumed.120.241901. doi: 10.2967/jnumed.120.241901.
    PubMed     Abstract available


  282. WEBER M, Kurek CE, Barbato F, Eiber M, et al
    PSMA-ligand PET for early castration-resistant prostate cancer: a retrospective single-center study.
    J Nucl Med. 2020 May 22. pii: jnumed.120.245456. doi: 10.2967/jnumed.120.245456.
    PubMed     Abstract available


  283. IRAVANI A, Hicks RJ
    Imaging the cancer immune environment and its response to pharmacological intervention- Part 1- The role of FDG PET/CT.
    J Nucl Med. 2020 May 22. pii: jnumed.119.234278. doi: 10.2967/jnumed.119.234278.
    PubMed     Abstract available


  284. KLINGENBERG S, Jochumsen MR, Ulhoi BP, Fredsoe J, et al
    (68)Ga-PSMA PET/CT for primary NM staging of high-risk prostate cancer.
    J Nucl Med. 2020 May 22. pii: jnumed.120.245605. doi: 10.2967/jnumed.120.245605.
    PubMed     Abstract available


  285. HEO GS, Bajpai G, Li W, Luehmann HP, et al
    Targeted PET Imaging of Chemokine Receptor 2+ Monocytes and Macrophages in the Injured Heart.
    J Nucl Med. 2020 May 22. pii: jnumed.120.244673. doi: 10.2967/jnumed.120.244673.
    PubMed     Abstract available


  286. LOFT M, Carlsen EA, Johnbeck CB, Johannesen HH, et al
    (64)Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.
    J Nucl Med. 2020 May 22. pii: jnumed.120.244509. doi: 10.2967/jnumed.120.244509.
    PubMed     Abstract available


  287. DITTMANN H, Kaltenbach S, Weissinger M, Fiz F, et al
    The prognostic value of quantitative bone scan SPECT/CT prior to (223)Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
    J Nucl Med. 2020 May 22. pii: jnumed.119.240408. doi: 10.2967/jnumed.119.240408.
    PubMed     Abstract available


  288. BAGUNA TORRES J, Mosley M, Koustoulidou S, Hopkins S, et al
    Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.
    J Nucl Med. 2020 May 15. pii: jnumed.120.243113. doi: 10.2967/jnumed.120.243113.
    PubMed     Abstract available


  289. ABOIAN M, Huang SY, Pampaloni MH, Hawkins RA, et al
    (124)I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
    J Nucl Med. 2020 May 15. pii: jnumed.120.243139. doi: 10.2967/jnumed.120.243139.
    PubMed     Abstract available


  290. BARTHEL H, Seibyl J, Lammertsma AA, Villemagne VL, et al
    Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing.
    J Nucl Med. 2020 May 15. pii: jnumed.119.228346. doi: 10.2967/jnumed.119.228346.
    PubMed    


  291. SHI Z, Fu LP, Zhang N, Zhao X, et al
    Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study.
    J Nucl Med. 2020 May 8. pii: jnumed.119.240325. doi: 10.2967/jnumed.119.240325.
    PubMed     Abstract available


  292. REKOWSKI J, Huttmann A, Schmitz C, Muller SP, et al
    Interim PET evaluation in diffuse large B-cell lymphoma employing published recommendations: Comparison of the Deauville 5-point scale and the DeltaSUVmax method.
    J Nucl Med. 2020 May 8. pii: jnumed.120.244145. doi: 10.2967/jnumed.120.244145.
    PubMed     Abstract available


  293. ZUBAL IG
    Time for a Next-Generation Nuclear Medicine Gamma Camera? [NEWSLINE].
    J Nucl Med. 2020 May 8. pii: jnumed.120.249219. doi: 10.2967/jnumed.120.249219.
    PubMed    


  294. HARSINI S, Saprunoff H, Alden TM, Mohammadi B, et al
    The effects of monosodium glutamate on PSMA radiotracer uptake in men with recurrent prostate cancer: a prospective, randomized, double-blind, placebo-controlled intra-individual imaging study.
    J Nucl Med. 2020 May 8. pii: jnumed.120.246983. doi: 10.2967/jnumed.120.246983.
    PubMed     Abstract available


  295. GORDON L
    ABNM: Helping Diplomates and Trainees During the COVID-19 Pandemic.
    J Nucl Med. 2020;61:13N.
    PubMed    


  296. CZERNIN J
    The Standard of Care: From Nuclear Radiology to Nuclear Medicine.
    J Nucl Med. 2020;61:637.
    PubMed    


  297. FENDLER WP, Ferdinandus J, Czernin J, Eiber M, et al
    Impact of (68)Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
    J Nucl Med. 2020 May 1. pii: jnumed.120.242180. doi: 10.2967/jnumed.120.242180.
    PubMed     Abstract available


  298. STUTVOET TS, van der Veen EL, Kol A, Antunes IF, et al
    Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer (18)F-BMS-986192.
    J Nucl Med. 2020 May 1. pii: jnumed.119.241364. doi: 10.2967/jnumed.119.241364.
    PubMed     Abstract available


  299. RIPP I, Stadhouders T, Savio A, Goldhardt O, et al
    Integrity of neurocognitive networks in dementing disorders as measured with simultaneous PET/fMRI.
    J Nucl Med. 2020 May 1. pii: jnumed.119.234930. doi: 10.2967/jnumed.119.234930.
    PubMed     Abstract available


  300. LOPEZ MORA DA, Flotats A, Fuentes-Ocampo F, Carrio I, et al
    Reported differences between Digital and Analog PET/CT studies.
    J Nucl Med. 2020 May 1. pii: jnumed.120.244608. doi: 10.2967/jnumed.120.244608.
    PubMed    


  301. RULLMANN M, McLeod A, Grothe M, Sabri O, et al
    Reshaping the amyloid buildup curve in Alzheimer's disease? - Partial volume effect correction of longitudinal amyloid PET data.
    J Nucl Med. 2020 May 1. pii: jnumed.119.238477. doi: 10.2967/jnumed.119.238477.
    PubMed     Abstract available


  302. CUDA TJ, Riddell AD, Liu C, Whitehall VL, et al
    PET imaging quantifying (68)Ga-PSMA-11 uptake in metastatic colorectal cancer.
    J Nucl Med. 2020 May 1. pii: jnumed.119.233312. doi: 10.2967/jnumed.119.233312.
    PubMed     Abstract available


  303. CZERNIN J, Fanti S, Meyer PT, Allen-Auerbach M, et al
    Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences.
    J Nucl Med. 2020;61:626-629.
    PubMed    


  304. CARRIO I, Herrmann K
    A Conversation Between Ignasi Carrio and Ken Herrmann.
    J Nucl Med. 2020;61:638-640.
    PubMed    


  305. O'NEILL E, Kersemans V, Allen PD, Terry SYA, et al
    Imaging DNA Damage Repair In Vivo After (177)Lu-DOTATATE Therapy.
    J Nucl Med. 2020;61:743-750.
    PubMed     Abstract available


  306. KRATOCHWIL C, Giesel FL, Heussel CP, Kazdal D, et al
    Patients Resistant Against PSMA-Targeting alpha-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes.
    J Nucl Med. 2020;61:683-688.
    PubMed     Abstract available


  307. ABBOTT EM, Falzone N, Lee BQ, Kartsonaki C, et al
    The Impact of Radiobiologically-Informed Dose Prescription on the Clinical Benefit of Yttrium-90 SIRT in Colorectal Cancer Patients.
    J Nucl Med. 2020 May 1. pii: jnumed.119.233650. doi: 10.2967/jnumed.119.233650.
    PubMed     Abstract available


    April 2020
  308. SEIFERT R, Herrmann K, Kleesiek J, Schafers MA, et al
    Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancer.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.242057. doi: 10.2967/jnumed.120.242057.
    PubMed     Abstract available


  309. HERHAUS P, Lipkova J, Lammer F, Yakushev I, et al
    CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.241703. doi: 10.2967/jnumed.120.241703.
    PubMed     Abstract available


  310. CHIU LW, Lawhn-Heath C, Behr S, Juarez R, et al
    Factors predicting metastatic disease in (68)Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
    J Nucl Med. 2020 Apr 17. pii: jnumed.119.241174. doi: 10.2967/jnumed.119.241174.
    PubMed     Abstract available


  311. JUENGLING FD, Maldonado A, Wuest F, Schindler TH, et al
    The role of Nuclear Medicine for COVID-19 - Time to act now.
    J Nucl Med. 2020 Apr 17. pii: jnumed.120.246611. doi: 10.2967/jnumed.120.246611.
    PubMed    


  312. WERNER RA, Thackeray JT, Diekmann J, Weiberg D, et al
    The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care towards Molecular Medicine.
    J Nucl Med. 2020 Apr 17. pii: jnumed.119.240440. doi: 10.2967/jnumed.119.240440.
    PubMed     Abstract available


  313. REYNOLDS JC, Maass-Moreno R, Thomas A, Ling A, et al
    FDG-PET assessment of malignant pleural mesothelioma: Total Lesion volume and Total Lesion Glycolysis; the central role of volume.
    J Nucl Med. 2020 Apr 13. pii: jnumed.119.238733. doi: 10.2967/jnumed.119.238733.
    PubMed     Abstract available


  314. JAHANDIDEH A, Uotila S, Stahle M, Virta J, et al
    Folate Receptor beta Targeted PET Imaging of Macrophages in Autoimmune Myocarditis.
    J Nucl Med. 2020 Apr 13. pii: jnumed.119.241356. doi: 10.2967/jnumed.119.241356.
    PubMed     Abstract available


  315. WEIDNER LD, Wakabayashi Y, Stolz LA, Collins MT, et al
    PET imaging of phosphodiesterase-4 identifies affected dysplastic bone in McCune-Albright syndrome, a genetic mosaic disorder.
    J Nucl Med. 2020 Apr 13. pii: jnumed.120.241976. doi: 10.2967/jnumed.120.241976.
    PubMed     Abstract available


  316. WALKER MD, Morgan AJ, Bradley KM, McGowan DR, et al
    Data Driven Respiratory Gating Outperforms Device-Based Gating for Clinical FDG PET/CT.
    J Nucl Med. 2020 Apr 3. pii: jnumed.120.242248. doi: 10.2967/jnumed.120.242248.
    PubMed     Abstract available


  317. HOFMAN MS
    ProPSMA: a callout to the nuclear medicine community to change practice with prospective, high-quality data.
    J Nucl Med. 2020 Apr 3. pii: jnumed.120.245647. doi: 10.2967/jnumed.120.245647.
    PubMed    


  318. ALBANO D, Bertagna F, Bertolia M, Bosio G, et al
    INCIDENTAL FINDINGS SUGGESTIVE OF COVID-19 IN ASYMPTOMATIC PATIENTS UNDERGOING NUCLEAR MEDICINE PROCEDURES IN A HIGH PREVALENCE REGION.
    J Nucl Med. 2020 Apr 1. pii: jnumed.120.246256. doi: 10.2967/jnumed.120.246256.
    PubMed     Abstract available


  319. ZUCKIER LS, Moadel RM, Haramati LB, Freeman L, et al
    Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic.
    J Nucl Med. 2020 Apr 1. pii: jnumed.120.245571. doi: 10.2967/jnumed.120.245571.
    PubMed    


  320. SABOUR S
    Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation: Mistakes in Diagnostic Value and Prognosis.
    J Nucl Med. 2020;61:622.
    PubMed    


  321. SUNDERLAND JJ, Czernin J, Hope T
    A Conversation with John Sunderland, Johannes Czernin, and Thomas Hope.
    J Nucl Med. 2020;61:477-479.
    PubMed    


  322. MAYERHOEFER ME, Materka A, Langs G, Haggstrom I, et al
    Introduction to Radiomics.
    J Nucl Med. 2020;61:488-495.
    PubMed     Abstract available


  323. SUNDERLAND JJ
    The Academic NDA: Justification, Process, and Lessons Learned.
    J Nucl Med. 2020;61:480-487.
    PubMed     Abstract available


  324. GLASENAPP A, Derlin K, Wang Y, Bankstahl M, et al
    Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure.
    J Nucl Med. 2020;61:590-596.
    PubMed     Abstract available


  325. BASTIAANNET R, van Roekel C, Smits MLJ, Elias SG, et al
    First Evidence for a Dose-Response Relationship in Patients Treated with (166)Ho Radioembolization: A Prospective Study.
    J Nucl Med. 2020;61:608-612.
    PubMed     Abstract available


  326. PANDIT-TASKAR N, Postow MA, Hellmann MD, Harding JJ, et al
    First-in-Humans Imaging with (89)Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting.
    J Nucl Med. 2020;61:512-519.
    PubMed     Abstract available


  327. WATABE T, Liu Y, Kaneda-Nakashima K, Shirakami Y, et al
    Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: (64)Cu- and (225)Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.
    J Nucl Med. 2020;61:563-569.
    PubMed     Abstract available


  328. VAN WEEHAEGHE D, Van Schoor E, De Vocht J, Koole M, et al
    TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study.
    J Nucl Med. 2020;61:604-607.
    PubMed     Abstract available


    March 2020
  329. RUIZ-BEDOYA CA, Ordonez AA, Werner RA, Plyku D, et al
    (11)C-PABA as a Novel PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Studies.
    J Nucl Med. 2020 Mar 20. pii: jnumed.119.239806. doi: 10.2967/jnumed.119.239806.
    PubMed     Abstract available


  330. SURTI S, Viswanath V, Daube-Witherspoom ME, Conti M, et al
    Benefit of improved performance with state-of-the art digital PET/CT for lesion detection in oncology.
    J Nucl Med. 2020 Mar 20. pii: jnumed.120.242305. doi: 10.2967/jnumed.120.242305.
    PubMed     Abstract available


  331. ORTEGA C, Schaefferkoetter J, Veit-Haibach P, Anconina R, et al
    (18)F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
    J Nucl Med. 2020 Mar 20. pii: jnumed.120.241737. doi: 10.2967/jnumed.120.241737.
    PubMed     Abstract available


  332. MALTAIS DD, Jordan LG 3rd, Min HK, Miyawaga T, et al
    Confirmation of (123)I-FP-CIT-SPECT (ioflupane) quantification methods in dementia with Lewy body and other neurodegenerative disorders.
    J Nucl Med. 2020 Mar 20. pii: jnumed.119.239418. doi: 10.2967/jnumed.119.239418.
    PubMed     Abstract available


  333. WANG L, Wang M, Yang T, Wu D, et al
    A Prospective, Comparative Study of Planar and Single-photon Emission Computed Tomography Ventilation/Perfusion Imaging for Chronic Thromboembolic Pulmonary Hypertension.
    J Nucl Med. 2020 Mar 20. pii: jnumed.120.243188. doi: 10.2967/jnumed.120.243188.
    PubMed     Abstract available


  334. ROUSSEAU C, Goldenberg DM, Colombie M, Sebille JC, et al
    Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.236000. doi: 10.2967/jnumed.119.236000.
    PubMed     Abstract available


  335. VAN WEEHAEGHE D, Babu S, De Vocht J, Zurcher NR, et al
    Moving towards multicenter therapeutic trials in ALS: feasibility of data pooling using different TSPO positron emission tomography (PET) radioligands.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.241059. doi: 10.2967/jnumed.119.241059.
    PubMed     Abstract available


  336. NAGANAWA M, Li S, Nabulsi NB, Lin SF, et al
    Kinetic modeling and test-retest reproducibility of (11)C-EKAP and (11)C-FEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.227694. doi: 10.2967/jnumed.119.227694.
    PubMed     Abstract available


  337. ZHANG J, Liu Q, Singh A, Schuchardt C, et al
    Prognostic Value of (18)F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.241414. doi: 10.2967/jnumed.119.241414.
    PubMed     Abstract available


  338. KREBS S, Veach DR, Carter LM, Grkovski M, et al
    First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.234864. doi: 10.2967/jnumed.119.234864.
    PubMed     Abstract available


  339. CHAUVIN M, Borys D, Botta F, Bzowski P, et al
    OpenDose: open access resources for nuclear medicine dosimetry.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.240366. doi: 10.2967/jnumed.119.240366.
    PubMed     Abstract available


  340. LINDNER T, Altmann A, Kraemer S, Kleist C, et al
    Design and development of (99m)Tc labeled FAPI-tracers for SPECT-imaging and 188Re therapy.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.239731. doi: 10.2967/jnumed.119.239731.
    PubMed     Abstract available


  341. DE JONG AC, Smits M, van Riet J, Futterer JJ, et al
    (68)Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
    J Nucl Med. 2020 Mar 13. pii: jnumed.119.241109. doi: 10.2967/jnumed.119.241109.
    PubMed     Abstract available


  342. DILSIZIAN V
    SNMMI Leadership Update: The Nuclear Medicine Community: From 1970s Cookbook to 2020 Global Influence.
    J Nucl Med. 2020;61:19N-20N.
    PubMed    


  343. MIRZAEI S, Hustinx R, Prior JO, Ozcan Z, et al
    Improving Nuclear Medicine Practice with UEMS/EBNM Committees.
    J Nucl Med. 2020;61:18N-20N.
    PubMed    


  344. DONOHOE KJ, Aloff J, Avram AM, Bennet KG, et al
    Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer.
    J Nucl Med. 2020;61:375-396.
    PubMed    


  345. COLLINGRIDGE D, Barthel H
    A Conversation Between David Collingridge and Henryk Barthel.
    J Nucl Med. 2020;61:307-310.
    PubMed    


  346. ZHANG W, Fan W, Ottemann BM, Alshehri S, et al
    Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic Constructs.
    J Nucl Med. 2020;61:443-450.
    PubMed     Abstract available


  347. FLOBERG JM, Wang L, Bandara N, Rashmi R, et al
    Alteration of Cellular Reduction Potential Will Change (64)Cu-ATSM Signal With or Without Hypoxia.
    J Nucl Med. 2020;61:427-432.
    PubMed     Abstract available


  348. WU J, Gensheimer MF, Zhang N, Guo M, et al
    Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer.
    J Nucl Med. 2020;61:327-336.
    PubMed     Abstract available


    February 2020
  349. VAN DER VEEN EL, Suurs FV, Cleeren F, Bormans G, et al
    Development and evaluation of interleukin-2 derived radiotracers for PET imaging of T-cells in mice.
    J Nucl Med. 2020 Feb 28. pii: jnumed.119.238782. doi: 10.2967/jnumed.119.238782.
    PubMed     Abstract available


  350. KENNEDY JA, Lugassi R, Gill R, Keidar Z, et al
    Digital Solid-State SPECT/CT Quantitation of Absolute (177)Lu-Radiotracer Concentration: In Vivo/In Vitro Validation.
    J Nucl Med. 2020 Feb 28. pii: jnumed.119.239277. doi: 10.2967/jnumed.119.239277.
    PubMed     Abstract available


  351. CARLSEN EA, Johnbeck CB, Binderup T, Loft M, et al
    (64)Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms.
    J Nucl Med. 2020 Feb 28. pii: jnumed.119.240143. doi: 10.2967/jnumed.119.240143.
    PubMed     Abstract available


  352. LABELLA A, Cao X, Petersen E, Lubinsky R, et al
    High Resolution Depth-Encoding PET Detector Module with Prismatoid Light Guide Array.
    J Nucl Med. 2020 Feb 28. pii: jnumed.119.239343. doi: 10.2967/jnumed.119.239343.
    PubMed     Abstract available


  353. SEBAN RD, Schwartz LH, Bonardel G, Dercle L, et al
    Diagnosis of Hyper-progressive Disease in Patients Treated with Checkpoint Inhibitors using (18)F-FDG PET/CT.
    J Nucl Med. 2020 Feb 21. pii: jnumed.120.242768. doi: 10.2967/jnumed.120.242768.
    PubMed    


  354. FENG X, Wang Y, Lu D, Xu X, et al
    Clinical Translation of a (68)Ga-labeled Integrin alphavbeta6-targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer.
    J Nucl Med. 2020 Feb 21. pii: jnumed.119.237347. doi: 10.2967/jnumed.119.237347.
    PubMed     Abstract available


  355. NIEMEIJER AL, Hoekstra O, Smit E, De Langen A, et al
    Imaging responses to immunotherapy with novel PET tracers.
    J Nucl Med. 2020 Feb 21. pii: jnumed.119.236158. doi: 10.2967/jnumed.119.236158.
    PubMed    


  356. MESGUICH C, Bouabdallah K, Bordenave L, Milpied N, et al
    Interim PET assessment of advanced Hodgkin Lymphoma: is it sufficient?
    J Nucl Med. 2020 Feb 14. pii: jnumed.120.242594. doi: 10.2967/jnumed.120.242594.
    PubMed    


  357. BUTHER F, Jones J, Seifert R, Stegger L, et al
    Clinical evaluation of a data-driven respiratory gating algorithm for whole-body positron emission tomography with continuous bed motion.
    J Nucl Med. 2020 Feb 14. pii: jnumed.119.235770. doi: 10.2967/jnumed.119.235770.
    PubMed     Abstract available


  358. KOOPMAN D, van Dalen JA, Stevens H, Slump CH, et al
    Performance of digital PET compared to high-resolution conventional PET in patients with cancer.
    J Nucl Med. 2020 Feb 14. pii: jnumed.119.238105. doi: 10.2967/jnumed.119.238105.
    PubMed     Abstract available


  359. KOERBER SA, Staudinger F, Kratochwil C, Adeberg S, et al
    The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract - first clinical experience.
    J Nucl Med. 2020 Feb 14. pii: jnumed.119.237016. doi: 10.2967/jnumed.119.237016.
    PubMed     Abstract available


  360. BEHESHTI M, Manafi-Farid R, Geinitz H, Vali R, et al
    Multi-phasic (68)Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.
    J Nucl Med. 2020 Feb 14. pii: jnumed.119.238071. doi: 10.2967/jnumed.119.238071.
    PubMed     Abstract available


  361. HUISMAN M, Niemeijer AL, Windhorst B, Schuit R, et al
    Quantification of PD-L1 expression with [(18)F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
    J Nucl Med. 2020 Feb 14. pii: jnumed.119.240895. doi: 10.2967/jnumed.119.240895.
    PubMed     Abstract available


  362. LIU C, Liu T, Zhang Z, Zhang N, et al
    PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies.
    J Nucl Med. 2020 Feb 7. pii: jnumed.119.235333. doi: 10.2967/jnumed.119.235333.
    PubMed     Abstract available


  363. LERAY H, Gabiache E, Courbon F, Brenot-Rossi I, et al
    FDG-PET/CT identifies predictors of survival in patients with locally advanced cervical carcinoma and para-aortic lymph node involvement to increase treatment.
    J Nucl Med. 2020 Feb 7. pii: jnumed.119.238824. doi: 10.2967/jnumed.119.238824.
    PubMed     Abstract available


  364. HOPE TA, Bodei L, Chan JA, El-Haddad G, et al
    NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of (177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
    J Nucl Med. 2020;61:222-227.
    PubMed    


  365. CALAIS J
    FAP: The Next Billion Dollar Nuclear Theranostics Target?
    J Nucl Med. 2020;61:163-165.
    PubMed    


  366. ANDERSEN TL, Baun C, Olsen BB, Dam JH, et al
    Improving Contrast and Detectability: Imaging with [(55)Co]Co-DOTATATE in Comparison with [(64)Cu]Cu-DOTATATE and [(68)Ga]Ga-DOTATATE.
    J Nucl Med. 2020;61:228-233.
    PubMed     Abstract available


  367. CECCARINI J, Leurquin-Sterk G, Crunelle CL, de Laat B, et al
    Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients.
    J Nucl Med. 2020;61:256-262.
    PubMed     Abstract available


  368. HENSBERGEN AW, Buckle T, van Willigen DM, Schottelius M, et al
    Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction.
    J Nucl Med. 2020;61:234-241.
    PubMed     Abstract available


  369. MILLER RJH, Manabe O, Tamarappoo B, Hayes S, et al
    Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation.
    J Nucl Med. 2020;61:249-255.
    PubMed     Abstract available


  370. MINARIK D, Enqvist O, Tragardh E
    Denoising of Scintillation Camera Images Using a Deep Convolutional Neural Network: A Monte Carlo Simulation Approach.
    J Nucl Med. 2020;61:298-303.
    PubMed     Abstract available


  371. ZHANG X, Xie Z, Berg E, Judenhofer MS, et al
    Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER.
    J Nucl Med. 2020;61:285-291.
    PubMed     Abstract available


  372. KLINGENSMITH WC 3RD, Osborne JR
    George de Hevesy in America.
    J Nucl Med. 2020;61:304-305.
    PubMed    


  373. ILAN E, Velikyan I, Sandstrom M, Sundin A, et al
    Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using (68)Ga-DOTATOC and (68)Ga-DOTATATE.
    J Nucl Med. 2020;61:217-221.
    PubMed     Abstract available


    January 2020
  374. PEREIRA PMR, Roberts S, Figueira F, Tome JPC, et al
    PET/CT imaging with a (18)F-labeled galactodendritic unit in a galectin-1 overexpressing orthotopic bladder cancer model.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.236430. doi: 10.2967/jnumed.119.236430.
    PubMed     Abstract available


  375. MONTES DE JESUS F, Glaudemans AWJM, Tissing W, Dierckx RA, et al
    (18)F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.239624. doi: 10.2967/jnumed.119.239624.
    PubMed     Abstract available


  376. HILLMER AT, Matuskey D, Huang H, Nabulsi NB, et al
    Tobacco smoking in people is not associated with altered 18 kDa-translocator protein levels: A Positron Emission Tomography study.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.237735. doi: 10.2967/jnumed.119.237735.
    PubMed     Abstract available


  377. FILSS CP, Schmitz AK, Stoffels G, Stegmayr C, et al
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.238568. doi: 10.2967/jnumed.119.238568.
    PubMed     Abstract available


  378. LU Y, Naganawa M, Toyonaga T, Gallezot JD, et al
    Data-driven motion detection and event-by-event correction for brain PET: Comparison with Vicra.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.235515. doi: 10.2967/jnumed.119.235515.
    PubMed     Abstract available


  379. HAMILL J, Meier JG, Betancourt Cuellar SL, Sabloff B, et al
    Improved Alignment of PET and CT Images in Whole-Body PET/CT in Cases of Respiratory Motion During CT.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.235804. doi: 10.2967/jnumed.119.235804.
    PubMed     Abstract available


  380. JANSEN BHE, Cysouw MCF, Vis AN, van Moorselaar RJA, et al
    Repeatability of Quantitative (18)F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.236075. doi: 10.2967/jnumed.119.236075.
    PubMed     Abstract available


  381. CAI L, Liow JS, Morse CL, Telu S, et al
    Evaluation of (11)C-NR2B-SMe and its Enantiomers as PET Radioligands for Imaging the NR2B Subunit within the NMDA Receptor Complex in Rats.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.235143. doi: 10.2967/jnumed.119.235143.
    PubMed     Abstract available


  382. SOLNES L, Werner R, Jones KM, Sadaghiani MS, et al
    Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine.
    J Nucl Med. 2020 Jan 10. pii: jnumed.118.220665. doi: 10.2967/jnumed.118.220665.
    PubMed     Abstract available


  383. DELPASSAND ES, Ranganathan D, Wagh N, Shafie A, et al
    (64)Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First US Prospective, Reader-Blinded Clinical Trial.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.236091. doi: 10.2967/jnumed.119.236091.
    PubMed     Abstract available


  384. LAFFON E, Marthan R
    (11)C-(+)-PHNO Trapping Reversibility for Quantitative PET Imaging of Beta-Cell-Mass in Patients with Type-1 Diabetes.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.241075. doi: 10.2967/jnumed.119.241075.
    PubMed    


  385. HANSCHEID H, Lassmann M
    Will SPECT/CT Cameras soon be able to display Absorbed Doses? Dosimetry from Single Activity Concentration Measurements.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.239970. doi: 10.2967/jnumed.119.239970.
    PubMed    


  386. LAFFON E, Marthan R
    SUVmax-V for assessing treatment response in FDG-PET Imaging of Patient-Derived Tumor Xenografts involving Triple-Negative Breast Cancer.
    J Nucl Med. 2020 Jan 10. pii: jnumed.120.241778. doi: 10.2967/jnumed.120.241778.
    PubMed    


  387. SANAAT A, Arabi H, Mainta I, Garibotto V, et al
    Projection-space implementation of deep learning-guided low-dose brain PET imaging improves performance over implementation in image-space.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.239327. doi: 10.2967/jnumed.119.239327.
    PubMed     Abstract available


  388. SONNI I, Eiber M, Fendler WP, Alano RM, et al
    Impact of (68)Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.237602. doi: 10.2967/jnumed.119.237602.
    PubMed     Abstract available


  389. LUKAS M, Kluge A, Beindorff N, Brenner W, et al
    Multi-Isotope Capabilities of a Small-Animal Multi-Pinhole SPECT System.
    J Nucl Med. 2020;61:152-161.
    PubMed     Abstract available


  390. POMPER MG, Choyke PL
    Discussions with Leaders: A Conversation Between Martin Pomper and Peter Choyke.
    J Nucl Med. 2020;61:3-5.
    PubMed    


  391. WEBER WA, Bengel FM, Blasberg RG
    The AQARA Principle: Proposing Standard Requirements for Radionuclide-Based Images in Medical Journals.
    J Nucl Med. 2020;61:1-2.
    PubMed    


  392. YOO SH, Kang SY, Cheon GJ, Oh DY, et al
    Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study.
    J Nucl Med. 2020;61:33-39.
    PubMed     Abstract available


  393. MAURER T, Graefen M, van der Poel H, Hamdy F, et al
    Prostate-Specific Membrane Antigen-Guided Surgery.
    J Nucl Med. 2020;61:6-12.
    PubMed     Abstract available


  394. VAN LEEUWEN FWB, Schottelius M, Brouwer OR, Vidal-Sicart S, et al
    Trending: Radioactive and Fluorescent Bimodal/Hybrid Tracers as Multiplexing Solutions for Surgical Guidance.
    J Nucl Med. 2020;61:13-19.
    PubMed     Abstract available


  395. PANTEL AR, Viswanath V, Daube-Witherspoon ME, Dubroff JG, et al
    PennPET Explorer: Human Imaging on a Whole-Body Imager.
    J Nucl Med. 2020;61:144-151.
    PubMed     Abstract available


  396. CARLOS DOS SANTOS J, Beijer B, Bauder-Wust U, Schafer M, et al
    Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
    J Nucl Med. 2020;61:70-79.
    PubMed     Abstract available


  397. KARP JS, Viswanath V, Geagan MJ, Muehllehner G, et al
    PennPET Explorer: Design and Preliminary Performance of a Whole-Body Imager.
    J Nucl Med. 2020;61:136-143.
    PubMed     Abstract available


    December 2019
  398. CASTELLO A, Rossi S, Toschi L, Mazziotti E, et al
    Hyper-progressive Disease in Patients With Non-Small Cell Lung Cancer Treated With Checkpoint Inhibitors: The Role of (18)F-FDG PET/CT.
    J Nucl Med. 2019 Dec 20. pii: jnumed.119.237768. doi: 10.2967/jnumed.119.237768.
    PubMed     Abstract available


  399. MICHAUD L, Touijer K, Mauguen A, Zelefsky M, et al
    (11)C-choline PET/CT in recurrent prostate cancer: retrospective analysis in a large US patient series.
    J Nucl Med. 2019 Dec 20. pii: jnumed.119.233098. doi: 10.2967/jnumed.119.233098.
    PubMed     Abstract available


  400. ADAMS LC, Bressem KK, Brangsch J, Reimann C, et al
    Quantitative 3D assessment of (68)Ga-DOTATOC PET/MRI with diffusion-weighted imaging to assess imaging markers for gastroendopancreatic neuroendocrine tumors: Preliminary results.
    J Nucl Med. 2019 Dec 20. pii: jnumed.119.234062. doi: 10.2967/jnumed.119.234062.
    PubMed     Abstract available


  401. HERNANDEZ R, Grudzinski JJ, Aluicio-Sarduy E, Massey CF, et al
    (177)Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer.
    J Nucl Med. 2019 Dec 20. pii: jnumed.119.236265. doi: 10.2967/jnumed.119.236265.
    PubMed     Abstract available


  402. ARNON-SHELEG E, Haberfeld O, Kremer R, Keidar Z, et al
    Head to head prospective comparison of quantitative lung scintigraphy and segment counting in predicting pulmonary function of lung cancer patients undergoing video-assisted thoracoscopic lobectomy.
    J Nucl Med. 2019 Dec 20. pii: jnumed.119.234526. doi: 10.2967/jnumed.119.234526.
    PubMed     Abstract available


  403. OH SW, Wurzer A, Teoh EJ, Oh S, et al
    Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of Novel Radiohybrid PSMA, (18)F- rhPSMA-7, in Patients with Prostate Cancer.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.234609. doi: 10.2967/jnumed.119.234609.
    PubMed     Abstract available


  404. MEYER C, Dahlbom M, Lindner T, Vauclin S, et al
    Radiation dosimetry and biodistribution of (68)Ga-FAPI-46 PET imaging in cancer patients.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.236786. doi: 10.2967/jnumed.119.236786.
    PubMed     Abstract available


  405. FANTONI E, Collij L, Alves IL, Buckley C, et al
    The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.235879. doi: 10.2967/jnumed.119.235879.
    PubMed     Abstract available


  406. EIBER M, Kronke M, Wurzer A, Ulbrich L, et al
    (18)F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.234914. doi: 10.2967/jnumed.119.234914.
    PubMed     Abstract available


  407. KRONKE M, Wurzer A, Schwamborn K, Ulbrich L, et al
    Histologically-confirmed diagnostic efficacy of (18)F-rhPSMA-7 positron emission tomography for N-staging of patients with primary high risk prostate cancer.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.234906. doi: 10.2967/jnumed.119.234906.
    PubMed     Abstract available


  408. MCDONALD ES, Doot RK, Young AJ, Schubert EK, et al
    Breast Cancer (18)F-ISO-1 Uptake as a Marker of Proliferation Status.
    J Nucl Med. 2019 Dec 13. pii: jnumed.119.232363. doi: 10.2967/jnumed.119.232363.
    PubMed     Abstract available


  409. ROSENKRANS ZT, Cai W
    Total-body PET Imaging for up to 30 Days after Injection of (89)Zr-labeled Antibodies.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.236166. doi: 10.2967/jnumed.119.236166.
    PubMed    


  410. MARTIN O, Schaarschmidt BM, Kirchner J, Suntharalingam S, et al
    PET/MRI versus PET/CT in whole-body staging: results from a unicenter observational study in 1003 subsequent examinations.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.233940. doi: 10.2967/jnumed.119.233940.
    PubMed     Abstract available


  411. PAUWELS E, Van Binnebeek S, Vandecaveye V, Baete K, et al
    Inflammation-based index and (68)Ga-DOTATOC PET-derived uptake and volumetric parameters predict outcome in neuroendocrine tumor patients treated with (90)Y-DOTATOC.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.236935. doi: 10.2967/jnumed.119.236935.
    PubMed     Abstract available


  412. FANTI S, Hadaschik B, Herrmann K
    Proposal of Systemic Therapy Response Assessment Criteria in time of PSMA PET/CT imaging: PSMA PET Progression (PPP).
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.233817. doi: 10.2967/jnumed.119.233817.
    PubMed     Abstract available


  413. FAROLFI A, Ilhan H, Gafita A, Calais J, et al
    Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection using repeat PSMA-PET.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.235374. doi: 10.2967/jnumed.119.235374.
    PubMed     Abstract available


  414. JACKSON PA, Hofman MS, Hicks RJ, Scalzo M, et al
    Radiation Dosimetry in (177)Lu-PSMA-617 Therapy Using a Single Post-treatment SPECT/CT: A Novel Methodology to Generate Time- and Tissue-specific Dose Factors.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.233411. doi: 10.2967/jnumed.119.233411.
    PubMed     Abstract available


  415. SOMMERLATH SOHNS J, Kroehn H, Schoede A, Derlin T, et al
    (18)F-Fluorodeoxyglucose Positron Emission Tomography / Computed Tomography in Left-Ventricular Assist Device Infection: Initial Results Supporting the Usefulness of Image-Guided Therapy.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.237628. doi: 10.2967/jnumed.119.237628.
    PubMed     Abstract available


  416. ROSSI G, Bauckneht M, Genova C, Rijavec E, et al
    Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.233056. doi: 10.2967/jnumed.119.233056.
    PubMed     Abstract available


  417. ZOUFAL V, Mairinger S, Brackhan M, Krohn M, et al
    Imaging P-glycoprotein Induction at the Blood-Brain Barrier of a Beta-Amyloidosis Mouse Model with (11)C-Metoclopramide PET.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.237198. doi: 10.2967/jnumed.119.237198.
    PubMed     Abstract available


  418. BASCUNANA P, Hess A, Borchert T, Wang Y, et al
    (11)C-Methionine PET Identifies Astroglia Involvement in Heart-Brain Inflammation Networking after Acute Myocardial Infarction.
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.236885. doi: 10.2967/jnumed.119.236885.
    PubMed     Abstract available


    November 2019
  419. WANG B, Gao J, Zhang Q, Fu Y, et al
    Diagnostic value of (68)Ga-PSMA PET/CT for detection of PTEN expression in prostate cancer: a pilot study.
    J Nucl Med. 2019 Nov 22. pii: jnumed.119.236059. doi: 10.2967/jnumed.119.236059.
    PubMed     Abstract available


  420. BIEGON A, Shroyer KR, Franceschi D, Dhawan J, et al
    Initial studies with [(11)C]vorozole positron emission tomography detect over-expression of intra-tumoral aromatase in breast cancer.
    J Nucl Med. 2019 Nov 22. pii: jnumed.119.231589. doi: 10.2967/jnumed.119.231589.
    PubMed     Abstract available


  421. GYORKE T, Carr R, Cerci JJ, Meneghetti C, et al
    Combined Visual and Semi-quantitative Evaluation Improves Outcome Prediction by Early Mid-treatment (18)F-fluoro-deoxi-glucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
    J Nucl Med. 2019 Nov 22. pii: jnumed.119.231621. doi: 10.2967/jnumed.119.231621.
    PubMed     Abstract available


  422. SAVAIKAR MA, Whitehead T, Roy S, Strong L, et al
    SUV25 and microPERCIST: Precision Imaging of Response to Therapy in Co-Clinical FDG-PET Imaging of Triple Negative Breast Cancer (TNBC) Patient-Derived Tumor Xenografts (PDX).
    J Nucl Med. 2019 Nov 22. pii: jnumed.119.234286. doi: 10.2967/jnumed.119.234286.
    PubMed     Abstract available


  423. DISSAUX G, Visvikis D, Do-Ano R, Pradier O, et al
    Pre-treatment (18)F-FDG PET/CT Radiomics predict local recurrence in patients treated with stereotactic radiotherapy for early-stage non-small cell lung cancer: a multicentric study.
    J Nucl Med. 2019 Nov 15. pii: jnumed.119.228106. doi: 10.2967/jnumed.119.228106.
    PubMed     Abstract available


  424. BODEI L, Chiti A, Modlin IM, Scott A, et al
    The path to the future: Education of nuclear medicine therapeutic specialists as responsible physicians.
    J Nucl Med. 2019 Nov 15. pii: jnumed.119.232454. doi: 10.2967/jnumed.119.232454.
    PubMed    


  425. BULLICH S, Barret O, Constantinescu C, Sandiego C, et al
    Evaluation of dosimetry, quantitative methods and test-retest variability of (18)F-PI-2620 PET for the assessment of tau deposits in the human brain.
    J Nucl Med. 2019 Nov 11. pii: jnumed.119.236240. doi: 10.2967/jnumed.119.236240.
    PubMed     Abstract available


  426. MUELLER A, Bullich S, Barret O, Madonia J, et al
    Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study.
    J Nucl Med. 2019 Nov 11. pii: jnumed.119.236224. doi: 10.2967/jnumed.119.236224.
    PubMed     Abstract available


  427. MEERSHOEK P, Buckle T, van Oosterom MN, KleinJan GH, et al
    Can fluorescence-guided surgery help identify all lesions in unknown locations or is the integrated use of a roadmap created by preoperative imaging mandatory? A blinded study in prostate cancer patients.
    J Nucl Med. 2019 Nov 11. pii: jnumed.119.235234. doi: 10.2967/jnumed.119.235234.
    PubMed     Abstract available


  428. MENA E, Lindenberg ML, Turkbey IB, Shih JH, et al
    (18)F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy.
    J Nucl Med. 2019 Nov 1. pii: jnumed.119.234799. doi: 10.2967/jnumed.119.234799.
    PubMed     Abstract available


  429. ZHU W, Cheng Y, Wang X, Yao S, et al
    Head-to-head comparison of (68)Ga-DOTA-JR11 and (68)Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study.
    J Nucl Med. 2019 Nov 1. pii: jnumed.119.235093. doi: 10.2967/jnumed.119.235093.
    PubMed     Abstract available


  430. BARRIO JR, Satyamurthy N, Huang SC, Scafoglio C, et al
    Does 2-FDG-PET Accurately Reflect Quantitative In vivo Glucose Utilization?
    J Nucl Med. 2019 Nov 1. pii: jnumed.119.237446. doi: 10.2967/jnumed.119.237446.
    PubMed     Abstract available


  431. EMMETT L, Tang R, Nandurkar RH, Hruby G, et al
    3-year freedom from progression following (68)GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi-center trial.
    J Nucl Med. 2019 Nov 1. pii: jnumed.119.235028. doi: 10.2967/jnumed.119.235028.
    PubMed     Abstract available


  432. HABERKORN U, Czernin J
    A Conversation Between Uwe Haberkorn and Johannes Czernin.
    J Nucl Med. 2019;60:1495-1498.
    PubMed    


  433. SAADANI H, van der Hiel B, Aalbersberg EA, Zavrakidis I, et al
    Metabolic Biomarker-Based BRAFV600 Mutation Association and Prediction in Melanoma.
    J Nucl Med. 2019;60:1545-1552.
    PubMed     Abstract available


  434. GARCIA EV, Slomka P, Moody JB, Germano G, et al
    Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.
    J Nucl Med. 2019;60:1507-1516.
    PubMed     Abstract available


  435. PEREIRA PMR, Mandleywala K, Ragupathi A, Carter LM, et al
    Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors.
    J Nucl Med. 2019;60:1569-1578.
    PubMed     Abstract available


  436. KHERA E, Zhang L, Roberts S, Nessler I, et al
    Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for beta-Cells in a Mouse Model of Type 1 Diabetes.
    J Nucl Med. 2019;60:1635-1641.
    PubMed     Abstract available


    October 2019
  437. CHEN BY, Ghezzi C, Villegas B, Quon A, et al
    (18)F-FAC PET visualizes brain-infiltrating leukocytes in a mouse model of multiple sclerosis.
    J Nucl Med. 2019 Oct 25. pii: jnumed.119.229351. doi: 10.2967/jnumed.119.229351.
    PubMed     Abstract available


  438. KIRCHER M, Tran-Gia J, Kemmer L, Zhang X, et al
    Imaging Inflammation in Atherosclerosis with CXCR4-directed (68)Ga-Pentixafor PET/CT - Correlation with (18)F-FDG PET/CT.
    J Nucl Med. 2019 Oct 25. pii: jnumed.119.234484. doi: 10.2967/jnumed.119.234484.
    PubMed     Abstract available


  439. CHEN A, Mokrane FZ, Schwartz L, Morschhauser F, et al
    Early (18)F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab.
    J Nucl Med. 2019 Oct 18. pii: jnumed.119.232827. doi: 10.2967/jnumed.119.232827.
    PubMed     Abstract available


  440. DIETLEIN F, Kobe C, Hohberg M, Zlatopolskiy BD, et al
    Intraindividual comparison of (18)F-PSMA-1007 with renally excreted PSMA ligands for PSMA-PET imaging in patients with relapsed prostate cancer.
    J Nucl Med. 2019 Oct 18. pii: jnumed.119.234898. doi: 10.2967/jnumed.119.234898.
    PubMed     Abstract available


  441. SONG H, Harrison C, Duan H, Guja K, et al
    Prospective Evaluation in an Academic Center of (18)F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer: A Focus on Localizing Disease and Changes in Management.
    J Nucl Med. 2019 Oct 18. pii: jnumed.119.231654. doi: 10.2967/jnumed.119.231654.
    PubMed     Abstract available


  442. BLAZHENETS G, Ma Y, Sorensen A, Schiller F, et al
    Predictive Value of (18)F-Florbetapir and (18)F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia.
    J Nucl Med. 2019 Oct 18. pii: jnumed.119.230797. doi: 10.2967/jnumed.119.230797.
    PubMed     Abstract available


  443. VAN SLUIS J, Boellaard R, Dierckx RA, Stormezand G, et al
    Image quality and activity optimization in oncological (18)F-FDG PET using the digital Biograph Vision PET/CT.
    J Nucl Med. 2019 Oct 18. pii: jnumed.119.234351. doi: 10.2967/jnumed.119.234351.
    PubMed     Abstract available


  444. CALDERONI L, Farolfi A, Pianori D, Maietti E, et al
    Automated synthesis module and sterile cold kit for (68)Ga-PSMA-11 do not show differences in PET/CT image quality.
    J Nucl Med. 2019 Oct 10. pii: jnumed.119.231605. doi: 10.2967/jnumed.119.231605.
    PubMed     Abstract available


  445. LIU Y, Dang Y, Huo L, Hu Y, et al
    Preoperative localisation of adenomas in primary hyperparathyroidism: the value of (11)C-choline PET/CT in patients with negative or discordant ultrasonography and (99m)Tc-Sesta-MIBI-SPECT/CT.
    J Nucl Med. 2019 Oct 10. pii: jnumed.119.233213. doi: 10.2967/jnumed.119.233213.
    PubMed     Abstract available


  446. BINI J, Sanchez-Rangel E, Gallezot JD, Naganawa M, et al
    PET Imaging of Pancreatic Dopamine D3/D2 receptor density with (11)C (+)-PHNO in Type-1 Diabetes Mellitus.
    J Nucl Med. 2019 Oct 10. pii: jnumed.119.234013. doi: 10.2967/jnumed.119.234013.
    PubMed     Abstract available


  447. JACENE HA
    2019 SNMMI Highlights Lecture: General Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2019;60:13N-18N.
    PubMed    


    September 2019
  448. TORIIHARA A, Nobashi T, Baratto L, Duan H, et al
    Comparison of three interpretation criteria of (68)Ga-PSMA11 PET based on inter- and intra-reader agreement.
    J Nucl Med. 2019 Sep 27. pii: jnumed.119.232504. doi: 10.2967/jnumed.119.232504.
    PubMed     Abstract available


  449. KUTEN J, Fahoum I, Savin Z, Shamni O, et al
    Head- to head Comparison of (68)Ga-PSMA-11 with (18)F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard.
    J Nucl Med. 2019 Sep 27. pii: jnumed.119.234187. doi: 10.2967/jnumed.119.234187.
    PubMed     Abstract available


  450. HINSENVELD FJ, Wit EMK, van Leeuwen PJ, Brouwer OR, et al
    Prostate-specific membrane antigen positron emission tomography/computed tomography combined with sentinel node biopsy for primary lymph node staging in prostate cancer.
    J Nucl Med. 2019 Sep 27. pii: jnumed.119.232199. doi: 10.2967/jnumed.119.232199.
    PubMed     Abstract available


  451. CUDERMAN A, Senica K, Rep S, Hocevar M, et al
    (18)F-Fluorocholine PET/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands.
    J Nucl Med. 2019 Sep 27. pii: jnumed.119.229914. doi: 10.2967/jnumed.119.229914.
    PubMed     Abstract available


  452. MCDOUGALD W, Vanhove C, Lehnert A, Lewellen B, et al
    Standardization of preclinical PET/CT imaging to improve quantitative accuracy, precision and reproducibility: a multi-center study.
    J Nucl Med. 2019 Sep 27. pii: jnumed.119.231308. doi: 10.2967/jnumed.119.231308.
    PubMed     Abstract available


  453. BERG E, Gill H, Marik J, Ogasawara A, et al
    Total-body PET and highly stable chelators together enable meaningful (89)Zr-antibody-PET studies up to 30 days post-injection.
    J Nucl Med. 2019 Sep 27. pii: jnumed.119.230961. doi: 10.2967/jnumed.119.230961.
    PubMed     Abstract available


  454. PICCARDO A, Morana G, Puntoni M, Campora S, et al
    Diagnosis, Treatment Response and Prognosis. The role of (18)F-DOPA PET/CT in children affected by Neuroblastoma in comparison with (123)I-mIBG scan. The first prospective study.
    J Nucl Med. 2019 Sep 20. pii: jnumed.119.232553. doi: 10.2967/jnumed.119.232553.
    PubMed     Abstract available


  455. POMYKALA KL, Czernin J, Grogan TR, Armstrong WR, et al
    Total-body (68)Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer patients: Potential impact on bone scan guidelines.
    J Nucl Med. 2019 Sep 20. pii: jnumed.119.230318. doi: 10.2967/jnumed.119.230318.
    PubMed     Abstract available


  456. DE ZWART PL, van Dijken BR, Holtman GA, Stormezand GN, et al
    Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.
    J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809.
    PubMed     Abstract available


  457. GREENWOOD HE, Nyitrai Z, Mocsai G, Hobor S, et al
    High throughput PET/CT imaging using a multiple mouse imaging system.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.228692. doi: 10.2967/jnumed.119.228692.
    PubMed     Abstract available


  458. MAURER GD, Brucker DP, Stoffels G, Filipski K, et al
    (18)F-FET PET imaging in differentiating glioma progression from treatment-related changes - a single-center experience.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.234757. doi: 10.2967/jnumed.119.234757.
    PubMed     Abstract available


  459. BOSS M, Buitinga M, Jansen TJ, Brom M, et al
    PET-based dosimetry of [(68)Ga]Ga-NODAGA-exendin-4 in humans, a tracer for beta cell imaging.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.228627. doi: 10.2967/jnumed.119.228627.
    PubMed     Abstract available


  460. LOBEEK D, Bouwman FCM, Aarntzen EHJG, Molkenboer-Kuenen JDM, et al
    A Clinical Feasibility Study To Image Angiogenesis in Patients With Arteriovenous Malformations Using (68)Ga-RGD PET/CT.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.231167. doi: 10.2967/jnumed.119.231167.
    PubMed     Abstract available


  461. ROTTENBURGER C, Nicolas GP, McDougall L, Kaul F, et al
    Cholecystokinin-2 Receptor Agonist (177)Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma - Results of the Lumed Phase 0a Study.
    J Nucl Med. 2019 Sep 13. pii: jnumed.119.233031. doi: 10.2967/jnumed.119.233031.
    PubMed     Abstract available


  462. RAMOS N, Baquero J, Gironda Z, Zaim-Wadghiri Y, et al
    Non invasive PET imaging of CDK4/6 activation in Breast Cancer.
    J Nucl Med. 2019 Sep 3. pii: jnumed.119.232603. doi: 10.2967/jnumed.119.232603.
    PubMed     Abstract available


  463. JANSEN BHE, Jansen RW, Wondergem M, Srbljin S, et al
    Lesion Detection and Interobserver Agreement with Advanced Image-Reconstructions for (18)F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2019 Sep 3. pii: jnumed.118.222513. doi: 10.2967/jnumed.118.222513.
    PubMed     Abstract available


  464. ZACHO HD, Fonager RF, Nielsen JB, Haarmark C, et al
    Observer agreement and accuracy of (18)F-sodium-fluoride PET/CT in the diagnosis of bone metastases in prostate cancer.
    J Nucl Med. 2019 Sep 3. pii: jnumed.119.232686. doi: 10.2967/jnumed.119.232686.
    PubMed     Abstract available


  465. SPECK I, Arnst S, Thurow J, Blazhenets G, et al
    [(18)F]FDG PET Imaging of the Inferior Colliculi in Asymmetric Hearing Loss.
    J Nucl Med. 2019 Sep 3. pii: jnumed.119.231407. doi: 10.2967/jnumed.119.231407.
    PubMed     Abstract available


  466. ZACHO HD, Petersen LJ
    Reply LTE, Off-Target Report on (18)F-Sodium Fluoride PET/CT for Detection of Skeletal Metastases in Prostate Cancer.
    J Nucl Med. 2019 Sep 3. pii: jnumed.119.234146. doi: 10.2967/jnumed.119.234146.
    PubMed    


  467. GHAFOOR S, Burger IA, Vargas HA
    Multimodality Imaging of Prostate Cancer.
    J Nucl Med. 2019 Sep 3. pii: jnumed.119.228320. doi: 10.2967/jnumed.119.228320.
    PubMed     Abstract available



  468. Bill Targets Expanded Access to Diagnostic Radiopharmaceuticals.
    J Nucl Med. 2019;60:19N.
    PubMed    


  469. LINDEMANN ME, Quick HH
    Reply to: Improved Scatter Correction to Eliminate Halo Artifacts for (68)Ga-Labeled Radiopharmaceuticals in PET Imaging.
    J Nucl Med. 2019;60:1334.
    PubMed    


  470. CZERNIN J, Sonni I, Razmaria A, Calais J, et al
    The Future of Nuclear Medicine as an Independent Specialty.
    J Nucl Med. 2019;60.
    PubMed     Abstract available


  471. NENSA F, Demircioglu A, Rischpler C
    Artificial Intelligence in Nuclear Medicine.
    J Nucl Med. 2019;60.
    PubMed     Abstract available


  472. LARSON SM
    Do You Want an Inspirational Career? Choose Nuclear Medicine.
    J Nucl Med. 2019;60.
    PubMed     Abstract available


  473. SHERMAN M, Levine R
    Nuclear Medicine and Wall Street: An Evolving Relationship.
    J Nucl Med. 2019;60.
    PubMed     Abstract available


  474. HERRMANN K, Veit-Haibach P, Weber WA
    Driving the Future of Nuclear Medicine.
    J Nucl Med. 2019;60.
    PubMed    


  475. LANGBEIN T, Weber WA, Eiber M
    Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
    J Nucl Med. 2019;60.
    PubMed     Abstract available


    August 2019
  476. ROWE SP, Li X, Trock BJ, Werner RA, et al
    Prospective Comparison of PET Imaging with PSMA-targeted (18)F-DCFPyL versus Na(18)F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2019 Aug 26. pii: jnumed.119.227793. doi: 10.2967/jnumed.119.227793.
    PubMed     Abstract available


  477. LAWAL I, Fourie B, Mathebula M, Moagi I, et al
    FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS.
    J Nucl Med. 2019 Aug 26. pii: jnumed.119.233783. doi: 10.2967/jnumed.119.233783.
    PubMed     Abstract available


  478. XIE L, Hanyu M, Fujinaga M, Zhang Y, et al
    (131)I-IITM and (211)At-AITM: Two Novel Small-molecule Radiopharmaceuticals Targeting Oncoprotein Metabotropic Glutamate Receptor 1.
    J Nucl Med. 2019 Aug 26. pii: jnumed.119.230946. doi: 10.2967/jnumed.119.230946.
    PubMed     Abstract available


  479. LAFFON E, Marthan R
    Reversibility of (68)Ga-FAPI-2 trapping might prove an asset for PET quantitative imaging.
    J Nucl Med. 2019 Aug 16. pii: jnumed.119.234393. doi: 10.2967/jnumed.119.234393.
    PubMed    


  480. COUGHLIN JM, Rubin LH, Du Y, Rowe SP, et al
    High availability of the alpha7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: A pilot study using (18)F-ASEM PET.
    J Nucl Med. 2019 Aug 16. pii: jnumed.119.230979. doi: 10.2967/jnumed.119.230979.
    PubMed     Abstract available


  481. PFAEHLER E, van Sluis J, Merema BBJ, van Ooijen P, et al
    Experimental multicenter and multivendor evaluation of PET radiomic features performance using 3D printed phantom inserts.
    J Nucl Med. 2019 Aug 16. pii: jnumed.119.229724. doi: 10.2967/jnumed.119.229724.
    PubMed     Abstract available


  482. DAVENPORT MS, Montgomery JS, Kunju LP, Siddiqui J, et al
    (18)F-choline PET/mpMRI for Detection of clinically significant prostate cancer: Part 1. Improved risk stratification for MRI-guided transrectal prostate biopsies.
    J Nucl Med. 2019 Aug 16. pii: jnumed.119.225789. doi: 10.2967/jnumed.119.225789.
    PubMed     Abstract available


  483. MASON C, Kossatz S, Carter L, Pirovano G, et al
    A (89)Zr-HDL PET tracer monitors response to a CSF1R inhibitor.
    J Nucl Med. 2019 Aug 16. pii: jnumed.119.230466. doi: 10.2967/jnumed.119.230466.
    PubMed     Abstract available


  484. VARASTEH Z, Mohanta S, Robu S, Braeuer M, et al
    Molecular imaging of fibroblast activity after myocardial infarction using a (68)Ga-labelled fibroblast activation protein inhibitor FAPI-04.
    J Nucl Med. 2019 Aug 12. pii: jnumed.119.226993. doi: 10.2967/jnumed.119.226993.
    PubMed     Abstract available


  485. SLOMKA P, Miller RJ, Hu LH, Germano G, et al
    Solid-State Detector SPECT myocardial perfusion imaging.
    J Nucl Med. 2019 Aug 2. pii: jnumed.118.220657. doi: 10.2967/jnumed.118.220657.
    PubMed     Abstract available


  486. SHIYAM SUNDAR LK, Muzik O, Rischka L, Hahn A, et al
    The promise of fully-integrated PET/MR imaging: Non-invasive clinical quantification of cerebral glucose metabolism.
    J Nucl Med. 2019 Aug 2. pii: jnumed.119.229567. doi: 10.2967/jnumed.119.229567.
    PubMed     Abstract available


  487. KRANZBUHLER B, Muller J, Becker AS, Garcia Schuler HI, et al
    Detection rate and localization of prostate cancer recurrence using (68)Ga-PSMA-11 PET/MRI in patients with low PSA values </= 0.5 ng/ml.
    J Nucl Med. 2019 Aug 2. pii: jnumed.118.225276. doi: 10.2967/jnumed.118.225276.
    PubMed     Abstract available


  488. CZERNIN J
    Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
    J Nucl Med. 2019;60:1037.
    PubMed    


    July 2019
  489. BARNETT C, Davenport MS, Montgomery JS, Kunju LP, et al
    (18)F-choline PET/mpMRI for Detection of Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis.
    J Nucl Med. 2019 Jul 26. pii: jnumed.119.225771. doi: 10.2967/jnumed.119.225771.
    PubMed     Abstract available


  490. DIETLEIN F, Hohberg M, Kobe C, Zlatopolskiy BD, et al
    A novel (18)F-labeled PSMA ligand for PET/CT imaging of prostate cancer patients: First-in-man observational study and clinical experience with (18)F-JK-PSMA-7 during the first year of application.
    J Nucl Med. 2019 Jul 19. pii: jnumed.119.229542. doi: 10.2967/jnumed.119.229542.
    PubMed     Abstract available


  491. MANSUR A, Rabiner EA, Comley RA, Lewis Y, et al
    Characterization of 3 PET tracers for Quantification of Mitochondrial and Synaptic function in Healthy Human Brain: (18)F-BCPP-EF, (11)C-SA-4503, (11)C-UCB-J.
    J Nucl Med. 2019 Jul 19. pii: jnumed.119.228080. doi: 10.2967/jnumed.119.228080.
    PubMed     Abstract available


  492. RAUSCHER I, Fendler WP, Hope T, Quon A, et al
    Can the injected dose be reduced in (68)Ga-PSMA-11 PET/CT maintaining high image quality for lesion detection?
    J Nucl Med. 2019 Jul 19. pii: jnumed.119.227207. doi: 10.2967/jnumed.119.227207.
    PubMed     Abstract available


  493. CURRIE GM
    BIODISTRIBUTION OF (18)F FDG POST ORAL ADMINISTRATION TO A HONEYBEE; PET/CT PROOF OF CONCEPT.
    J Nucl Med. 2019 Jul 19. pii: jnumed.119.231381. doi: 10.2967/jnumed.119.231381.
    PubMed    


  494. KOERBER SA, Stach G, Kratochwil C, Haefner MF, et al
    Lymph node involvement in treatment-naive prostate cancer patients - correlation of PSMA-PET/CT imaging and Roach formula in 280 men in the Radiotherapeutic management.
    J Nucl Med. 2019 Jul 13. pii: jnumed.119.227637. doi: 10.2967/jnumed.119.227637.
    PubMed     Abstract available


  495. HOILUND-CARLSEN PF, Alavi A
    Off-Target Report on (18)F-Sodium Fluoride PET/CT for Detection of Skeletal Metastases in Prostate Cancer.
    J Nucl Med. 2019 Jul 13. pii: jnumed.119.232348. doi: 10.2967/jnumed.119.232348.
    PubMed    


  496. SARNYAI Z, Nagy K, Patay G, Molnar M, et al
    Performance Evaluation of a High Resolution Non-Human Primate PET/CT System.
    J Nucl Med. 2019 Jul 13. pii: jnumed.117.206243. doi: 10.2967/jnumed.117.206243.
    PubMed     Abstract available


  497. SACHER C, Blume T, Beyer L, Peters F, et al
    Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second Generation Amyloid-beta Mouse Model.
    J Nucl Med. 2019 Jul 13. pii: jnumed.119.227322. doi: 10.2967/jnumed.119.227322.
    PubMed     Abstract available



  498. NRC Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive.
    J Nucl Med. 2019;60:9N.
    PubMed    



  499. Lawhn-Heath Named 2019 Henkin Fellow.
    J Nucl Med. 2019;60:14N.
    PubMed    


  500. DILSIZIAN V
    SNMMI Leadership Update: Influx of New Ideas and Opportunities Collaboration Propels Growth.
    J Nucl Med. 2019;60:13N.
    PubMed    


  501. SEGALL GM
    The Distinction Between an AU and an ABNM-Certified MD.
    J Nucl Med. 2019;60:10N.
    PubMed    


  502. HOPE TA, Abbott A, Colucci K, Bushnell DL, et al
    NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE.
    J Nucl Med. 2019;60:937-943.
    PubMed     Abstract available


  503. REILLY RM
    Immuno-PET to Optimize the Dose of Monoclonal Antibodies for Cancer Therapy: How Much Is Enough?
    J Nucl Med. 2019;60:899-901.
    PubMed    


  504. LUTJE S, Franssen GM, Herrmann K, Boerman OC, et al
    In Vitro and In Vivo Characterization of an (18)F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts.
    J Nucl Med. 2019;60:1017-1022.
    PubMed     Abstract available


    June 2019
  505. LEITHNER D, Helbich TH, Bernard-Davila B, Marino MA, et al
    Multiparametric (18)F-FDG PET-MRI of the breast: are there differences in imaging biomarkers of contralateral healthy tissue between patients with and without breast cancer?
    J Nucl Med. 2019 Jun 28. pii: jnumed.119.230003. doi: 10.2967/jnumed.119.230003.
    PubMed     Abstract available


  506. RAY BANERJEE S, Minn IL, Kumar V, Josefsson A, et al
    Preclinical evaluation of (203/212)Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer.
    J Nucl Med. 2019 Jun 28. pii: jnumed.119.229393. doi: 10.2967/jnumed.119.229393.
    PubMed     Abstract available


  507. LV G, Qiu L, Sun Y, Li K, et al
    PET imaging of tumor PD-L1 expression with a highly specific non-blocking nanobody.
    J Nucl Med. 2019 Jun 28. pii: jnumed.119.226712. doi: 10.2967/jnumed.119.226712.
    PubMed     Abstract available


  508. VAN SLUIS J, Boellaard R, Somasundaram A, van Snick P, et al
    Image quality and semi-quantitative measurements of the Siemens Biograph Vision PET/CT: Initial experiences and comparison with Siemens Biograph mCT PET/CT.
    J Nucl Med. 2019 Jun 28. pii: jnumed.119.227801. doi: 10.2967/jnumed.119.227801.
    PubMed     Abstract available


  509. RAUSCHER I, Kronke M, Konig M, Gafita A, et al
    Matched-pair comparison of (68)Ga-PSMA-11 and (18)F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy.
    J Nucl Med. 2019 Jun 28. pii: jnumed.119.229187. doi: 10.2967/jnumed.119.229187.
    PubMed     Abstract available


  510. JREIGE M, Dunet V, Letovanec I, Prior JO, et al
    Pulmonary lymphangitic carcinomatosis: diagnostic performance of HRCT and (18)F-FDG-PET/CT in correlation to clinical pathologic outcome.
    J Nucl Med. 2019 Jun 21. pii: jnumed.119.229575. doi: 10.2967/jnumed.119.229575.
    PubMed     Abstract available


  511. BURKE B, Miranda C, Lee R, Renard I, et al
    Copper-64 PET imaging of the CXCR4 chemokine receptor using a cross-bridged cyclam bis-tetraazamacrocyclic antagonist.
    J Nucl Med. 2019 Jun 14. pii: jnumed.118.218008. doi: 10.2967/jnumed.118.218008.
    PubMed     Abstract available


  512. ROWE SP, Campbell SP, Mana-Ay M, Szabo Z, et al
    Prospective Evaluation of PSMA-Targeted (18)F-DCFPyL PET/CT in Men with Biochemical Failure after Radical Prostatectomy for Prostate Cancer.
    J Nucl Med. 2019 Jun 14. pii: jnumed.119.226514. doi: 10.2967/jnumed.119.226514.
    PubMed     Abstract available


  513. COTTEREAU AS, Nioche C, Dirand AS, Clerc J, et al
    (18)F-FDG-PET dissemination features in diffuse large B cell lymphoma are prognostic of outcome.
    J Nucl Med. 2019 Jun 14. pii: jnumed.119.229450. doi: 10.2967/jnumed.119.229450.
    PubMed     Abstract available


  514. TAHMI M, Bou-Zeid W, Razlighi QR
    A fully automatic technique for precise localization and quanti fi cation of Amyloid-beta PET scans.
    J Nucl Med. 2019 Jun 6. pii: jnumed.119.228510. doi: 10.2967/jnumed.119.228510.
    PubMed     Abstract available


  515. BEINAT C, Gowrishankar G, Shen B, Alam IS, et al
    The characterization of (18)F-hGTS13 for molecular imaging of xC- transporter activity with positron emission tomography.
    J Nucl Med. 2019 Jun 6. pii: jnumed.119.225870. doi: 10.2967/jnumed.119.225870.
    PubMed     Abstract available



  516. SNMMI Leadership Update: SNMMI Value Initiative 2.0-Advancing the Value of Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2019;60:23N-24N.
    PubMed    



  517. NRC Advisory Committee on Medical Uses of Isotopes Spring Meeting.
    J Nucl Med. 2019;60:19N.
    PubMed    



  518. Outstanding JNMT Articles for 2018.
    J Nucl Med. 2019;60:17N.
    PubMed    



  519. Best JNM Articles for 2018.
    J Nucl Med. 2019;60:16N.
    PubMed    


  520. GREENSPAN BS, Ahuja S, Avram AM, Gulec S, et al
    Overview of the Martinique Meetings: What Has Been Established and Where Are We Going?
    J Nucl Med. 2019;60:15N.
    PubMed    


  521. VOLKOW N, Czernin J
    A Conversation Between Nora Volkow and Johannes Czernin.
    J Nucl Med. 2019;60:717-720.
    PubMed    


  522. MEERSHOEK P, van den Berg NS, Brouwer OR, Teertstra HJ, et al
    Three-Dimensional Tumor Margin Demarcation Using the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid: A Proof-of-Concept Study in Tongue Cancer Patients Scheduled for Sentinel Node Biopsy.
    J Nucl Med. 2019;60:764-769.
    PubMed     Abstract available


  523. EMMETT L, Metser U, Bauman G, Hicks RJ, et al
    Prospective, Multisite, International Comparison of (18)F-Fluoromethylcholine PET/CT, Multiparametric MRI, and (68)Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and P
    J Nucl Med. 2019;60:794-800.
    PubMed     Abstract available


    May 2019
  524. DEWARAJA YK, Devasia T, Kaza RK, Mikell JK, et al
    Prediction of tumor control in (90)Y radioembolization by logit models with PET/CT based dose metrics.
    J Nucl Med. 2019 May 30. pii: jnumed.119.226472. doi: 10.2967/jnumed.119.226472.
    PubMed     Abstract available


  525. ZACHO H, Jochumsen MR, Langkilde NC, Mortensen JC, et al
    No added value of (18)F-sodium fluoride PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer with normal bone scintigraphy.
    J Nucl Med. 2019 May 30. pii: jnumed.119.229062. doi: 10.2967/jnumed.119.229062.
    PubMed     Abstract available


  526. JAUW Y, o'Donoghue J, Zijlstra J, Hoekstra O, et al
    (89)Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.
    J Nucl Med. 2019 May 30. pii: jnumed.118.224568. doi: 10.2967/jnumed.118.224568.
    PubMed     Abstract available


  527. HOPE TA, Fayad ZA, Fowler KJ, Holley D, et al
    State of the Art PET/MRI: Applications and Limitations - Summary of the First ISMRM/SNMMI Co-Provided Workshop on PET/MRI.
    J Nucl Med. 2019 May 23. pii: jnumed.119.227231. doi: 10.2967/jnumed.119.227231.
    PubMed     Abstract available


  528. LUO Y, Cao X, Pan Q, Li J, et al
    (68)Ga-pentixafor PET/CT for imaging of chemokine receptor-4 expression in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma: comparison to (18)F-FDG PET/CT.
    J Nucl Med. 2019 May 17. pii: jnumed.119.226134. doi: 10.2967/jnumed.119.226134.
    PubMed     Abstract available


  529. SATHEKGE M, Bruchertseifer F, Vorster M, Lawal I, et al
    PREDICTORS OF OVERALL AND DISEASE FREE SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS RECEIVING (225)Ac-PSMA-617 RADIOLIGAND THERAPY.
    J Nucl Med. 2019 May 17. pii: jnumed.119.229229. doi: 10.2967/jnumed.119.229229.
    PubMed     Abstract available


  530. THORWARTH D, Welz S, Monnich D, Pfannenberg C, et al
    Prospective evaluation of a tumor control probability model based on dynamic (18)F-FMISO PET for head-and-neck cancer radiotherapy.
    J Nucl Med. 2019 May 10. pii: jnumed.119.227744. doi: 10.2967/jnumed.119.227744.
    PubMed     Abstract available


  531. WANGERIN KA, Iagaru A
    Improved Scatter Correction to Eliminate Halo-Artifacts for (68)Ga-labeled Radiopharmaceuticals in PET Imaging.
    J Nucl Med. 2019 May 10. pii: jnumed.119.230557. doi: 10.2967/jnumed.119.230557.
    PubMed    


  532. BRAUNE A, Hofheinz F, Bluth T, Kiss T, et al
    Comparison of static (18)F-FDG-PET/CT (SUV, SUR) and dynamic (18)F-FDG-PET/CT (Ki) for quantification of pulmonary inflammation in acute lung injury.
    J Nucl Med. 2019 May 3. pii: jnumed.119.226597. doi: 10.2967/jnumed.119.226597.
    PubMed     Abstract available


  533. PORENTA G
    Is there value for AI applications in molecular imaging and nuclear medicine?
    J Nucl Med. 2019 May 3. pii: jnumed.119.227702. doi: 10.2967/jnumed.119.227702.
    PubMed    


  534. CARRASQUILLO JA, Fine B, Pandit-Taskar N, Larson SM, et al
    Imaging metastatic castration-resistant prostate cancer patients with (89)Zr-DFO-MSTP2109A anti-STEAP1 antibody.
    J Nucl Med. 2019 May 3. pii: jnumed.118.222844. doi: 10.2967/jnumed.118.222844.
    PubMed     Abstract available



  535. High Country Nuclear Medicine Conference Celebrates 40th Anniversary with First Hal O'Brien Rising Star Awards.
    J Nucl Med. 2019;60:7N-8N.
    PubMed    


  536. MINOSHIMA S
    SNMMI Leadership Update: Nuclear Medicine: Trailblazing Imaging Practice and Sciences for More than a Century.
    J Nucl Med. 2019;60:10N-13N.
    PubMed    



  537. FDA Updates Bulk Drug Substances List.
    J Nucl Med. 2019;60:8N.
    PubMed    


  538. SCHWAIGER M, Czernin J
    A Conversation Between Markus Schwaiger and Johannes Czernin.
    J Nucl Med. 2019;60:573-576.
    PubMed    


  539. KELLY JM, Amor-Coarasa A, Ponnala S, Nikolopoulou A, et al
    Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.
    J Nucl Med. 2019;60:656-663.
    PubMed     Abstract available


    April 2019
  540. SCHILLER F, Frings L, Thurow J, Meyer PT, et al
    Limits for reduction of acquisition time or administered activity in (18)F-FDG PET studies in Alzheimer's and frontotemporal dementia.
    J Nucl Med. 2019 Apr 26. pii: jnumed.119.227132. doi: 10.2967/jnumed.119.227132.
    PubMed     Abstract available


  541. CATANA C
    Development of Dedicated Brain PET Imaging Devices - Recent Advances and Future Perspectives.
    J Nucl Med. 2019 Apr 26. pii: jnumed.118.217901. doi: 10.2967/jnumed.118.217901.
    PubMed     Abstract available


  542. PIRON S, De Man K, Van Laeken N, D'Asseler Y, et al
    Radiation dosimetry and biodistribution of (18)F-PSMA-11 for PET imaging of prostate cancer.
    J Nucl Med. 2019 Apr 26. pii: jnumed.118.225250. doi: 10.2967/jnumed.118.225250.
    PubMed     Abstract available


  543. JANSEN BHE, Yaqub M, Voortman J, Cysouw MCF, et al
    Simplified Methods for Quantification of (18)F-DCFPyL Uptake in Patients with Prostate Cancer.
    J Nucl Med. 2019 Apr 18. pii: jnumed.119.227520. doi: 10.2967/jnumed.119.227520.
    PubMed     Abstract available


  544. REZAEI A, Schramm G, Willekens SM, Delso G, et al
    A Quantitative Evaluation of Joint Activity and Attenuation Reconstruction in TOF-PET/MR Brain Imaging.
    J Nucl Med. 2019 Apr 12. pii: jnumed.118.220871. doi: 10.2967/jnumed.118.220871.
    PubMed     Abstract available


  545. ROUSSEAU E, Wilson D, Lacroix-Poisson F, Krauze A, et al
    A Prospective Study on (18)F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer.
    J Nucl Med. 2019 Apr 12. pii: jnumed.119.226381. doi: 10.2967/jnumed.119.226381.
    PubMed     Abstract available


  546. LINDEMANN ME, Guberina N, Wetter A, Fendler W, et al
    Improving 68-Ga-PSMA PET/MR hybrid imaging of the prostate with un-renormalized absolute scatter correction.
    J Nucl Med. 2019 Apr 12. pii: jnumed.118.224139. doi: 10.2967/jnumed.118.224139.
    PubMed     Abstract available


  547. EHMAN EC, El-Sady MS, Kijewski MF, Khor YM, et al
    Early Detection of Multiorgan Light Chain (AL) Amyloidosis by Whole Body (18)F-florbetapir PET/CT.
    J Nucl Med. 2019 Apr 6. pii: jnumed.118.221770. doi: 10.2967/jnumed.118.221770.
    PubMed     Abstract available


  548. KRATOCHWIL C, Flechsig P, Lindner T, Abderrahim L, et al
    FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer.
    J Nucl Med. 2019 Apr 6. pii: jnumed.119.227967. doi: 10.2967/jnumed.119.227967.
    PubMed     Abstract available


  549. ABIODUN-OJO OA, Akintayo AA, Akin-Akintayo OO, Tade FI, et al
    (18)F-Fluciclovine parameters on targeted prostate biopsy associated with true positivity in recurrent prostate cancer.
    J Nucl Med. 2019 Apr 6. pii: jnumed.119.227033. doi: 10.2967/jnumed.119.227033.
    PubMed     Abstract available


  550. TREVES ST, Gelfand M, Parisi M, Lassmann M, et al
    Update: Image Gently and Nuclear Medicine at 10 Years.
    J Nucl Med. 2019;60:7N-9N.
    PubMed    


  551. MINOSHIMA S
    News from SNMMI Leadership: SNMMI Acts to Ensure Patient Access to Safe and Effective Nuclear Medicine Procedures.
    J Nucl Med. 2019;60:11N.
    PubMed    


  552. GORDON L
    Report from ABNM: Board of Directors Selection.
    J Nucl Med. 2019;60:10N.
    PubMed    


  553. PHELPS ME, Lewis JS
    A Conversation Between Michael Phelps and Jason Lewis.
    J Nucl Med. 2019;60:439-442.
    PubMed    


    March 2019
  554. JADVAR H, Velez E, Desai B, Ji L, et al
    Prediction of time to hormonal treatment failure in metastatic castrate-sensitive prostate cancer with (18)F-FDG PET/CT.
    J Nucl Med. 2019 Mar 29. pii: jnumed.118.223263. doi: 10.2967/jnumed.118.223263.
    PubMed     Abstract available


  555. GRUENEISEN J, Schaarschmidt BM, Demircioglu A, Chodyla M, et al
    (18)F-FDG PET/MRI for therapy response assessment of isolated limp perfusion in patients with soft-tissue sarcomas.
    J Nucl Med. 2019 Mar 29. pii: jnumed.119.226761. doi: 10.2967/jnumed.119.226761.
    PubMed     Abstract available


  556. FAY R, Holland JP
    The impact of emerging bioconjugation chemistries on radiopharmaceuticals.
    J Nucl Med. 2019 Mar 22. pii: jnumed.118.220806. doi: 10.2967/jnumed.118.220806.
    PubMed     Abstract available


  557. SOEDA F, Watabe T, Naka S, Liu Y, et al
    Impact of (18)F-PSMA-1007 uptake in prostate cancer using different peptide concentrations: preclinical PET/CT study in mice.
    J Nucl Med. 2019 Mar 22. pii: jnumed.118.223479. doi: 10.2967/jnumed.118.223479.
    PubMed     Abstract available


  558. METSER U, Chua SS, Ho B, Punwani S, et al
    The contribution of multiparametric pelvic & whole body MR to interpretation of (18)F-fluoromethylcholine or (68)Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
    J Nucl Med. 2019 Mar 22. pii: jnumed.118.225185. doi: 10.2967/jnumed.118.225185.
    PubMed     Abstract available


  559. BROOS W, Wondergem M, van der Zant F, Knol R, et al
    Dual-time-point (18)F-fluorocholine PET/CT in Parathyroid Imaging.
    J Nucl Med. 2019 Mar 15. pii: jnumed.118.225599. doi: 10.2967/jnumed.118.225599.
    PubMed     Abstract available


  560. VALKEMA MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, et al
    Accuracy of (18)F-FDG PET/CT in predicting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer.
    J Nucl Med. 2019 Mar 15. pii: jnumed.118.224196. doi: 10.2967/jnumed.118.224196.
    PubMed     Abstract available


  561. ZUKOTYNSKI K, Niederkohr RD, Greenspan BS, Prior JO, et al
    Invited Perspective on an International Survey of PET/CT Clinical Reporting.
    J Nucl Med. 2019 Mar 15. pii: jnumed.118.223073. doi: 10.2967/jnumed.118.223073.
    PubMed    


  562. AVALLONE A, Aloj L, Pecori B, Caraco C, et al
    (18)F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival to Preoperative Radiochemotherapy with Bevacizumab in High Risk Locally Advanced Rectal Cancer.
    J Nucl Med. 2019 Mar 15. pii: jnumed.118.222604. doi: 10.2967/jnumed.118.222604.
    PubMed     Abstract available


  563. GALLEZOT JD, Nabulsi NB, Henry S, Pracitto R, et al
    IMAGING THE ENZYME 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE 1 WITH POSITRON EMISSION TOMOGRAPHY: EVALUATION OF THE NOVEL RADIOTRACER (11)C-AS2471907 IN HUMAN BRAIN.
    J Nucl Med. 2019 Mar 15. pii: jnumed.118.219766. doi: 10.2967/jnumed.118.219766.
    PubMed     Abstract available


  564. HOPE TA, Calais J, Zhang L, Dieckmann W, et al
    (111)In-pentetreotide scintigraphy vs. (68)Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.223016. doi: 10.2967/jnumed.118.223016.
    PubMed     Abstract available


  565. SCHUBERT JJ, Veronese M, Marchitelli L, Bodini B, et al
    Dynamic (11)C-PiB PET shows cerebrospinal fluid flow alterations in Alzheimer's disease and multiple sclerosis.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.223834. doi: 10.2967/jnumed.118.223834.
    PubMed     Abstract available


  566. EKMEKCIOGLU O, Busstra M, Klass ND, Verzijlbergen F, et al
    Bridging the imaging gap: PSMA PET/CT has a high impact on treatment planning in prostate cancer patients with biochemical recurrence - a narrative review of literature.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.222885. doi: 10.2967/jnumed.118.222885.
    PubMed     Abstract available


  567. SIITONEN R, Peuhu E, Autio AK, Liljenback H, et al
    (68)Ga-DOTA-E[c(RGDfK)]2 Positron Emission Tomography Imaging of SHARPIN-Regulated Integrin Activity in Mice.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.222026. doi: 10.2967/jnumed.118.222026.
    PubMed     Abstract available


  568. MANNHEIM JG, Mamach M, Reder S, Traxl A, et al
    Reproducibility and comparability of preclinical PET imaging data: A multi-center small animal PET study.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.221994. doi: 10.2967/jnumed.118.221994.
    PubMed     Abstract available


  569. WOFF E, Kehagias P, Vandeputte C, Ameye L, et al
    Combining (18)F-FDG PET/CT-based Metabolically Active Tumor Volume and Circulating Cell-free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.222919. doi: 10.2967/jnumed.118.222919.
    PubMed     Abstract available


  570. SCHWENCK J, Olthof SC, Pfannenberg C, Reischl G, et al
    Intention to treat analysis of (68)Ga-PSMA and (11)C-choline PET/CT versus CT for prostate cancer recurrences after surgery.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.224543. doi: 10.2967/jnumed.118.224543.
    PubMed     Abstract available


  571. KUMAR M, Salem K, Michel CJ, Jeffery JJ, et al
    (18)F-Fluoroestradiol Positron Emission Tomography Imaging of Activating Estrogen Receptor Alpha Mutations in Breast Cancer.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.224667. doi: 10.2967/jnumed.118.224667.
    PubMed     Abstract available


  572. MIRZAEI S, Dadparvar S, Alavi A
    Economic sanctions endanger nuclear medicine services in Iran.
    J Nucl Med. 2019 Mar 8. pii: jnumed.119.226852. doi: 10.2967/jnumed.119.226852.
    PubMed    


  573. GAFITA A, Bieth M, Kroenke M, Tetteh G, et al
    qPSMA: a semi-automatic software for whole-body tumor burden assessment in prostate cancer using (68)Ga-PSMA11 PET/CT.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.224055. doi: 10.2967/jnumed.118.224055.
    PubMed     Abstract available


  574. AZAD G, Siddique M, Taylor B, Green A, et al
    Reply to: Relevance of measurement uncertainty for quantitative response assessment of breast cancer bone metastases with (18)F-fluoride.
    J Nucl Med. 2019 Mar 8. pii: jnumed.119.226555. doi: 10.2967/jnumed.119.226555.
    PubMed    


  575. GEISLER S, Stegmayr C, Niemietz N, Lohmann P, et al
    Treatment-related uptake of O-(2-[(18)F]fluoroethyl)-L-tyrosine and L-[methyl-(3)H]-methionine after tumor resection in rat glioma models.
    J Nucl Med. 2019 Mar 8. pii: jnumed.119.225680. doi: 10.2967/jnumed.119.225680.
    PubMed     Abstract available


  576. KRAMER GM, Yaqub M, Vargas HA, Schuit R, et al
    Assessment of simplified methods for quantification of (18)F-FDHT uptake in patients with metastatic castration-resistant prostate cancer.
    J Nucl Med. 2019 Mar 8. pii: jnumed.118.220111. doi: 10.2967/jnumed.118.220111.
    PubMed     Abstract available


  577. CHERRY SR, Czernin J
    Discussions with Leaders: A Conversation between Simon Cherry and Johannes Czernin.
    J Nucl Med. 2019;60:295-298.
    PubMed    


  578. KIRCHER S, Stolzenburg A, Kortum KM, Kircher M, et al
    Hexokinase-2 Expression in (11)C-Methionine-Positive, (18)F-FDG-Negative Multiple Myeloma.
    J Nucl Med. 2019;60:348-352.
    PubMed     Abstract available


  579. ZHANG J, Kulkarni HR, Singh A, Niepsch K, et al
    Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
    J Nucl Med. 2019;60:377-385.
    PubMed     Abstract available


  580. SAUTER AW, Mansi R, Hassiepen U, Muller L, et al
    Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog (177)Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
    J Nucl Med. 2019;60:393-399.
    PubMed     Abstract available


    February 2019
  581. WERNER RA, Bundschuh R, Bundschuh L, Fanti S, et al
    Introduction of Novel Structured Reporting Systems for PET Radiotracers with Potential Theranostic Applications.
    J Nucl Med. 2019 Feb 22. pii: jnumed.118.223537. doi: 10.2967/jnumed.118.223537.
    PubMed     Abstract available


  582. ALESAWI HM, Yakar D, Glaudemans AW, Kwee TC, et al
    Frequency, determinants, and costs of recommendations for additional imaging in clinical FDG-PET/CT reports.
    J Nucl Med. 2019 Feb 22. pii: jnumed.118.223362. doi: 10.2967/jnumed.118.223362.
    PubMed     Abstract available


  583. XING Y, Chand G, Liu C, Cook GJR, et al
    Early phase I study of a (99m)Tc labeled anti-PD-L1 single domain antibody in SPECT/CT assessment of programmed death ligand-1 expression in non-small cell lung cancer.
    J Nucl Med. 2019 Feb 22. pii: jnumed.118.224170. doi: 10.2967/jnumed.118.224170.
    PubMed     Abstract available


  584. LIU T, Liu C, Xu X, Liu F, et al
    Preclinical evaluation and pilot clinical study of Al(18)F-PSMA-BCH for prostate cancer imaging.
    J Nucl Med. 2019 Feb 22. pii: jnumed.118.221671. doi: 10.2967/jnumed.118.221671.
    PubMed     Abstract available


  585. VELDHUIJZEN VAN ZANTEN SEM, De Witt Hamer PC, van Dongen GAMS
    Brain access of monoclonal antibodies as imaged and quantified by (89)Zr-antibody-PET: perspectives for treatment of brain diseases.
    J Nucl Med. 2019 Feb 8. pii: jnumed.118.220939. doi: 10.2967/jnumed.118.220939.
    PubMed    


  586. FRAUM TJ, Fowler KJ, Crandall JP, Laforest RA, et al
    Measurement Repeatability of (18)F-FDG-PET/CT versus (18)F-FDG-PET/MRI in Solid Tumors of the Pelvis.
    J Nucl Med. 2019 Feb 7. pii: jnumed.118.218735. doi: 10.2967/jnumed.118.218735.
    PubMed     Abstract available


  587. NABULSI NB, Holden D, Zheng MQ, Bois F, et al
    Evaluation of (11)C-LSN3172176 as a novel PET tracer for imaging M1 muscarinic acetylcholine receptors in non-human primates.
    J Nucl Med. 2019 Feb 7. pii: jnumed.118.222034. doi: 10.2967/jnumed.118.222034.
    PubMed     Abstract available


  588. URIBE CF, Mathotaarachchi S, Gaudet VC, Smith KC, et al
    Part 1: Introduction to Machine Learning in the Nuclear Medicine Context.
    J Nucl Med. 2019 Feb 7. pii: jnumed.118.223495. doi: 10.2967/jnumed.118.223495.
    PubMed     Abstract available


  589. KOLB H, Barret O, Bhattacharya A, Chen G, et al
    Preclinical evaluation and non-human primate receptor occupancy study of (18)F-JNJ-64413739, a novel PET radioligand for P2X7 receptors.
    J Nucl Med. 2019 Feb 7. pii: jnumed.118.212696. doi: 10.2967/jnumed.118.212696.
    PubMed     Abstract available


  590. BADAWI RD, Shi H, Hu P, Chen S, et al
    FIRST HUMAN IMAGING STUDIES WITH THE EXPLORER TOTAL-BODY PET SCANNER.
    J Nucl Med. 2019 Feb 7. pii: jnumed.119.226498. doi: 10.2967/jnumed.119.226498.
    PubMed     Abstract available


  591. LAFFON E, Marthan R
    Relevance of measurement uncertainty for quantitative response assessment of breast cancer bone metastases with (18)F-fluoride.
    J Nucl Med. 2019 Feb 7. pii: jnumed.119.226092. doi: 10.2967/jnumed.119.226092.
    PubMed    


    January 2019
  592. NODWELL MB, Yang H, Merkens H, Malik N, et al
    (18)F-branched chain amino acids: structure-activity relationships and PET imaging potential.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220483. doi: 10.2967/jnumed.118.220483.
    PubMed     Abstract available


  593. JILG CA, Drendel V, Rischke HC, Beck TIR, et al
    Detection Rate of (18)F-choline-PET/CT and (68)Ga-PSMA-HBED-CC-PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220541. doi: 10.2967/jnumed.118.220541.
    PubMed     Abstract available


  594. MARNER L, Nysom K, Sehested A, Borgwardt L, et al
    Early Postoperative (18)F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220293. doi: 10.2967/jnumed.118.220293.
    PubMed     Abstract available


  595. CERCI JJ, Etchebehere EC, Nadel H, Brink A, et al
    Is True Whole-body FDG-PET/CT required in paediatric lymphoma? An IAEA Multicentre Prospective Study.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.222299. doi: 10.2967/jnumed.118.222299.
    PubMed     Abstract available


  596. HAIDER A, Muller Herder A, Kramer SD, Varisco J, et al
    Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)- and (S)-(11)C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and Tightrope Walk between GluN2B- and Sigma1 Receptor-Targeted PET Imaging.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.221051. doi: 10.2967/jnumed.118.221051.
    PubMed     Abstract available


  597. BURGER IA, Muller J, Donati OF, Ferraro DA, et al
    (68)Ga-PSMA-11 PET/MR detects local recurrence occult on mpMRI in prostate cancer patients after HIFU.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.221564. doi: 10.2967/jnumed.118.221564.
    PubMed     Abstract available


  598. HWANG D, Kang SK, Kim KY, Seo S, et al
    Generation of PET attenuation map for whole-body time-of-flight (18)F-FDG PET/MRI using a deep neural network trained with simultaneously reconstructed activity and attenuation maps.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.219493. doi: 10.2967/jnumed.118.219493.
    PubMed     Abstract available


  599. JOCHUMSEN MR, Tolbod LP, Pedersen BG, Nielsen MM, et al
    Quantitative tumor perfusion imaging with (82)Rubidium-PET/CT in prostate cancer - analytical and clinical validation.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.219188. doi: 10.2967/jnumed.118.219188.
    PubMed     Abstract available


  600. DOOT RK
    Practical methods for estimating metabolic flux (Ki) to assess response to therapy via static PET scans.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220913. doi: 10.2967/jnumed.118.220913.
    PubMed    


  601. CHAREONTHAITAWEE P, Blankstein R
    Reply to LTE, "Role of (18)F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring: Addition to the Expert Consensus".
    J Nucl Med. 2019 Jan 17. pii: jnumed.118.221879. doi: 10.2967/jnumed.118.221879.
    PubMed    


  602. VAN SLUIS JJ, de Jong J, Schaar J, Noordzij W, et al
    Performance characteristics of the digital Biograph Vision PET/CT system.
    J Nucl Med. 2019 Jan 10. pii: jnumed.118.215418. doi: 10.2967/jnumed.118.215418.
    PubMed     Abstract available


  603. LI S, Zheng MQ, Naganawa M, Kim S, et al
    Development and in vivo evaluation of a novel kappa opioid receptor agonist as PET radiotracer with superior imaging characteristics.
    J Nucl Med. 2019 Jan 10. pii: jnumed.118.220517. doi: 10.2967/jnumed.118.220517.
    PubMed     Abstract available


  604. TOURNIER N, Bauer M, Pichler V, Nics L, et al
    Impact of P-glycoprotein Function on the Brain Kinetics of the Weak Substrate (11)C-Metoclopramide Assessed with PET Imaging in Humans.
    J Nucl Med. 2019 Jan 10. pii: jnumed.118.219972. doi: 10.2967/jnumed.118.219972.
    PubMed     Abstract available


  605. CHEN DL
    PET imaging of PARP expression using [(18)F]olaparib.
    J Nucl Med. 2019 Jan 10. pii: jnumed.118.219733. doi: 10.2967/jnumed.118.219733.
    PubMed    


  606. MINOSHIMA S
    SNMMI Leadership Update: At Home and Worldwide, Collaboration is Key for the Field of Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2019;60:18N.
    PubMed    


  607. BODEI L, Herrmann K, Baum RP, Kidd M, et al
    Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus.
    J Nucl Med. 2019;60:7-8.
    PubMed    


  608. WAHL RL, Czernin J
    Discussions with Leaders: A Conversation Between Richard Wahl and Johannes Czernin.
    J Nucl Med. 2019;60:3-6.
    PubMed    


  609. MORTIMER JE, Shively JE
    Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers and a Note about NOTA.
    J Nucl Med. 2019;60:23-25.
    PubMed    


  610. BOSS SD, Muller C, Siwowska K, Schmid RM, et al
    Diastereomerically Pure 6R- and 6S-3'-Aza-2'-(18)F-Fluoro-5-Methyltetrahydrofolates Show Unprecedentedly High Uptake in Folate Receptor-Positive KB Tumors.
    J Nucl Med. 2019;60:135-141.
    PubMed     Abstract available


  611. CECCARINI J, Ahmad R, Van de Vliet L, Casteels C, et al
    Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB1R Levels.
    J Nucl Med. 2019;60:115-121.
    PubMed     Abstract available


  612. KLETTING P, Thieme A, Eberhardt N, Rinscheid A, et al
    Modeling and Predicting Tumor Response in Radioligand Therapy.
    J Nucl Med. 2019;60:65-70.
    PubMed     Abstract available


    December 2018
  613. COUGHLIN J, Du Y, Crawford JL, Rubin LH, et al
    The availability of the alpha7 nicotinic acetylcholine receptor in recent-onset psychosis: a study using (18)F-ASEM PET.
    J Nucl Med. 2018 Dec 20. pii: jnumed.118.213686. doi: 10.2967/jnumed.118.213686.
    PubMed     Abstract available


  614. PYO A, Kim HS, Kim G, Kim HS, et al
    N-(2-(dimethylamino)ethyl)-4-(18)F-fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma.
    J Nucl Med. 2018 Dec 14. pii: jnumed.118.221416. doi: 10.2967/jnumed.118.221416.
    PubMed     Abstract available


  615. SCHMIDT-HEGEMANN NS, Chukwuka E, Minglun L, Rogowski P, et al
    Impact of (68)Ga-PSMA-PET/CT on the radiotherapeutic approach for prostate cancer in comparison to CT - a retrospective analysis.
    J Nucl Med. 2018 Dec 14. pii: jnumed.118.220855. doi: 10.2967/jnumed.118.220855.
    PubMed     Abstract available


  616. BERREVOETS MAH, Kouijzer IJE, Slieker K, Aarntzen E, et al
    (18)F-FDG-PET/CT-guided treatment duration in patients with high-risk Staphylococcus aureus bacteremia: a proof of principle.
    J Nucl Med. 2018 Dec 14. pii: jnumed.118.221929. doi: 10.2967/jnumed.118.221929.
    PubMed     Abstract available


  617. CHEN M, Zhang Q, Zhang C, Zhao X, et al
    Combination of (68)Ga-PSMA PET/CT and multiparameter MRI improves the detection of clinically significant prostate cancer: a lesion by lesion analysis.
    J Nucl Med. 2018 Dec 14. pii: jnumed.118.221010. doi: 10.2967/jnumed.118.221010.
    PubMed     Abstract available


  618. EMMETT LM, Yin C, Crumbaker M, Hruby G, et al
    Rapid modulation of PSMA expression by Androgen deprivation: Serial (68)Ga PSMA-11 PET in men with hormone sensitive and castrate resistant prostate cancer commencing androgen blockade.
    J Nucl Med. 2018 Dec 14. pii: jnumed.118.223099. doi: 10.2967/jnumed.118.223099.
    PubMed     Abstract available


  619. TAKANO A, Chen L, Nag S, Brodney MA, et al
    Quantitative Analysis of (18)F-PF-06684511, a Novel PET Radioligand for Selective beta-secretase 1 Imaging, in Non-human Primate Brain.
    J Nucl Med. 2018 Dec 7. pii: jnumed.118.217372. doi: 10.2967/jnumed.118.217372.
    PubMed     Abstract available


  620. HOPE TA, Goodman JZ, Allen IE, Calais J, et al
    Meta-analysis of (68)Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology.
    J Nucl Med. 2018 Dec 7. pii: jnumed.118.219501. doi: 10.2967/jnumed.118.219501.
    PubMed     Abstract available


  621. FAHEY FH, Christian PE, Zukotynski K, Sexton-Stallone B, et al
    Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network.
    J Nucl Med. 2018 Dec 7. pii: jnumed.118.219998. doi: 10.2967/jnumed.118.219998.
    PubMed     Abstract available


    November 2018
  622. PAQUETTE M, Turcotte E
    Measuring Estrogen Receptor Functionality using Progesterone Receptor PET Imaging: Rising to the (Estradiol) Challenge!
    J Nucl Med. 2018 Nov 21. pii: jnumed.118.220921. doi: 10.2967/jnumed.118.220921.
    PubMed    


  623. BEHR SC, Aggarwal R, Van Brocklin HF, Flavell RR, et al
    First-in-Human Phase I study of CTT1057, a Novel (18)F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer.
    J Nucl Med. 2018 Nov 21. pii: jnumed.118.220715. doi: 10.2967/jnumed.118.220715.
    PubMed     Abstract available


  624. LASSEN ML, Kwiecinski J, Cadet S, Dey D, et al
    Data-driven gross patient motion detection and compensation: Implications for coronary (18)F-NaF PET imaging.
    J Nucl Med. 2018 Nov 15. pii: jnumed.118.217877. doi: 10.2967/jnumed.118.217877.
    PubMed     Abstract available


  625. MIRANDA A, Glorie D, Bertoglio D, Vleugels J, et al
    Awake (18)F-FDG PET imaging of memantine-induced brain activation and test-retest in freely running mice.
    J Nucl Med. 2018 Nov 15. pii: jnumed.118.218669. doi: 10.2967/jnumed.118.218669.
    PubMed     Abstract available


  626. PANDYA DN, Bhatt NB, Almaguel F, Rideout-Danner S, et al
    Zirconium-89 chloride can be used for immuno-PET radiochemistry without loss of antigen reactivity in vivo.
    J Nucl Med. 2018 Nov 15. pii: jnumed.118.216457. doi: 10.2967/jnumed.118.216457.
    PubMed     Abstract available


  627. HICKS RJ, Jackson P, Kong G, Ware RE, et al
    First-in-human trial of (64)Cu-SARTATE PET imaging of patients with neuroendocrine tumours demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor radionuclide therapy.
    J Nucl Med. 2018 Nov 15. pii: jnumed.118.217745. doi: 10.2967/jnumed.118.217745.
    PubMed     Abstract available


  628. LARIMER BM
    Reporter Genes for PET Imaging of CAR-T Cells Offers Insight into Adoptive Cell Transfer.
    J Nucl Med. 2018 Nov 15. pii: jnumed.118.220897. doi: 10.2967/jnumed.118.220897.
    PubMed    


  629. ITO K, Teng R, Schoder H, Humm JL, et al
    F-18 FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.213652. doi: 10.2967/jnumed.118.213652.
    PubMed     Abstract available


  630. YOUSSEF M, Matthews R
    Nuclear Medicine Board Review: Questions and Answers for Self-Assessment, 4th Edition.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.223172. doi: 10.2967/jnumed.118.223172.
    PubMed    


  631. VAN BERKEL A, Vriens D, Visser E, Janssen M, et al
    Metabolic subtyping of pheochromocytoma and paraganglioma by (18)F-FDG pharmacokinetics using dynamic PET/CT scanning.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.216796. doi: 10.2967/jnumed.118.216796.
    PubMed     Abstract available


  632. DMOCHOWSKA N, Tieu W, Keller M, Wardill H, et al
    Immuno-PET of innate immune markers CD11b and IL-1beta detect inflammation in murine colitis.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.219287. doi: 10.2967/jnumed.118.219287.
    PubMed     Abstract available


  633. LU Y, Sweiss N
    Role of (18)F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring: Addition to the Expert Consensus.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.221549. doi: 10.2967/jnumed.118.221549.
    PubMed    


  634. ZHUANG M, Vallez Garcia D, Kramer GM, Frings V, et al
    Variability and repeatability of quantitative uptake metrics in [(18)F]FDG PET/CT imaging of non-small cell lung cancer: impact of segmentation method, uptake interval, and reconstruction protocol.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.216028. doi: 10.2967/jnumed.118.216028.
    PubMed     Abstract available


  635. ZLATOPOLSKIY BD, Endepols H, Krapf P, Guliyev M, et al
    Discovery of (18)F-JK-PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.218495. doi: 10.2967/jnumed.118.218495.
    PubMed     Abstract available


  636. WILSON T, Xavier MA, Knight J, Verhoog S, et al
    PET imaging of PARP expression using [(18)F]olaparib.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.213223. doi: 10.2967/jnumed.118.213223.
    PubMed     Abstract available


  637. PAPP L, Rausch I, Grahovac M, Hacker M, et al
    Optimized feature extraction for radiomics analysis of (18)F-FDG-PET imaging.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217612. doi: 10.2967/jnumed.118.217612.
    PubMed     Abstract available


  638. MELLHAMMAR EM, Dahlbom M, Evans-Axelsson S, Strand SE, et al
    Preserving preclinical PET quality during intratherapeutic imaging in radionuclide therapy with Rose metal shielding reducing photon flux.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217117. doi: 10.2967/jnumed.118.217117.
    PubMed     Abstract available


  639. PERRIN M, Roch V, Claudin M, Verger A, et al
    Assessment of myocardial CZT-SPECT recording in a forward-leaning "biker-like" position.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217695. doi: 10.2967/jnumed.118.217695.
    PubMed     Abstract available


  640. FREUDENBERG LS, Hicks RJ, Beyer T
    AN INTERNATIONAL SURVEY ON CLINICAL REPORTING OF DUAL-MODALITY PET/CT IMAGING EXAMINATIONS: A STARTING POINT FOR CROSS-SPECIALTY ENGAGEMENT.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.218073. doi: 10.2967/jnumed.118.218073.
    PubMed     Abstract available


  641. LI Y, Langhorst J, Koch AK, Demircioglu A, et al
    Assessment of ileocolonic inflammation in Crohn's disease - Which surrogate marker is better? MaRIA, Clermont or PET-MR index? Initial results of a feasibility trial.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.216937. doi: 10.2967/jnumed.118.216937.
    PubMed     Abstract available


  642. MINOSHIMA S
    SNMMI Leadership Update: SNMMI Committed to Promotion of Women in Nuclear Medicine.
    J Nucl Med. 2018;59:18N.
    PubMed    


    October 2018
  643. RAUSCH I, Ruiz A, Valverde-Pascual I, Cal-Gonzalez J, et al
    Performance evaluation of the Philips Vereos PET/CT system according to the NEMA NU2-2012 standard.
    J Nucl Med. 2018 Oct 25. pii: jnumed.118.215541. doi: 10.2967/jnumed.118.215541.
    PubMed     Abstract available


  644. KURLAND BF, Peterson LM, Shields AT, Lee JH, et al
    Test-retest reproducibility of FDG-PET/CT uptake in cancer patients within a qualified and calibrated local network.
    J Nucl Med. 2018 Oct 25. pii: jnumed.118.209544. doi: 10.2967/jnumed.118.209544.
    PubMed     Abstract available


  645. LESNIAK WG, Chu C, Jablonska A, Du Y, et al
    PET imaging of intra-arterial (89)Zr bevacizumab in mice with and without osmotic opening of the blood-brain barrier: distinct advantage of intra-arterial delivery.
    J Nucl Med. 2018 Oct 12. pii: jnumed.118.218792. doi: 10.2967/jnumed.118.218792.
    PubMed     Abstract available


  646. COLLIJ L, Konijnenberg E, Reimand J, Ten Kate M, et al
    Assessing Amyloid Pathology in Cognitively Normal Subjects using [(18)F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods.
    J Nucl Med. 2018 Oct 12. pii: jnumed.118.211532. doi: 10.2967/jnumed.118.211532.
    PubMed     Abstract available


  647. ROHDE M, Nielsen AL, Pareek M, Johansen J, et al
    PET/CT versus standard imaging for prediction of survival in patients with recurrent head and neck squamous cell carcinoma.
    J Nucl Med. 2018 Oct 12. pii: jnumed.118.217976. doi: 10.2967/jnumed.118.217976.
    PubMed     Abstract available


  648. LEE H, Lazor JW, Assadsangabi R, Shah J, et al
    An imager's guide to perineural tumor spread in head and neck cancers: radiological footprints on (18)F-FDG PET with CT and MRI correlates.
    J Nucl Med. 2018 Oct 5. pii: jnumed.118.214312. doi: 10.2967/jnumed.118.214312.
    PubMed     Abstract available


  649. JACENE HA
    2018 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2018;59:7N-13N.
    PubMed    


    September 2018
  650. SCHWARZ SW, Decristoforo C, Goodbody AE, Singhal N, et al
    Harmonization of United States, European Union and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals-Is This Possible?
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.209460. doi: 10.2967/jnumed.118.209460.
    PubMed     Abstract available


  651. KOOLE M, Schmidt M, Hijzen A, Ravenstijn P, et al
    (18)F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability and occupancy of the P2X7 antagonist JNJ-54175446.
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.216747. doi: 10.2967/jnumed.118.216747.
    PubMed     Abstract available


  652. BETANCUR JA, Hu LH, Commandeur F, Sharir T, et al
    Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study.
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.213538. doi: 10.2967/jnumed.118.213538.
    PubMed     Abstract available


  653. CHAPLE IF, Lapi SE
    Production and use of first row transition metal PET radionuclides, (43,44)Sc, (52)Mn, and (45)Ti.
    J Nucl Med. 2018 Sep 27. pii: jnumed.118.213264. doi: 10.2967/jnumed.118.213264.
    PubMed     Abstract available


  654. RAY BANEREJEE S, Kumar V, Lisok A, Plyku D, et al
    Evaluation of (111)In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.
    J Nucl Med. 2018 Sep 20. pii: jnumed.118.214403. doi: 10.2967/jnumed.118.214403.
    PubMed     Abstract available


  655. ULANER GA, Juarez J, Riedl C, Goldman D, et al
    (18)F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men.
    J Nucl Med. 2018 Sep 20. pii: jnumed.118.217836. doi: 10.2967/jnumed.118.217836.
    PubMed     Abstract available


  656. SCHOTTELIUS M, Wurzer A, Wissmiller K, Beck R, et al
    Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer.
    J Nucl Med. 2018 Sep 20. pii: jnumed.118.212720. doi: 10.2967/jnumed.118.212720.
    PubMed     Abstract available


  657. BURLEY TA, Pieve CD, Martins CD, Ciobota DM, et al
    Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.216069. doi: 10.2967/jnumed.118.216069.
    PubMed     Abstract available


  658. KWIECINSKI J, Berman DS, Lee SE, Dey D, et al
    Three-hour delayed imaging improves assessment of coronary (18)F-sodium fluoride PET.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.217885. doi: 10.2967/jnumed.118.217885.
    PubMed     Abstract available


  659. LANDAU SM
    Optimizing longitudinal beta-amyloid PET measurement: The challenges of intensity normalization.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.212662. doi: 10.2967/jnumed.118.212662.
    PubMed    


  660. PAUL S, Haskali MB, Liow JS, Zoghbi SS, et al
    Evaluation of a novel PET radioligand to image O-GlcNAcase in brain and periphery of rhesus monkey and knock-out mouse.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.213231. doi: 10.2967/jnumed.118.213231.
    PubMed     Abstract available


  661. BIEGON A, Franceschi D, Schweitzer M
    Response to Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women - Unappreciated or Otherwise.
    J Nucl Med. 2018 Sep 13. pii: jnumed.118.218834. doi: 10.2967/jnumed.118.218834.
    PubMed    


  662. WERNER RA, Bundschuh RA, Bundschuh L, Javadi MS, et al
    Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on (18)F-DCFPyL PET/CT Imaging.
    J Nucl Med. 2018 Sep 6. pii: jnumed.118.217588. doi: 10.2967/jnumed.118.217588.
    PubMed     Abstract available


  663. YIN Y, Werner RA, Higuchi T, Lapa C, et al
    Follow-Up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.
    J Nucl Med. 2018 Sep 6. pii: jnumed.118.217653. doi: 10.2967/jnumed.118.217653.
    PubMed     Abstract available


  664. MINOSHIMA S
    SNMMI Leadership Update: Training Future Nuclear Medicine Physicians.
    J Nucl Med. 2018;59:17N-18N.
    PubMed    


    August 2018
  665. TORRADO-CARVAJAL A, Vera-Olmos J, Izquierdo-Garcia D, Catalano OA, et al
    Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction.
    J Nucl Med. 2018 Aug 30. pii: jnumed.118.209288. doi: 10.2967/jnumed.118.209288.
    PubMed     Abstract available


  666. SPUHLER KD, Gardus J 3rd, Gao Y, DeLorenzo C, et al
    Synthesis of patient-specific transmission image for PET attenuation correction for PET/MR imaging of the brain using a convolutional neural network'.
    J Nucl Med. 2018 Aug 30. pii: jnumed.118.214320. doi: 10.2967/jnumed.118.214320.
    PubMed     Abstract available


  667. SIEGEL JA, Greenspan BS, Silberstein EB, Sacks B, et al
    Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women - Unappreciated or Otherwise.
    J Nucl Med. 2018 Aug 30. pii: jnumed.118.218842. doi: 10.2967/jnumed.118.218842.
    PubMed    


  668. MEIER JG, Wu CC, Betancourt Cuellar SL, Truong MT, et al
    Evaluation of a novel elastic respiratory motion correction algorithm on quantification and image quality in abdomino-thoracic PET/CT.
    J Nucl Med. 2018 Aug 16. pii: jnumed.118.213884. doi: 10.2967/jnumed.118.213884.
    PubMed     Abstract available


  669. GOULD KL, Johnson NP, Roby A, Nguyen TT, et al
    Regional Artery Specific Thresholds Of Quantitative Myocardial Perfusion By PET Associated With Reduced MI and Death After Revascularization In Stable CAD.
    J Nucl Med. 2018 Aug 16. pii: jnumed.118.211953. doi: 10.2967/jnumed.118.211953.
    PubMed     Abstract available


  670. EVANGELISTA L, Zattoni F
    THE WAR IS OPENED: PSMA VS. (64)CuCL2 VS. CHOLINE PET/CT.
    J Nucl Med. 2018 Aug 16. pii: jnumed.118.218289. doi: 10.2967/jnumed.118.218289.
    PubMed    


  671. KUWABARA H, Comley RA, Borroni E, Honer M, et al
    Evaluation of (18)F-RO-948 ((18)F-RO6958948) for quantitative assessment of tau accumulation in the human brain with positron emission tomography.
    J Nucl Med. 2018 Aug 10. pii: jnumed.118.214437. doi: 10.2967/jnumed.118.214437.
    PubMed     Abstract available


  672. ROUSSEAU E, Lau J, Kuo HT, Zhang Z, et al
    Monosodium glutamate reduces (68)Ga-PSMA-11 uptake in salivary glands and kidneys in preclinical prostate cancer model.
    J Nucl Med. 2018 Aug 10. pii: jnumed.118.215350. doi: 10.2967/jnumed.118.215350.
    PubMed     Abstract available


  673. SCHENKE S, Seifert P, Zimny M, Winkens T, et al
    Risk stratification of thyroid nodules using Thyroid Imaging Reporting And Data System (TIRADS): The omission of thyroid scintigraphy increases the rate of falsely suspected lesions.
    J Nucl Med. 2018 Aug 10. pii: jnumed.118.211912. doi: 10.2967/jnumed.118.211912.
    PubMed     Abstract available


  674. TINKLE C, Duncan E, Doubrovin M, Han Y, et al
    Evaluation of (11)C-methionine PET and anatomic MRI associations in diffuse intrinsic pontine glioma.
    J Nucl Med. 2018 Aug 2. pii: jnumed.118.212514. doi: 10.2967/jnumed.118.212514.
    PubMed     Abstract available


  675. VOUTSINAS N, Lekperic S, Barazani S, Titano JJ, et al
    Interventional Oncology: Treatment of primary liver tumors and liver metastases. Part I: Nuclear medicine techniques (all about spheres).
    J Nucl Med. 2018 Aug 2. pii: jnumed.116.186346. doi: 10.2967/jnumed.116.186346.
    PubMed     Abstract available


  676. GIESEL F, Kratochwil C, Lindner T, Marschalek M, et al
    FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers.
    J Nucl Med. 2018 Aug 2. pii: jnumed.118.215913. doi: 10.2967/jnumed.118.215913.
    PubMed     Abstract available


  677. PAPPAS V
    SNMMI Leadership Update: The SNMMI 2018 Annual Meeting-New Energy and Excitement in Nuclear Medicine.
    J Nucl Med. 2018;59:17N.
    PubMed    


    July 2018
  678. GIESEL FL, Knorr K, Spohn F, Will L, et al
    Detection efficacy of [(18)F]PSMA-1007 PET/CT in 251 Patients with biochemical recurrence after radical prostatectomy.
    J Nucl Med. 2018 Jul 24. pii: jnumed.118.212233. doi: 10.2967/jnumed.118.212233.
    PubMed     Abstract available


  679. AZAD G, Siddique MM, Taylor B, Green A, et al
    Does measurement of (18)F-fluoride metabolic flux improve response assessment of breast cancer bone metastases compared with standardised uptake values in (18)F-fluoride PET/CT?
    J Nucl Med. 2018 Jul 24. pii: jnumed.118.208710. doi: 10.2967/jnumed.118.208710.
    PubMed     Abstract available


  680. PICHLER V, Berroteran-Infante N, Philippe C, Vraka C, et al
    An overview on PET radiochemistry: part 1 - covalent labels - (18)F, (11)C, and (13)N.
    J Nucl Med. 2018 Jul 24. pii: jnumed.117.190793. doi: 10.2967/jnumed.117.190793.
    PubMed     Abstract available


  681. COLLARINO A, Garganese G, Fragomeni SM, Pereira Arias-Bouda LM, et al
    Radiomics in vulvar cancer: first clinical experience using (18)F-FDG PET/CT images.
    J Nucl Med. 2018 Jul 20. pii: jnumed.118.215889. doi: 10.2967/jnumed.118.215889.
    PubMed     Abstract available


  682. TURGEON GA, Iravani A, Akhurst T, Beaulieu A, et al
    What FDG-PET response-assessment method best predicts survival after curative-intent chemoradiation in non-small cell lung cancer (NSCLC): EORTC, PERCIST, Peter Mac or Deauville criteria?
    J Nucl Med. 2018 Jul 20. pii: jnumed.118.214148. doi: 10.2967/jnumed.118.214148.
    PubMed     Abstract available


  683. HAN S, Suh CH, Woo S, Kim YJ, et al
    Performance of (68)Ga-DOTA-Conjugated Somatostatin Receptor Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Meta-Analysis.
    J Nucl Med. 2018 Jul 20. pii: jnumed.118.211706. doi: 10.2967/jnumed.118.211706.
    PubMed     Abstract available


  684. KESLER M, Levine C, Hershkovitz D, Mishani E, et al
    (68)Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study.
    J Nucl Med. 2018 Jul 12. pii: jnumed.118.214833. doi: 10.2967/jnumed.118.214833.
    PubMed     Abstract available


  685. AL-ZAGHAL A, Mehdizadeh Seraj S, Werner TJ, Gerke O, et al
    Assessment of Physiological Intracranial Calcification in Healthy Adults Using (18)F-NaF PET/CT.
    J Nucl Med. 2018 Jul 12. pii: jnumed.118.213678. doi: 10.2967/jnumed.118.213678.
    PubMed     Abstract available


  686. SCHMIDT-HEGEMANN NS, Stief C, Kim TH, Eze C, et al
    Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.
    J Nucl Med. 2018 Jul 12. pii: jnumed.118.212563. doi: 10.2967/jnumed.118.212563.
    PubMed     Abstract available


  687. DE BRUYCKER S, Vangestel C, Van den Wyngaert T, Pauwels P, et al
    (18)F-HX4 Hypoxia PET Holds Promise as a Prognostic and Predictive Imaging Biomarker in a Lung Cancer Xenograft Model Treated with Metformin and Radiotherapy.
    J Nucl Med. 2018 Jul 6. pii: jnumed.118.212225. doi: 10.2967/jnumed.118.212225.
    PubMed     Abstract available


  688. TRAN-GIA J, Lassmann M
    Characterization of Noise and Resolution for Quantitative (177)Lu SPECT/CT with xSPECT Quant.
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.211094. doi: 10.2967/jnumed.118.211094.
    PubMed     Abstract available


  689. KOERBER SA, Will L, Kratochwil C, Haefner MF, et al
    (68)Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients.
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.211086. doi: 10.2967/jnumed.118.211086.
    PubMed     Abstract available


  690. BARTNICKA JJ, Blower P
    Insights into trace metal metabolism in health and disease from PET: "PET metallomics".
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.212803. doi: 10.2967/jnumed.118.212803.
    PubMed     Abstract available


  691. CHANEY A, Cropper HC, Johnson EM, Lechtenberg KJ, et al
    (11)C-DPA-713 versus (18)F-GE-180: A preclinical comparison of TSPO-PET tracers to visualize acute and chronic neuroinflammation in a mouse model of ischemic stroke.
    J Nucl Med. 2018 Jul 5. pii: jnumed.118.209155. doi: 10.2967/jnumed.118.209155.
    PubMed     Abstract available


    June 2018
  692. IMANLI H HASAN.IMAN, Ume KL, Jeudy J, Bob-Manuel T, et al
    VT Substrate Characteristics: Insights from Multi-modality Structural and Functional Imaging of the VT Substrate Using CMR Scar, (123)I-mIBG-SPECT Innervation and Bipolar Voltage.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.211698. doi: 10.2967/jnumed.118.211698.
    PubMed     Abstract available


  693. HEISS WD
    The additional value of PET in the assessment of cerebral small vessel disease.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.214270. doi: 10.2967/jnumed.118.214270.
    PubMed     Abstract available


  694. KIM MJ, Shrestha SS, Cortes M, Singh P, et al
    Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.211144. doi: 10.2967/jnumed.118.211144.
    PubMed     Abstract available


  695. KIM C, Lee JS, Han Y, Chae SY, et al
    Glycoprotein IIb/IIIa receptor imaging with (18)F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.212084. doi: 10.2967/jnumed.118.212084.
    PubMed     Abstract available


  696. WOFF E, Hendlisz A, Ameye L, Garcia C, et al
    Metabolic Active Tumor Volume and Total Lesion Glycolysis by (18)F-FDG PET/CT Validated as Prognostic Imaging Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.210161. doi: 10.2967/jnumed.118.210161.
    PubMed     Abstract available


  697. DIVGI CR
    Radiopharmaceutical therapy in the new millenium.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.214122. doi: 10.2967/jnumed.118.214122.
    PubMed    


  698. CHEN KT, Salcedo S, Gong K, Chonde DB, et al
    An Efficient Approach to Perform MR-assisted PET Data Optimization in Simultaneous PET/MR Neuroimaging Studies.
    J Nucl Med. 2018 Jun 22. pii: jnumed.117.207142. doi: 10.2967/jnumed.117.207142.
    PubMed     Abstract available


  699. GU Z, Taschereau R, Vu N, Prout DL, et al
    Performance evaluation of G8, a high sensitivity benchtop preclinical PET/CT tomograph.
    J Nucl Med. 2018 Jun 14. pii: jnumed.118.208827. doi: 10.2967/jnumed.118.208827.
    PubMed     Abstract available


  700. LODGE MA, Leal JP, Rahmim A, Sunderland JJ, et al
    Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle.
    J Nucl Med. 2018 Jun 14. pii: jnumed.118.209593. doi: 10.2967/jnumed.118.209593.
    PubMed     Abstract available


  701. LILJA J, Leuzy A, Chiotis K, Savitcheva I, et al
    Spatial normalization of [(18)F]flutemetamol PET images utilizing an adaptive principal components template.
    J Nucl Med. 2018 Jun 14. pii: jnumed.118.207811. doi: 10.2967/jnumed.118.207811.
    PubMed     Abstract available


  702. LOHITH TG, Bennacef I, Vandenberghe R, Vandenbulcke M, et al
    First-in-human brain imaging of Alzheimer dementia patients and elderly controls with (18)F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology.
    J Nucl Med. 2018 Jun 7. pii: jnumed.118.208215. doi: 10.2967/jnumed.118.208215.
    PubMed     Abstract available


  703. SAH BR, Ghafoor S, Burger IA, Ter Voert EEGW, et al
    Feasibility of (18)F-FDG Dose Reductions in Breast Cancer PET/MRI.
    J Nucl Med. 2018 Jun 7. pii: jnumed.118.209007. doi: 10.2967/jnumed.118.209007.
    PubMed     Abstract available


  704. MEHARI A, Igbineweka N Dr, Allen D, Nichols J, et al
    Abnormal Ventilation-Perfusion Scan is Associated with Pulmonary Hypertension in Sickle Cell Adults.
    J Nucl Med. 2018 Jun 7. pii: jnumed.118.211466. doi: 10.2967/jnumed.118.211466.
    PubMed     Abstract available


    May 2018
  705. MEIER SR, Syvanen S, Hultqvist G, Fang XT, et al
    Antibody-based in vivo PET imaging detects amyloid-beta reduction in Alzheimer transgenic mice after BACE-1 inhibition.
    J Nucl Med. 2018 May 31. pii: jnumed.118.213140. doi: 10.2967/jnumed.118.213140.
    PubMed     Abstract available


  706. MA X, Shengjun W, Wang S, Liu D, et al
    Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin Targeted PET Probe (18)F-P3BZA in Patients.
    J Nucl Med. 2018 May 31. pii: jnumed.118.209643. doi: 10.2967/jnumed.118.209643.
    PubMed     Abstract available


  707. LARIMER BM, Dubois F, Bloch E, Nesti S, et al
    Specific (18)F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models is Facilitated by Pre-Binding to Sex Hormone Binding Globulin.
    J Nucl Med. 2018 May 31. pii: jnumed.118.208785. doi: 10.2967/jnumed.118.208785.
    PubMed     Abstract available


  708. BERTOGLIO D, Kosten L, Verhaeghe J, Thomae D, et al
    Longitudinal characterization of mGluR5 using (11)C-ABP688 PET imaging in the Q175 mouse model of Huntington's disease.
    J Nucl Med. 2018 May 24. pii: jnumed.118.210658. doi: 10.2967/jnumed.118.210658.
    PubMed     Abstract available


  709. HEINZMANN K, Nguyen QD, Honess DJ, Smith DM, et al
    Depicting changes in tumor biology in response to cetuximab mono- or combination therapy by apoptosis and proliferation imaging using (18)F-ICMT-11 and 3'-Deoxy-3'-[(18)F]Fluorothymidine ((18)F-FLT) PET.
    J Nucl Med. 2018 May 24. pii: jnumed.118.209304. doi: 10.2967/jnumed.118.209304.
    PubMed     Abstract available


  710. THALGOTT M, Duwel C, Rauscher I, Heck MM, et al
    One-stop shop whole-body (68)Ga-PSMA-11 PET/MRI compared to clinical Nomograms for preoperative T- and N-Staging of High-Risk Prostate Cancer.
    J Nucl Med. 2018 May 24. pii: jnumed.117.207696. doi: 10.2967/jnumed.117.207696.
    PubMed     Abstract available


  711. WOO SK, Jang SJ, Seo MJ, Park JH, et al
    Development of (64)Cu-NOTA-Trastuzumab for HER2 targeting: radiopharmaceutical with improved pharmacokinetics for human study.
    J Nucl Med. 2018 May 18. pii: jnumed.118.210294. doi: 10.2967/jnumed.118.210294.
    PubMed     Abstract available


  712. BETTHAUSER TJ, Cody KA, Zammit MD, Murali D, et al
    In vivo characterization and quantification of neurofibrillary tau PET radioligand [(18)F]MK-6240 in humans from Alzheimer's disease dementia to young controls.
    J Nucl Med. 2018 May 18. pii: jnumed.118.209650. doi: 10.2967/jnumed.118.209650.
    PubMed     Abstract available


  713. HAN Z, Xiao Y, Wang K, Yan J, et al
    Development of a Novel SPECT Tracer to Image c-Met Expression in Non-Small Cell Lung Cancer in a Human Tumor Xenograft.
    J Nucl Med. 2018 May 18. pii: jnumed.117.206730. doi: 10.2967/jnumed.117.206730.
    PubMed     Abstract available


  714. CHIAO P, Bedell BJ, Avants B, Zijdenbos AP, et al
    Impact of Reference/Target Region Selection on Amyloid PET Standard Uptake Value Ratios in the Phase 1b PRIME Study of Aducanumab.
    J Nucl Med. 2018 May 18. pii: jnumed.118.209130. doi: 10.2967/jnumed.118.209130.
    PubMed     Abstract available


  715. BRANDT M, Cardinale J, Aulsebrook M, Gasser G, et al
    AN OVERVIEW ON PET RADIOCHEMISTRY: PART 2 - RADIOMETALS.
    J Nucl Med. 2018 May 10. pii: jnumed.117.190801. doi: 10.2967/jnumed.117.190801.
    PubMed     Abstract available


  716. AUVITY S, Caille F, Marie S, Wimberley C, et al
    P-glycoprotein (ABCB1) inhibits the influx and increases the efflux of (11)C-metoclopramide across the blood-brain barrier: a PET study on non-human primates.
    J Nucl Med. 2018 May 10. pii: jnumed.118.210104. doi: 10.2967/jnumed.118.210104.
    PubMed     Abstract available


  717. PETERSON LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, et al
    Prospective study of serial (18)F-FDG PET and (18)F-fluoride ((18)F-NaF) PET to predict time to skeletal related events, time-to-progression, and survival in patients with bone-dominant metastatic breast cancer.
    J Nucl Med. 2018 May 10. pii: jnumed.118.211102. doi: 10.2967/jnumed.118.211102.
    PubMed     Abstract available


  718. SCHMIDT M, Gorges R, Drzezga A, Dietlein M, et al
    Radioiodine therapy in differentiated thyroid cancer - a matter of controversy - PRO Radioiodine.
    J Nucl Med. 2018 May 10. pii: jnumed.117.191338. doi: 10.2967/jnumed.117.191338.
    PubMed     Abstract available


  719. WONG DF, Comley R, Kuwabara H, Rosenberg PB, et al
    First in-human PET study of 3 novel tau radiopharmaceuticals: [(11)C]RO6924963, [(11)C]RO6931643, and [(18)F]RO6958948.
    J Nucl Med. 2018 May 4. pii: jnumed.118.209916. doi: 10.2967/jnumed.118.209916.
    PubMed     Abstract available


  720. DOUGHTON JA, Hofman MS, Eu P, Hicks RJ, et al
    A first-in-man study of (68)Ga-nanocolloid PET-CT sentinel lymph node imaging in prostate cancer demonstrates aberrant lymphatic drainage pathways.
    J Nucl Med. 2018 May 4. pii: jnumed.118.209171. doi: 10.2967/jnumed.118.209171.
    PubMed     Abstract available


  721. ELSCHOT M, Selnaes KM, Johansen H, Kruger-Stokke B, et al
    The Effect of Including Bone in DIXON-based Attenuation Correction for (18)F-fluciclovine PET/MRI of Prostate Cancer.
    J Nucl Med. 2018 May 4. pii: jnumed.118.208868. doi: 10.2967/jnumed.118.208868.
    PubMed     Abstract available


  722. BURGGRAAFF CN, Cornelisse AC, Hoekstra OS, Lugtenburg PJ, et al
    Interobserver agreement of interim and end-of-treatment (18)F-FDG PET/CT in diffuse large B-cell lymphoma (DLBCL): impact on clinical practice and trials.
    J Nucl Med. 2018 May 4. pii: jnumed.118.210807. doi: 10.2967/jnumed.118.210807.
    PubMed     Abstract available


  723. WEIST MR, Starr R, Aguilar B, Chea J, et al
    Positron emission tomography of adoptively transferred chimeric antigen receptor T cells with Zirconium-89 oxine.
    J Nucl Med. 2018 May 4. pii: jnumed.117.206714. doi: 10.2967/jnumed.117.206714.
    PubMed     Abstract available



  724. Reclassifying Diagnostic Radiopharmaceuticals.
    J Nucl Med. 2018;59:8N.
    PubMed    


    April 2018
  725. WU J, Wang S, Zhang X, Teng Z, et al
    (18)F-Alfatide II PET/CT for Identification of Breast Cancer: A Preliminary Clinical Study.
    J Nucl Med. 2018 Apr 26. pii: jnumed.118.208637. doi: 10.2967/jnumed.118.208637.
    PubMed     Abstract available


  726. HATHI D, DeLassus E, Achilefu S, McConathy J, et al
    Imaging melphalan therapy response in preclinical extramedullary myeloma with (18)F-FDOPA and (18)F-FDG PET.
    J Nucl Med. 2018 Apr 26. pii: jnumed.118.208744. doi: 10.2967/jnumed.118.208744.
    PubMed     Abstract available


  727. SALAS JR, Chen BY, Wong A, Cheng D, et al
    (18)F-FAC PET selectively images hepatic infiltrating CD4 and CD8 T cells in a mouse model of autoimmune hepatitis.
    J Nucl Med. 2018 Apr 26. pii: jnumed.118.210328. doi: 10.2967/jnumed.118.210328.
    PubMed     Abstract available


  728. FOSS CA, Plyku D, Ordonez AA, Sanchez-Bautista J, et al
    Biodistribution and Radiation Dosimetry of (124)I-iodo-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation.
    J Nucl Med. 2018 Apr 26. pii: jnumed.117.207431. doi: 10.2967/jnumed.117.207431.
    PubMed     Abstract available


  729. MCHUGH C, Thipparthi MR, Lawhorn-Crews JM, Polin L, et al
    Utilizing radiolabeled 3'-deoxy-3'-[(18)F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.
    J Nucl Med. 2018 Apr 19. pii: jnumed.117.207258. doi: 10.2967/jnumed.117.207258.
    PubMed     Abstract available


  730. GROHEUX D
    Now is the time to use FDG-PET/CT to optimize neoadjuvant treatment in triple negative breast cancer!
    J Nucl Med. 2018 Apr 19. pii: jnumed.118.210922. doi: 10.2967/jnumed.118.210922.
    PubMed    


  731. LOWE VJ, Lundt ES, Senjem ML, Schwarz CG, et al
    White matter reference region in PET studies of (11)C-Pittsburgh Compound B uptake: effects of age and amyloid-beta deposition.
    J Nucl Med. 2018 Apr 19. pii: jnumed.117.204271. doi: 10.2967/jnumed.117.204271.
    PubMed     Abstract available


  732. GEORGI TW, Kluge R, Kurch L, Chavdarova L, et al
    FDG-PET response of skeletal (bone marrow and bone) involvement after induction chemotherapy in pediatric Hodgkin lymphoma - Are specific response criteria required?
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.205633. doi: 10.2967/jnumed.117.205633.
    PubMed     Abstract available


  733. CALAIS J, Kishan AU, Cao M, Fendler WP, et al
    Potential impact of (68)Ga-PSMA-11 PET/CT on prostate cancer definitive radiation therapy planning.
    J Nucl Med. 2018 Apr 13. pii: jnumed.118.209387. doi: 10.2967/jnumed.118.209387.
    PubMed     Abstract available


  734. WARDAK M, Gowrishankar G, Gambhir SS
    Reply: 6"-18F-Fluoromaltotriose PET Evaluation in Escherichia-Coli-Induced Myositis: is there Uptake Saturation in Control?
    J Nucl Med. 2018 Apr 13. pii: jnumed.118.208736. doi: 10.2967/jnumed.118.208736.
    PubMed    


  735. REILHAC A, Merida I, Irace Z, Stephenson M, et al
    Development and validation of a rebinner with rigid motion correction for the Siemens PET-MR scanner: Application to a large cohort of [(11)C]-PIB scans.
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.206375. doi: 10.2967/jnumed.117.206375.
    PubMed     Abstract available


  736. TANG L, Peng C, Tang B, Li Z, et al
    Radioiodinated Small Molecule Tyrosine Kinase Inhibitor for HER2 Selective SPECT Imaging.
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.205088. doi: 10.2967/jnumed.117.205088.
    PubMed     Abstract available


  737. PIJL JP, Glaudemans AWJM, Slart RHJA, Kwee TC, et al
    FDG-PET/CT in autosomal dominant polycystic kidney disease patients with suspected cyst infection.
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.199448. doi: 10.2967/jnumed.117.199448.
    PubMed     Abstract available


  738. TULCHINSKY M, Binse I, Campenni A, Dizdarevic S, et al
    Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.
    J Nucl Med. 2018 Apr 13. pii: jnumed.118.211359. doi: 10.2967/jnumed.118.211359.
    PubMed    


  739. RADHAKRISHNAN R, Nabulsi N, Gaiser E, Gallezot JD, et al
    Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with (11)C-GSK215083 PET.
    J Nucl Med. 2018 Apr 6. pii: jnumed.117.206516. doi: 10.2967/jnumed.117.206516.
    PubMed     Abstract available


  740. BOELLAARD R, Kobe C, Zijlstra JM, Mikhaeel G, et al
    Does PET reconstruction method affect Deauville scoring in lymphoma patients?
    J Nucl Med. 2018 Apr 6. pii: jnumed.118.211607. doi: 10.2967/jnumed.118.211607.
    PubMed    


  741. DE BLASI B, Barnes A, Boscolo Galazzo I, Hua CH, et al
    Age-Specific (18)F-FDG Image Processing Pipelines and Analysis Are Essential for Individual Mapping of Seizure Foci in Paediatric Patients with Intractable Epilepsy.
    J Nucl Med. 2018 Apr 6. pii: jnumed.117.203950. doi: 10.2967/jnumed.117.203950.
    PubMed     Abstract available


  742. VARGAS HA, Kramer GM, Scott AM, Weickhardt A, et al
    Reproducibility and repeatability of semi-quantitative (18)F-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study.
    J Nucl Med. 2018 Apr 6. pii: jnumed.117.206490. doi: 10.2967/jnumed.117.206490.
    PubMed     Abstract available


  743. GRKOVSKI M, Gharzeddine K, Sawan P, Schoder H, et al
    (11)C-choline pharmacokinetics in recurrent prostate cancer.
    J Nucl Med. 2018 Apr 6. pii: jnumed.118.210088. doi: 10.2967/jnumed.118.210088.
    PubMed     Abstract available



  744. Nuclear Medicine Procedure Performance and Cataracts.
    J Nucl Med. 2018;59:10N.
    PubMed    


    March 2018
  745. HARMON SA STEPHANIE., Bergvall E, Mena E, Shih JH, et al
    A Prospective Comparison of (18)F-Sodium Fluoride PET/CT and PSMA-targeted (18)F-DCFBC PET/CT in Metastatic Prostate Cancer.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.207373. doi: 10.2967/jnumed.117.207373.
    PubMed     Abstract available


  746. LUCKERATH K, Stuparu AD, Wei L, Kim W, et al
    Detection threshold and reproducibility of (68)Ga-PSMA11 PET/CT in a mouse model of prostate cancer.
    J Nucl Med. 2018 Mar 30. pii: jnumed.118.207704. doi: 10.2967/jnumed.118.207704.
    PubMed     Abstract available


  747. SCHWARZ SW, Clarke BN
    Invited Perspective on JNM manuscript titled, "How Should FDA Review Diagnostic Radiopharmaceuticals?" by Carol Marcus.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.204446. doi: 10.2967/jnumed.117.204446.
    PubMed    


  748. VAN DEN WYNGAERT T, Palli SR, Imhoff RJ, Hirschmann MT, et al
    Cost-Effectiveness of Bone SPECT/CT in Painful Total Knee Arthroplasty.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.205567. doi: 10.2967/jnumed.117.205567.
    PubMed     Abstract available


  749. NIENHUIS HH, van Kruchten M, Elias SG, Glaudemans AWJM, et al
    ((18))F-fluoroestradiol Tumor Uptake is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.198846. doi: 10.2967/jnumed.117.198846.
    PubMed     Abstract available


  750. ZETTLITZ KA, Tsai WK, Knowles SM, Kobayashi N, et al
    Dual-modality immunoPET and near-infrared fluorescence (NIRF) imaging of pancreatic cancer using an anti-prostate cancer stem cell antigen (PSCA) cys-diabody.
    J Nucl Med. 2018 Mar 30. pii: jnumed.117.207332. doi: 10.2967/jnumed.117.207332.
    PubMed     Abstract available


  751. WERNER RA, Solnes L, Javadi M, Weich A, et al
    SSTR-RADS Version 1.0 as a Reporting System for SSTR-PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework.
    J Nucl Med. 2018 Mar 23. pii: jnumed.117.206631. doi: 10.2967/jnumed.117.206631.
    PubMed     Abstract available


  752. MONTEMAGNO C, Bacot S, Ahmadi M, Kerfelec B, et al
    Preclinical evaluation of novel mesothelin-specific ligands for SPECT imaging of Triple Negative Breast Cancer.
    J Nucl Med. 2018 Mar 23. pii: jnumed.117.203489. doi: 10.2967/jnumed.117.203489.
    PubMed     Abstract available


  753. JANNETTI SA, Carlucci G, Carney B, Kossatz S, et al
    PARP1-Targeted Radiotherapy in Mouse Models of Glioblastoma.
    J Nucl Med. 2018 Mar 23. pii: jnumed.117.205054. doi: 10.2967/jnumed.117.205054.
    PubMed     Abstract available


  754. MILES KA, Voo SA, Groves AM
    ADDITIONAL CLINICAL VALUE FOR PET/MRI IN ONCOLOGY: MOVING BEYOND SIMPLE DIAGNOSIS.
    J Nucl Med. 2018 Mar 15. pii: jnumed.117.203612. doi: 10.2967/jnumed.117.203612.
    PubMed     Abstract available


  755. BIERSACK HJ
    Nuclear Medicine Training: Two different pathways?
    J Nucl Med. 2018 Mar 15. pii: jnumed.118.210401. doi: 10.2967/jnumed.118.210401.
    PubMed    


  756. PARENT EE, Schuster DM
    Update on (18)F-fluciclovine PET for prostate cancer imaging.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.204032. doi: 10.2967/jnumed.117.204032.
    PubMed     Abstract available


  757. MANBER R, Thielemans K, Hutton BF, Wan S, et al
    Clinical Impact of Respiratory Motion Correction in Simultaneous PET/MR with a Joint PET/MR Predictive Motion Model.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.191460. doi: 10.2967/jnumed.117.191460.
    PubMed     Abstract available


  758. SSALI T, Anazodo UC, Thiessen JD, Prato FS, et al
    A Non-invasive Method for Quantifying Cerebral Blood Flow by Hybrid PET/MR.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.203414. doi: 10.2967/jnumed.117.203414.
    PubMed     Abstract available


  759. TYACKE RJ, Myers JFM, Venkataraman A, Mick I, et al
    Evaluation of (11)C-BU99008, a positron emission tomography ligand for the Imidazoline2 binding site in human brain.
    J Nucl Med. 2018 Mar 9. pii: jnumed.118.208009. doi: 10.2967/jnumed.118.208009.
    PubMed     Abstract available


  760. ZULLO L, Buschiazzo A, Massollo M, Riondato M, et al
    (18)F-FDG micro-PET imaging for research investigations in the Octopus vulgaris: applications and future directions in invertebrate neuroscience and tissue regeneration.
    J Nucl Med. 2018 Mar 9. pii: jnumed.117.205393. doi: 10.2967/jnumed.117.205393.
    PubMed     Abstract available



  761. Thomas Named Editor of the Journal of Nuclear Medicine Technology.
    J Nucl Med. 2018;59:11N.
    PubMed    


  762. HICKS RJ
    The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement.
    J Nucl Med. 2018;59:418-420.
    PubMed    


  763. CZERNIN J
    The National Oncologic PET Registry (NOPR): A Monumental Effort by a Few Leaders.
    J Nucl Med. 2018;59:379.
    PubMed    


  764. SALAS JR, Chen BY, Wong A, Duarte S, et al
    Non-invasive imaging of drug-induced liver injury with (18)F-DFA PET.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.206961. doi: 10.2967/jnumed.117.206961.
    PubMed     Abstract available


  765. SPANU A, Nuvoli S, Gelo I, Mele L, et al
    The role of diagnostic (131)I-SPECT/TC in patients with papillary thyroid microcarcinoma in long-term follow-up.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.204636. doi: 10.2967/jnumed.117.204636.
    PubMed     Abstract available


  766. DE LAAT B, Weerasekera A, Leurquin-Sterk G, Bormans GM, et al
    Glutamatergic biomarkers for cocaine addiction: A longitudinal study in self-administering rats using MRS and mGluR5 PET.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.202614. doi: 10.2967/jnumed.117.202614.
    PubMed     Abstract available


  767. COUGHLIN JM, Slania S, Du Y, Rosenthal HB, et al
    (18)F-XTRA PET for enhanced imaging of the extrathalamic alpha4beta2 nicotinic acetylcholine receptor.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.205492. doi: 10.2967/jnumed.117.205492.
    PubMed     Abstract available


  768. CALAIS J, Fendler WP, Herrmann K, Eiber M, et al
    Reply: Comparison of (68)Ga-PSMA-11 and (18)F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective trial is on its way.
    J Nucl Med. 2018 Mar 1. pii: jnumed.118.209965. doi: 10.2967/jnumed.118.209965.
    PubMed    


  769. REZAEI A, Deroose CM, Vahle T, Boada F, et al
    Joint reconstruction of activity and attenuation in Time-of-Flight PET: A Quantitative Analysis.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.204156. doi: 10.2967/jnumed.117.204156.
    PubMed     Abstract available


  770. KARAM M
    Regarding "Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?"
    J Nucl Med. 2018;59:545-546.
    PubMed    


  771. GREENSPAN BS
    SNMMI Leadership Update: Advancing Research and Discovery.
    J Nucl Med. 2018;59:14N.
    PubMed    


  772. GORDON L
    ABNM Launches CertLink Longitudinal Assessment Program.
    J Nucl Med. 2018;59:13N.
    PubMed    



  773. Image Gently Alliance 2017 Butterfly Award.
    J Nucl Med. 2018;59:10N.
    PubMed    


  774. LUTJE S, Gerrits D, Molkenboer-Kuenen JD, Herrmann K, et al
    Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.
    J Nucl Med. 2018;59:494-501.
    PubMed     Abstract available


  775. NIMMAGADDA S, Pullambhatla M, Chen Y, Parsana P, et al
    Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and Imaging.
    J Nucl Med. 2018;59:486-493.
    PubMed     Abstract available


  776. LAMB J, Holland JP
    Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI.
    J Nucl Med. 2018;59:382-389.
    PubMed     Abstract available


  777. WONDERGEM M, van der Zant F, Vlottes P, Knol R, et al
    Effects of fasting on (18)F-DCFPyL uptake in prostate cancer lesions and tissues with known high physiologic uptake.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.207316. doi: 10.2967/jnumed.117.207316.
    PubMed     Abstract available


    February 2018
  778. NAPIECZYNSKA H, Kolb A, Katiyar P, Tonietto M, et al
    Impact of the AIF Recording Method on Kinetic Parameters in Small Animal PET.
    J Nucl Med. 2018 Feb 23. pii: jnumed.117.204164. doi: 10.2967/jnumed.117.204164.
    PubMed     Abstract available


  779. WU J, Gallezot JD, Lu Y, Ye Q, et al
    Simplified Quantification and Acquisition Protocol of (123)I-mIBG Dynamic SPECT.
    J Nucl Med. 2018 Feb 23. pii: jnumed.117.202143. doi: 10.2967/jnumed.117.202143.
    PubMed     Abstract available


  780. DENES B, Gardiner P
    Comparison of (68)Ga-PSMA-11 PET/CT and (18)F-Fluciclovone PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive.
    J Nucl Med. 2018 Feb 23. pii: jnumed.118.209817. doi: 10.2967/jnumed.118.209817.
    PubMed    


  781. LAFFON E, Marthan R
    6"-(18)F-Fluoromaltotriose PET Evaluation in Escherichia-Coli-Induced Myositis: is there Uptake Saturation in Control?
    J Nucl Med. 2018 Feb 15. pii: jnumed.118.208645. doi: 10.2967/jnumed.118.208645.
    PubMed    


  782. LINDSTROM E, Sundin A, Trampal C, Lindsjo L, et al
    Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for (18)F-FDG whole-body examinations.
    J Nucl Med. 2018 Feb 15. pii: jnumed.117.200790. doi: 10.2967/jnumed.117.200790.
    PubMed     Abstract available


  783. LU Y, Fontaine K, Mulnix T, Onofrey JA, et al
    Respiratory Motion Compensation for PET/CT with Motion Information Derived from Matched Attenuation Corrected Gated PET Data.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.203000. doi: 10.2967/jnumed.117.203000.
    PubMed     Abstract available


  784. DE LEON MJ, Li Y, Rusinek H
    Reply: Cerebrospinal Fluid, Hyposmia and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.207068. doi: 10.2967/jnumed.117.207068.
    PubMed    


  785. CRANDALL J, O JH, Gajwani P, Leal JP, et al
    Measurement of Brown Adipose Tissue Activity Using Microwave Radiometry (MRAD) and FDG PET/CT.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.204339. doi: 10.2967/jnumed.117.204339.
    PubMed     Abstract available


  786. HUMBERT O, Lasserre M, Bertaut A, Fumoleau P, et al
    Pattern of breast cancer blood flow and metabolism, assessed using dual-acquisition (18)FDG PET: correlation with tumor phenotypic features and pathological response to neoadjuvant chemotherapy.
    J Nucl Med. 2018 Feb 9. pii: jnumed.117.203075. doi: 10.2967/jnumed.117.203075.
    PubMed     Abstract available


  787. BERG E, Zhang X, Bec J, Judenhofer MS, et al
    Development and evaluation of mini-EXPLORER: a long axial field-of-view PET scanner for non-human primate imaging.
    J Nucl Med. 2018 Feb 1. pii: jnumed.117.200519. doi: 10.2967/jnumed.117.200519.
    PubMed     Abstract available


  788. CHANTEPIE S, Hovhannisyan N, Guillouet S, Pelage JP, et al
    (18)F-Fludarabine-PET for lymphoma imaging: first-in-man study in DLBCL and CLL patients.
    J Nucl Med. 2018 Feb 1. pii: jnumed.117.206920. doi: 10.2967/jnumed.117.206920.
    PubMed     Abstract available


  789. GIESEL F, Will L, Kesch C, Freitag M, et al
    Biochemical recurrence of prostate cancer: initial results with (18)F-PSMA-1007 PET/CT.
    J Nucl Med. 2018 Feb 1. pii: jnumed.117.196329. doi: 10.2967/jnumed.117.196329.
    PubMed     Abstract available


  790. DUNCAN JR, Lieber MR, Adachi N, Wahl RL, et al
    DNA Repair After Exposure to Ionizing Radiation Is Not Error-Free.
    J Nucl Med. 2018;59:348.
    PubMed    


  791. WEBER W
    2017 SNMMI Highlights Lecture: Oncology, Part 2.
    J Nucl Med. 2018;59:9N-15N.
    PubMed    


  792. PAPPAS V
    SNMMI Leadership Update: Strengthening Outreach to Patients and the Medical Community.
    J Nucl Med. 2018;59:18N.
    PubMed    


  793. HAROLDS JA
    Survey of Programs About the ABR 16-Month Nuclear Radiology Pathway for Diagnostic Radiology Residents.
    J Nucl Med. 2018;59:16N-17N.
    PubMed    


  794. GHAI A, Maji D, Cho N, Chanswangphuwana C, et al
    Preclinical Development of CD38-Targeted [(89)Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.
    J Nucl Med. 2018;59:216-222.
    PubMed     Abstract available


  795. ADHIKARLA V, Dunlop BW, Jarkas N, Goodman MM, et al
    Test-Retest Reliability of the SERT Imaging Agent (11)C-HOMADAM in Healthy Humans.
    J Nucl Med. 2018;59:315-319.
    PubMed     Abstract available


  796. VILLEMAGNE VL
    Selective Tau Imaging: Der Stand der Dinge.
    J Nucl Med. 2018;59:175-176.
    PubMed    


  797. GALLEZOT JD, Nabulsi NB, Holden D, Lin SF, et al
    Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand (11)C-BMT-136088 for Lung Imaging in Rhesus Monkeys.
    J Nucl Med. 2018;59:327-333.
    PubMed     Abstract available


  798. WIMBERLEY C, Lavisse S, Brulon V, Peyronneau MA, et al
    Impact of Endothelial 18-kDa Translocator Protein on the Quantification of (18)F-DPA-714.
    J Nucl Med. 2018;59:307-314.
    PubMed     Abstract available


  799. HASHIMOTO H, Nakanishi R, Mizumura S, Hashimoto Y, et al
    Prognostic Value of (123)I-BMIPP SPECT in Patients with Nonischemic Heart Failure with Preserved Ejection Fraction.
    J Nucl Med. 2018;59:259-265.
    PubMed     Abstract available


  800. BAIU DC, Marsh IR, Boruch AE, Shahi A, et al
    Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog.
    J Nucl Med. 2018;59:244-250.
    PubMed     Abstract available


  801. AYATI N, Lee ST, Zakavi R, Pathmaraj K, et al
    Long-Acting Somatostatin Analog Therapy Differentially Alters (68)Ga-DOTATATE Uptake in Normal Tissues Compared with Primary Tumors and Metastatic Lesions.
    J Nucl Med. 2018;59:223-227.
    PubMed     Abstract available


    January 2018
  802. CZERNIN J
    The National Oncology PET Registry (NOPR): A monumental effort by a few leaders.
    J Nucl Med. 2018 Jan 25. pii: jnumed.118.207860. doi: 10.2967/jnumed.118.207860.
    PubMed    


  803. XIE T, Zanotti-Fregonara P, Edet-Sanson A, Zaidi H, et al
    Patient-specific computational model and dosimetry calculations for a patient pregnant with twins undergoing a PET/CT examination.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.205286. doi: 10.2967/jnumed.117.205286.
    PubMed     Abstract available


  804. RISCHPLER C, Beck TI, Okamoto S, Schlitter AM, et al
    (68)Ga-PSMA-HBED-CC uptake in cervical, coeliac and sacral ganglia as an important pitfall in prostate cancer PET imaging.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.204677. doi: 10.2967/jnumed.117.204677.
    PubMed     Abstract available


  805. DITTMANN HJMH, Kopp D, Kupferschlaeger J, Feil D, et al
    A prospective study of quantitative SPECT/CT for evaluation of hepatopulmonary shunt fraction prior to SIRT of liver tumors.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.205203. doi: 10.2967/jnumed.117.205203.
    PubMed     Abstract available


  806. BINI J, Naganawa M, Nabulsi NB, Huang YH, et al
    Evaluation of PET Brain Radioligands for Imaging Pancreatic beta-Cell Mass: Potential Utility of (11)C-PHNO.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.197285. doi: 10.2967/jnumed.117.197285.
    PubMed     Abstract available


  807. FUIN N DR., Catalano OA, Scipioni M, Canjels LPW, et al
    Concurrent Respiratory Motion Correction of Abdominal PET and DCE-MRI using a Compressed Sensing Approach.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.203943. doi: 10.2967/jnumed.117.203943.
    PubMed     Abstract available


  808. ROWE SP, Pomper MG, Gorin MA
    Molecular Imaging of Prostate Cancer: Choosing the Right Agent.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.206318. doi: 10.2967/jnumed.117.206318.
    PubMed    


  809. RATHKE H, Afshar-Oromieh A, Giesel FL, Kremer C, et al
    Intra-individual comparison of Tc-99m-MDP bone scan and the PSMA-ligand Tc-99m-MIP-1427 in patients with osseous metastasized prostate cancer.
    J Nucl Med. 2018 Jan 25. pii: jnumed.117.200220. doi: 10.2967/jnumed.117.200220.
    PubMed     Abstract available


  810. AARNTZEN EHJG, Heijmen L, Oyen WJG
    [(18)F]FDG PET/CT in local ablative therapies: a systematic review.
    J Nucl Med. 2018 Jan 18. pii: jnumed.117.198184. doi: 10.2967/jnumed.117.198184.
    PubMed     Abstract available


  811. MAYER AT, Gambhir SS
    Response: Optimizing Strategies for Immune Checkpoint Imaging with Immuno-PET in Preclinical Study.
    J Nucl Med. 2018 Jan 18. pii: jnumed.117.205153. doi: 10.2967/jnumed.117.205153.
    PubMed    


  812. OTTOY J, De Picker L, Verhaeghe J, Deleye S, et al
    [(18)F]PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test - Retest Reproducibility and Quantification of Neuroinflammation.
    J Nucl Med. 2018 Jan 11. pii: jnumed.117.203315. doi: 10.2967/jnumed.117.203315.
    PubMed     Abstract available


  813. KUMARIA A
    Cerebrospinal Fluid, Hyposmia and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis.
    J Nucl Med. 2018 Jan 11. pii: jnumed.117.206888. doi: 10.2967/jnumed.117.206888.
    PubMed    


  814. BAILEY DL, Hofman MS, Forwood NJ, O'Keefe GJ, et al
    ACCURACY OF DOSE CALIBRATORS FOR GALLIUM-68 PET IMAGING: UNEXPECTED FINDINGS IN A MULTI-CENTRE CLINICAL PRE-TRIAL ASSESSMENT.
    J Nucl Med. 2018 Jan 11. pii: jnumed.117.202861. doi: 10.2967/jnumed.117.202861.
    PubMed     Abstract available


  815. ORLHAC F, Boughdad S, Philippe C, Stalla-Bourdillon H, et al
    A post-reconstruction harmonization method for multicenter radiomic studies in PET.
    J Nucl Med. 2018 Jan 4. pii: jnumed.117.199935. doi: 10.2967/jnumed.117.199935.
    PubMed     Abstract available


  816. CHO SY
    Proposed Criteria Positions PSMA PET for the Future.
    J Nucl Med. 2018 Jan 4. pii: jnumed.117.204057. doi: 10.2967/jnumed.117.204057.
    PubMed    


  817. CALAIS J, Cao M, Nickols NG
    The Utility of PET/CT in External Radiation Therapy Planning of Prostate Cancer.
    J Nucl Med. 2018 Jan 4. pii: jnumed.117.196444. doi: 10.2967/jnumed.117.196444.
    PubMed     Abstract available


  818. WEBER W
    2017 SNMMI Highlights Lecture: Oncology.
    J Nucl Med. 2018;59:7N-13N.
    PubMed    


  819. GREENSPAN BS
    SNMMI Leadership Update: Strengthening the Workforce Pipeline.
    J Nucl Med. 2018;59:17N.
    PubMed    



  820. SNMMI Submits Comments to NRC on Radioactive Materials.
    J Nucl Med. 2018;59:16N.
    PubMed    


  821. JADVAR H
    SNMMI Scientific Delegation to Cuba.
    J Nucl Med. 2018;59:15N.
    PubMed    


  822. JADVAR H
    The First Theranostic Conference at the American University of Beirut Medical Center.
    J Nucl Med. 2018;59:13N.
    PubMed    


  823. DILSIZIAN V
    Challenging Nuclear Cardiology Research: Stimulating Discovery, Validation, and Clinical Relevance.
    J Nucl Med. 2018;59:13-14.
    PubMed    


  824. DAS S, Haedicke K, Grimm J
    Cerenkov-Activated Sticky Tag for In Vivo Fluorescence Imaging.
    J Nucl Med. 2018;59:58-65.
    PubMed     Abstract available


  825. LINDBO S, Garousi J, Mitran B, Altai M, et al
    Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label.
    J Nucl Med. 2018;59:93-99.
    PubMed     Abstract available


  826. ALBRECHT DS, Normandin MD, Shcherbinin S, Wooten DW, et al
    Pseudoreference Regions for Glial Imaging with (11)C-PBR28: Investigation in 2 Clinical Cohorts.
    J Nucl Med. 2018;59:107-114.
    PubMed     Abstract available


  827. MORTIMER JE, Bading JR, Park JM, Frankel PH, et al
    Tumor Uptake of (64)Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.
    J Nucl Med. 2018;59:38-43.
    PubMed     Abstract available


  828. PELLETIER-GALARNEAU M, deKemp RA, Hunter CRRN, Klein R, et al
    Effects of Hypercapnia on Myocardial Blood Flow in Healthy Human Subjects.
    J Nucl Med. 2018;59:100-106.
    PubMed     Abstract available


  829. DAVIS JC, Daw NC, Navid F, Billups CA, et al
    (18)F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma.
    J Nucl Med. 2018;59:25-30.
    PubMed     Abstract available


    December 2017
  830. DEVOUS MD SR, Joshi AD, Navitsky M, Southekal S, et al
    Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
    J Nucl Med. 2017 Dec 28. pii: jnumed.117.200691. doi: 10.2967/jnumed.117.200691.
    PubMed     Abstract available


  831. TURPIN S, Martineau PJ, Levasseur MA, Lambert R, et al
    Modeling the effects of age and gender on normal pediatric brain metabolism using F18-FDG PET/CT.
    J Nucl Med. 2017 Dec 28. pii: jnumed.117.201889. doi: 10.2967/jnumed.117.201889.
    PubMed     Abstract available


  832. GAREEN IF, Hillner BE, Hanna L, Makineni R, et al
    Hospice Admission and Survival following (18)F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
    J Nucl Med. 2017 Dec 28. pii: jnumed.117.205120. doi: 10.2967/jnumed.117.205120.
    PubMed     Abstract available


  833. FRANGOS S, Hustinx R, Boubaker A, Varetto T, et al
    The future of the past is the present. The challenge to educate Nuclear Medicine Specialist in present time. The important role of UEMS Section and European Board of Nuclear Medicine.
    J Nucl Med. 2017 Dec 21. pii: jnumed.117.206052. doi: 10.2967/jnumed.117.206052.
    PubMed    


  834. GIESEL F, Will L, Lawal I, Lengana T, et al
    Intra-individual comparison of (18)F-PSMA-1007 and (18)F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: A pilot study.
    J Nucl Med. 2017 Dec 21. pii: jnumed.117.204669. doi: 10.2967/jnumed.117.204669.
    PubMed     Abstract available


  835. STABIN M
    New Generation Fetal Dose Estimates for Radiopharmaceuticals.
    J Nucl Med. 2017 Dec 21. pii: jnumed.117.204214. doi: 10.2967/jnumed.117.204214.
    PubMed     Abstract available


  836. CALAIS J, Fendler WP, Herrmann K, Eiber M, et al
    Head-to-head comparison of (68)Ga-PSMA-11 PET/CT and (18)F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203257. doi: 10.2967/jnumed.117.203257.
    PubMed     Abstract available


  837. ENILORAC B, Lasnon C, Nganoa C, Fruchart C, et al
    Does PET reconstruction method affect Deauville scoring in lymphoma patients?
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.202721. doi: 10.2967/jnumed.117.202721.
    PubMed     Abstract available


  838. CECI F, Fendler W, Eiber M
    A new type of prostate cancer imaging. Will (64)CuCl2 PET/CT flourish or vanish?
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.199885. doi: 10.2967/jnumed.117.199885.
    PubMed    


  839. HAMMES J, Tager P, Drzezga A
    EBONI: A tool for automated quantification of bone metastasis load in PSMA PET/CT.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203265. doi: 10.2967/jnumed.117.203265.
    PubMed     Abstract available


  840. JADVAR H, Ballas LK
    PSMA PET: Transformational Change in Prostate Cancer Management?
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203604. doi: 10.2967/jnumed.117.203604.
    PubMed    


  841. WERNER R, Wakabayashi H, Chen X, Hirano M, et al
    Novel functional renal imaging with (18)F-FDS PET in rat models of kidney diseases.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.203828. doi: 10.2967/jnumed.117.203828.
    PubMed     Abstract available


  842. CALAIS J, Fendler WP, Eiber M, Gartmann J, et al
    Actual impact of (68)Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.202945. doi: 10.2967/jnumed.117.202945.
    PubMed     Abstract available


  843. MURTHY VL, Bateman TM, Beanlands RS, Berman DS, et al
    Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.201368. doi: 10.2967/jnumed.117.201368.
    PubMed    


  844. CHOI H, Lee DS
    Generation of structural MR images from amyloid PET: Application to MR-less quantification.
    J Nucl Med. 2017 Dec 7. pii: jnumed.117.199414. doi: 10.2967/jnumed.117.199414.
    PubMed     Abstract available


  845. OYEN WJG, Jones C
    ImmunoPET in pontine glioma : more than meets the eye ?
    J Nucl Med. 2017 Dec 7. pii: jnumed.117.200527. doi: 10.2967/jnumed.117.200527.
    PubMed    


  846. TAMAKI N
    2017 SNMMI Highlights Lecture: Cardiovascular Nuclear Medicine.
    J Nucl Med. 2017;58:9N-14N.
    PubMed    


  847. DELEYE S, Waldron AM, Verhaeghe J, Bottelbergs A, et al
    Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease.
    J Nucl Med. 2017;58:1977-1983.
    PubMed     Abstract available


    November 2017
  848. KRAMER SD, Betzel T, Mu L, Haider A, et al
    Evaluation of [(11)C]Me-NB1 as a potential PET radioligand for measuring GluN2B-containing NMDA receptors, drug occupancy and receptor crosstalk.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.200451. doi: 10.2967/jnumed.117.200451.
    PubMed     Abstract available


  849. BARANSKI AC, Schafer M, Bauder-Wust U, Roscher M, et al
    PSMA-11 Derived Dual-labeled PSMA-Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.201293. doi: 10.2967/jnumed.117.201293.
    PubMed     Abstract available


  850. NICOLAS GP, Schreiter N, Kaul F, Uiters J, et al
    Comparison of (68)Ga-OPS202 ((68)Ga-NODAGA-JR11) and (68)Ga-DOTATOC ((68)Ga-Edotreotide) PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Evaluation of Sensitivity in a Prospective Phase II Imaging Study.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.199760. doi: 10.2967/jnumed.117.199760.
    PubMed     Abstract available


  851. HILLNER BE, Hanna L, Makineni R, Duan F, et al
    Intended vs. Inferred Treatment after (18)F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
    J Nucl Med. 2017 Nov 30. pii: jnumed.117.205047. doi: 10.2967/jnumed.117.205047.
    PubMed     Abstract available


  852. VERHEIJEN RB, Yaqub MM, Sawicki E, van Tellingen O, et al
    Molecular Imaging of ABCB1/ABCG2 Inhibition at the Human Blood Brain Barrier using Elacridar and (11)C-Erlotinib PET.
    J Nucl Med. 2017 Nov 24. pii: jnumed.117.195800. doi: 10.2967/jnumed.117.195800.
    PubMed     Abstract available


  853. BULLICH S, Barthel H, Koglin N, Becker GA, et al
    Validation of Non-Invasive Tracer Kinetic Analysis of (18)F-Florbetaben PET Using a Dual Time-Window Acquisition Protocol.
    J Nucl Med. 2017 Nov 24. pii: jnumed.117.200964. doi: 10.2967/jnumed.117.200964.
    PubMed     Abstract available


  854. PAPP L, Poetsch N, Grahovac M, Schmidbauer V, et al
    Glioma survival prediction with the combined analysis of in vivo 11C-MET-PET, ex vivo and patient features by supervised machine learning.
    J Nucl Med. 2017 Nov 24. pii: jnumed.117.202267. doi: 10.2967/jnumed.117.202267.
    PubMed     Abstract available


  855. CHEN J, Wang N, Yang X None, Li Y, et al
    Optimizing Strategies for Immune Checkpoint Imaging with Immumo-PET in Preclinical Study.
    J Nucl Med. 2017 Nov 16. pii: jnumed.117.204685. doi: 10.2967/jnumed.117.204685.
    PubMed    


  856. ULANER GA, Lyashchenko SK, Riedl C, Ruan S, et al
    First-in-human HER2-targeted imaging using 89Zr-pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer.
    J Nucl Med. 2017 Nov 16. pii: jnumed.117.202010. doi: 10.2967/jnumed.117.202010.
    PubMed     Abstract available


  857. BARRIO JR
    The Irony of PET Tau Probe Specificity.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198960. doi: 10.2967/jnumed.117.198960.
    PubMed    


  858. ZHANG J, Niu G, Fan X, Lang L, et al
    Positron Emission Tomography Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198929. doi: 10.2967/jnumed.117.198929.
    PubMed     Abstract available


  859. CALAIS J, Czernin J, Cao M, Kishan AU, et al
    68Ga-PSMA PET/CT mapping of prostate cancer biochemical recurrence following radical prostatectomy in 270 patients with PSA<1.0ng/ml: Impact on Salvage Radiotherapy Planning.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.201749. doi: 10.2967/jnumed.117.201749.
    PubMed     Abstract available


  860. EIBER M, Herrmann K, Calais J, Hadaschihk B, et al
    PROstate cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198119. doi: 10.2967/jnumed.117.198119.
    PubMed     Abstract available


  861. OLIN A, Ladefoged CN, Langer NH, Keller SH, et al
    Reproducibility of MR-based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198853. doi: 10.2967/jnumed.117.198853.
    PubMed     Abstract available


  862. YOUNG J, Johnson GB, Murphy RC, Go RS, et al
    F-18 FDG PET-CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.200741. doi: 10.2967/jnumed.117.200741.
    PubMed     Abstract available


  863. TRAN-GIA J, Lassmann M
    Optimizing Image Quantification for Lu-177 SPECT/CT Based on a 3D Printed 2-Compartment Kidney Phantom.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.200170. doi: 10.2967/jnumed.117.200170.
    PubMed     Abstract available


  864. CIPRIANO P, Yoon D, Gandhi H, Holley D, et al
    18F-FDG PET/MRI in Chronic Sciatica: Early Results Revealing Spinal and Non-spinal Abnormalities.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.198259. doi: 10.2967/jnumed.117.198259.
    PubMed     Abstract available


  865. NAKAMOTO R, Nakamoto Y, Ishimori T, Fushimi Y, et al
    Comparison of PET/CT with sequential PET/MRI using an MR-compatible mobile PET system.
    J Nucl Med. 2017 Nov 2. pii: jnumed.117.197665. doi: 10.2967/jnumed.117.197665.
    PubMed     Abstract available


  866. COLLETTI PM
    2017 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2017;58:11N-15N.
    PubMed    


  867. BARTHEL H, Sabri O
    Clinical Use and Utility of Amyloid Imaging.
    J Nucl Med. 2017;58:1711-1717.
    PubMed     Abstract available


  868. BODEI L, Ambrosini V, Herrmann K, Modlin I, et al
    Current Concepts in (68)Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies.
    J Nucl Med. 2017;58:1718-1726.
    PubMed     Abstract available


  869. GARRIGUE P, Bodin-Hullin A, Balasse L, Fernandez S, et al
    The Evolving Role of Succinate in Tumor Metabolism: An (18)F-FDG-Based Study.
    J Nucl Med. 2017;58:1749-1755.
    PubMed     Abstract available


  870. ZANOTTI-FREGONARA P, Stabin MG
    New Fetal Radiation Doses for (18)F-FDG Based on Human Data.
    J Nucl Med. 2017;58:1865-1866.
    PubMed     Abstract available


  871. GHOSH SC, Rodriguez M, Carmon KS, Voss J, et al
    A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.
    J Nucl Med. 2017;58:1858-1864.
    PubMed     Abstract available


    October 2017
  872. MINAMIMOTO R, Sonni I, Hancock S, Vasanawala S, et al
    Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Conventional Imaging.
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.197624. doi: 10.2967/jnumed.117.197624.
    PubMed     Abstract available


  873. STEPHENS AW
    Reply: 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi.
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.203687. doi: 10.2967/jnumed.117.203687.
    PubMed    


  874. LAM WW
    Letter to the Editor: RE: "Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?"
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.203240. doi: 10.2967/jnumed.117.203240.
    PubMed    


  875. LEYNES AP, Yang J, Wiesinger F, Kaushik SS, et al
    Direct PseudoCT Generation for Pelvis PET/MRI Attenuation Correction using Deep Convolutional Neural Networks with Multi-parametric MRI: Zero Echo-time and Dixon Deep pseudoCT (ZeDD-CT).
    J Nucl Med. 2017 Oct 30. pii: jnumed.117.198051. doi: 10.2967/jnumed.117.198051.
    PubMed     Abstract available


  876. BIRNIE D, Ohira H, Beanlands R
    Reply: Utilizing and Interpreting FDG-PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil is in the Details.
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.198226. doi: 10.2967/jnumed.117.198226.
    PubMed    


  877. MUYLLE K, Maffioli L
    Editorial, Nuclear Medicine Training in Europe: "All for one, one for all".
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.201012. doi: 10.2967/jnumed.117.201012.
    PubMed    


  878. EBENHAN T, Sathekge M, Lenagana T, Koole M, et al
    68Ga-NOTA-functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry and First-in-Human Positron Emission Tomography/Computed Tomography Imaging of Infections.
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.200048. doi: 10.2967/jnumed.117.200048.
    PubMed     Abstract available


  879. VASSAUX G, Zwarthoed C, Signetti L, Guglielmi J, et al
    Iodinated contrast agents perturb iodide uptake by the thyroid independently of free iodide.
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.195685. doi: 10.2967/jnumed.117.195685.
    PubMed     Abstract available


  880. DONNELLY DJ, Smith RA, Morin P, Lipovsek D, et al
    Synthesis and Biological Evaluation of a Novel 18F-labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.199596. doi: 10.2967/jnumed.117.199596.
    PubMed     Abstract available


  881. WERNER RA, Schmid JS, Higuchi T, Javadi MS, et al
    Predictive value of FDG-PET in patients with advanced medullary thyroid carcinoma treated with vandetanib.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.199778. doi: 10.2967/jnumed.117.199778.
    PubMed     Abstract available


  882. HOPE TA, Bergsland E, Bozkurt MF, Graham MM, et al
    Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.202275. doi: 10.2967/jnumed.117.202275.
    PubMed     Abstract available


  883. MARCUS CS
    How Should FDA Review Diagnostic Radiopharmaceuticals?
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.200337. doi: 10.2967/jnumed.117.200337.
    PubMed     Abstract available


  884. JADVAR H, Colletti P, Delgado-Bolton R, Esposito G, et al
    Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.197988. doi: 10.2967/jnumed.117.197988.
    PubMed    


  885. PATTISON DA, Bozin M, Gorelik A, Hofman MS, et al
    18F-fluorodeoxyglycose-avid thyroid incidentalomas: the importance of contextual interpretation.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.198085. doi: 10.2967/jnumed.117.198085.
    PubMed     Abstract available


  886. SEGALL GM, Grady EE, Fair JR, Ghesani MV, et al
    Editorial, Nuclear Medicine Training in the United States.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.200857. doi: 10.2967/jnumed.117.200857.
    PubMed    


  887. HOFMAN MS, Eu P, Jackson P, Hong E, et al
    Cold Kit PSMA PET Imaging: Phase I study of 68Ga-THP-PSMA PET/CT in patients with prostate cancer.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.199554. doi: 10.2967/jnumed.117.199554.
    PubMed     Abstract available


  888. LOPEZ-PICON FR, Snellman A, Eskola O, Helin S, et al
    Neuroinflammation appears early and then plateaus in a mouse model of Alzheimer's disease shown by PET imaging.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.197608. doi: 10.2967/jnumed.117.197608.
    PubMed     Abstract available


  889. ELSCHOT M, Selnaes KM, Sandsmark E, Kruger-Stokke B, et al
    Combined 18F-Fluciclovine PET/MRI shows potential for detection and characterization of high-risk prostate cancer.
    J Nucl Med. 2017 Oct 6. pii: jnumed.117.198598. doi: 10.2967/jnumed.117.198598.
    PubMed     Abstract available


  890. CZERNIN J
    Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?
    J Nucl Med. 2017;58:1535.
    PubMed    


  891. GRKOVSKI M, Emmas SA, Carlin SD
    18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.
    J Nucl Med. 2017;58:1567-1573.
    PubMed     Abstract available


    September 2017
  892. HONER M, Gobbi L, Knust H, Kuwabara H, et al
    Preclinical Evaluation of 18F-RO6958948, 11C-RO6931643 and 11C-RO6924963 as Novel Radiotracers for Imaging Aggregated Tau in AD with Positron Emission Tomography.
    J Nucl Med. 2017 Sep 28. pii: jnumed.117.196741. doi: 10.2967/jnumed.117.196741.
    PubMed     Abstract available


  893. FARAG S, de Geus-Oei LF, Van der Graaf WT, van Coevorden F, et al
    Early response evaluation by 18F-FDG-PET influences management in gastrointestinal stromal tumor (GIST) patients treated with imatinib with neo-adjuvant intent.
    J Nucl Med. 2017 Sep 28. pii: jnumed.117.196642. doi: 10.2967/jnumed.117.196642.
    PubMed     Abstract available


  894. IAGARU A
    Will GRPR Compete with PSMA as a Target in Prostate Cancer?
    J Nucl Med. 2017 Sep 28. pii: jnumed.117.198192. doi: 10.2967/jnumed.117.198192.
    PubMed    


  895. ANANTH M, DeLorenzo C, Yang J, Mann JJ, et al
    Decreased pretreatment amygdalae serotonin transporter binding in unipolar depression remitters: a prospective PET study.
    J Nucl Med. 2017 Sep 21. pii: jnumed.117.189654. doi: 10.2967/jnumed.117.189654.
    PubMed     Abstract available


  896. CHERRY SR, Jones T, Karp JS, Qi J, et al
    TOTAL-BODY PET: MAXIMIZING SENSITIVITY TO CREATE NEW OPPORTUNITIES FOR CLINICAL RESEARCH AND PATIENT CARE.
    J Nucl Med. 2017 Sep 21. pii: jnumed.116.184028. doi: 10.2967/jnumed.116.184028.
    PubMed     Abstract available


  897. ALVI R, Miller EJ, Hashemi Zonouz T, Sandoval V, et al
    Quantification and Determination of Normal 123I-Meta Iodobenzylguanidine Heart-to-Mediastinum Ratio (HMR) from Cardiac SPECT/CT and Correlation with Planar HMR.
    J Nucl Med. 2017 Sep 15. pii: jnumed.117.197152. doi: 10.2967/jnumed.117.197152.
    PubMed     Abstract available


  898. REUBI JC
    In Vitro Evaluation Of Molecular Tumor Targets In Nuclear Medicine: Immunohistochemistry Is One Option, But Under Which Conditions?
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.197582. doi: 10.2967/jnumed.117.197582.
    PubMed     Abstract available


  899. MEYER PT, Frings L, Rucker G, Hellwig S, et al
    18F-FDG PET in Parkinsonism: Differential Diagnosis and Cognitive Impairment in Parkinson's disease.
    J Nucl Med. 2017 Sep 14. pii: jnumed.116.186403. doi: 10.2967/jnumed.116.186403.
    PubMed     Abstract available


  900. ALAVI A, Werner TJ, Hess S, Hoilund-Carlsen PF, et al
    Letter: RE: 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.200378. doi: 10.2967/jnumed.117.200378.
    PubMed    


  901. LAW JM, Morris DE, Engbeaya CI, Salem V, et al
    Thermal imaging is a non-invasive alternative to PET-CT for measurement of brown adipose tissue activity in humans.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.190546. doi: 10.2967/jnumed.117.190546.
    PubMed     Abstract available


  902. STORTZ G, Thiessen JD, Bishop D, Khan MS, et al
    Performance of a PET Insert for High Resolution Small Animal PET/MR Imaging at 7T.
    J Nucl Med. 2017 Sep 14. pii: jnumed.116.187666. doi: 10.2967/jnumed.116.187666.
    PubMed     Abstract available


  903. LOCKAU HH, Neuschmelting V, Ogirala A, Vilaseca A, et al
    Dynamic 18F-FDG PET- Lymphography for in Vivo Identification of Lymph Node Metastases in Murine Melanoma.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.196303. doi: 10.2967/jnumed.117.196303.
    PubMed     Abstract available


  904. VENEMA CM, Mammatas LH, Schroder CP, van Kruchten M, et al
    Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.193649. doi: 10.2967/jnumed.117.193649.
    PubMed     Abstract available


  905. ROWE S, Pienta K, Pomper MG, Gorin M, et al
    Proposal of a Structured Reporting System for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging: PSMA-RADS Version 1.0.
    J Nucl Med. 2017 Sep 8. pii: jnumed.117.195255. doi: 10.2967/jnumed.117.195255.
    PubMed     Abstract available


  906. STABIN M, Siegel JA
    RADAR DOSE ESTIMATE REPORT: A COMPENDIUM OF RADIOPHARMACEUTICAL DOSE ESTIMATES BASED ON OLINDA/EXM VERSION 2.0.
    J Nucl Med. 2017 Sep 8. pii: jnumed.117.196261. doi: 10.2967/jnumed.117.196261.
    PubMed     Abstract available


  907. PICCARDO A, Paparo F, Puntoni M, Righi S, et al
    64CuCl2 PET/CT in prostate cancer relapse.
    J Nucl Med. 2017 Sep 8. pii: jnumed.117.195628. doi: 10.2967/jnumed.117.195628.
    PubMed     Abstract available


  908. HARADA R, Ishiki A, Kai H, Sato N, et al
    Correlations of 18F-THK5351 PET with post-mortem burden of tau and astrogliosis in Alzheimer's disease.
    J Nucl Med. 2017 Sep 1. pii: jnumed.117.197426. doi: 10.2967/jnumed.117.197426.
    PubMed     Abstract available


  909. ROHDE M, Nielsen AL, Pareek M, Johansen J, et al
    A PET/CT-based strategy is a stronger predictor of survival than a standard imaging strategy in patients with head and neck squamous cell carcinoma.
    J Nucl Med. 2017 Sep 1. pii: jnumed.117.197350. doi: 10.2967/jnumed.117.197350.
    PubMed     Abstract available


  910. COTTEREAU AS, El-Galaly TC, Becker S, Broussais F, et al
    Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients.
    J Nucl Med. 2017 Sep 1. pii: jnumed.117.193946. doi: 10.2967/jnumed.117.193946.
    PubMed     Abstract available


  911. HAROLDS JA, Segall GM
    Nuclear Medicine Career Portal for Young Physicians.
    J Nucl Med. 2017;58:12N.
    PubMed    


  912. EBERLEIN U, Cremonesi M, Lassmann M
    Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
    J Nucl Med. 2017;58.
    PubMed     Abstract available


  913. HSIAO IT, Lin KJ, Huang KL, Huang CC, et al
    Biodistribution and Radiation Dosimetry for the Tau Tracer 18F-THK-5351 in Healthy Human Subjects.
    J Nucl Med. 2017;58:1498-1503.
    PubMed     Abstract available


  914. DATTA G, Colasanti A, Kalk N, Owen D, et al
    11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.
    J Nucl Med. 2017;58:1477-1482.
    PubMed     Abstract available


  915. ZHU Y, Feng J, Ji J, Hou H, et al
    Alteration of Monoamine Receptor Activity and Glucose Metabolism in Pediatric Patients with Anticonvulsant-Induced Cognitive Impairment.
    J Nucl Med. 2017;58:1490-1497.
    PubMed     Abstract available


  916. SAKATA M, Ishibashi K, Imai M, Wagatsuma K, et al
    Initial Evaluation of an Adenosine A2A Receptor Ligand, 11C-Preladenant, in Healthy Human Subjects.
    J Nucl Med. 2017;58:1464-1470.
    PubMed     Abstract available


    August 2017
  917. HENRY KE, Dilling TR, Abdel-Atti D, Edwards KJ, et al
    Non-invasive 89Zr-Transferrin PET Shows Improved Tumor Targeting Compared to 18F-FDG PET in MYC-overexpressing Human Triple Negative Breast Cancer.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.192286. doi: 10.2967/jnumed.117.192286.
    PubMed     Abstract available


  918. HAGE C, Gremse F, Griessinger CM, Maurer A, et al
    Comparison of the Accuracy of FMT/CT and PET/MRI for the Assessment of Antibody Biodistribution in Squamous Cell Carcinoma Xenografts.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.197178. doi: 10.2967/jnumed.117.197178.
    PubMed     Abstract available


  919. LI J, Zheng H, Fodah RA, Warawa J, et al
    Validation of 2-18F-fluorodeoxysorbitol (18F-FDS) as a potential radiopharmaceutical for imaging bacterial infection in the lung.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.195420. doi: 10.2967/jnumed.117.195420.
    PubMed     Abstract available


  920. MAULER J, Maudsley AA, Langen KJ, Nikoubashman O, et al
    Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study.
    J Nucl Med. 2017 Aug 28. pii: jnumed.117.196709. doi: 10.2967/jnumed.117.196709.
    PubMed     Abstract available


  921. MANKOFF DA, Pryma DA
    Nuclear Medicine Training: What Now?
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.190132. doi: 10.2967/jnumed.117.190132.
    PubMed     Abstract available


  922. CORNELIS FH, Durack J, Pandit-Taskar N, Ulaner GA, et al
    Long Half-life 89Zr Labeled Radiotracers Can Guide In Suite Percutaneous Molecular Imaging PET/CT-guided Biopsies Without Reinjection of Radiotracer.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.194480. doi: 10.2967/jnumed.117.194480.
    PubMed     Abstract available


  923. VELDHUIJZEN VAN ZANTEN SEM, Sewing ACP, van Lingen A, Hoekstra OS, et al
    Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.197897. doi: 10.2967/jnumed.117.197897.
    PubMed     Abstract available


  924. ARRIETA O, Garcia-Perez FO, Michel-Tello D, Ramirez-Tirado LA, et al
    Response assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT for lung adenocarcinoma patients treated with nintedanib plus docetaxel.
    J Nucl Med. 2017 Aug 17. pii: jnumed.117.192393. doi: 10.2967/jnumed.117.192393.
    PubMed     Abstract available


  925. BARRINGTON SF, Johnson PW
    FDG PET-CT in lymphoma: Has imaging-directed personalized medicine become a reality?
    J Nucl Med. 2017 Aug 10. pii: jnumed.116.181347. doi: 10.2967/jnumed.116.181347.
    PubMed     Abstract available


  926. LOFGREN J, Mortensen J, Rasmussen SH, Madsen C, et al
    A prospective study comparing 99mTc-HDP planar bone scintigraphy and whole-body SPECT/CT with 18F-fluoride PET/CT and 18F-fluoride PET/MRI for diagnosing bone metastases.
    J Nucl Med. 2017 Aug 10. pii: jnumed.116.189183. doi: 10.2967/jnumed.116.189183.
    PubMed     Abstract available


  927. PAQUETTE M, Lavallee E, Phoenix S, Ouellet R, et al
    Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 4FMFES in ER+ Breast Cancer Patients: an Ongoing Phase II Clinical Trial.
    J Nucl Med. 2017 Aug 10. pii: jnumed.117.194654. doi: 10.2967/jnumed.117.194654.
    PubMed     Abstract available


  928. WEIBERG D, Thackeray JT, Daum G, Sohns JM, et al
    Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque using 68Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.196485. doi: 10.2967/jnumed.117.196485.
    PubMed     Abstract available


  929. WOYTHAL N, Arsenic R, Kempkensteffen C, Miller K, et al
    Immunohistochemical validation of PSMA-expression measured by 68Ga-PSMA PET/CT in primary prostate cancer.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.195172. doi: 10.2967/jnumed.117.195172.
    PubMed     Abstract available


  930. WANG H, Hou B, Lu L, Feng M, et al
    PET/MR imaging in the diagnosis of hormone-producing pituitary micro-adenoma: a prospective pilot study.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.191916. doi: 10.2967/jnumed.117.191916.
    PubMed     Abstract available


  931. CHEN X
    Reply: Dual Integrin alphavbeta3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer (68Ga-BBN-RGD).
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.198374. doi: 10.2967/jnumed.117.198374.
    PubMed    


  932. LE ROUX PY, Salaun PY
    Letter to the Editor: AUC for V/Q Imaging in Pulmonary Embolism. The Elephant in the Room: Planar or SPECT V/Q?
    J Nucl Med. 2017;58:17N.
    PubMed    


  933. CHAREONTHAITAWEE P, Beanlands RS, Chen W, Dorbala S, et al
    Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.
    J Nucl Med. 2017;58:1341-1353.
    PubMed    


  934. RICHARD MA, Fouquet JP, Lebel R, Lepage M, et al
    Determination of an Optimal Pharmacokinetic Model of 18F-FET for Quantitative Applications in Rat Brain Tumors.
    J Nucl Med. 2017;58:1278-1284.
    PubMed     Abstract available


  935. BERGSTROM M
    The Use of Microdosing in the Development of Small Organic and Protein Therapeutics.
    J Nucl Med. 2017;58:1188-1195.
    PubMed     Abstract available


  936. JO J, Kwon HW, Park S, Oh DY, et al
    Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer.
    J Nucl Med. 2017;58:1255-1261.
    PubMed     Abstract available


  937. VAN DER AART J, van der Doef TF, Horstman P, Huisman MC, et al
    Human Dosimetry of the N-Methyl-d-Aspartate Receptor Ligand 11C-GMOM.
    J Nucl Med. 2017;58:1330-1333.
    PubMed     Abstract available


    July 2017
  938. EMMETT L EMMETTHRUB, Van Leeuwen P, Nandurkar R, Scheltema MJ, et al
    Treatment outcomes from 68GaPSMA PET CT informed salvage radiation treatment in men with rising PSA following radical prostatectomy: Prognostic value of a negative PSMA PET.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.196683. doi: 10.2967/jnumed.117.196683.
    PubMed     Abstract available


  939. NASRALLAH IM, Chen YJ, Hsieh MK, Philips JS, et al
    18F-Flortaucipir PET-MRI correlations in non-amnestic and amnestic variants of Alzheimer Disease.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.194282. doi: 10.2967/jnumed.117.194282.
    PubMed     Abstract available


  940. DELLER TW, Khalighi MM, Jansen FP, Glover GH, et al
    PET imaging stability measurements during simultaneous pulsing of aggressive MR sequences on the GE SIGNA PET/MR.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.194928. doi: 10.2967/jnumed.117.194928.
    PubMed     Abstract available


  941. LI S, Cai Z, Zheng MQ, Holden D, et al
    A novel 18F-labeled kappa opioid receptor antagonist as PET radiotracer: Synthesis and in vivo evaluation of 18F-LY2459989 in non-human primates.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.195586. doi: 10.2967/jnumed.117.195586.
    PubMed     Abstract available


  942. AFAQ A, Alahmed S, Chen SH, Lengana T, et al
    68Ga-PSMA PET/CT impact on prostate cancer management.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.192625. doi: 10.2967/jnumed.117.192625.
    PubMed     Abstract available


  943. BOUTER C, Meller B, Sahlmann CO, Staab W, et al
    Imaging chemokine receptor CXCR4 in chronic infection of the bone with 68Ga-Pentixafor-PET/CT - first insights.
    J Nucl Med. 2017 Jul 20. pii: jnumed.117.193854. doi: 10.2967/jnumed.117.193854.
    PubMed     Abstract available


  944. ACKER G, Lange C, Schatka I, Pfeifer A, et al
    Brain perfusion imaging under acetazolamide challenge for detection of impaired cerebrovascular reserve capacity: positive findings with O-15-water PET in patients with negative Tc-99m-HMPAO SPECT.
    J Nucl Med. 2017 Jul 20. pii: jnumed.117.195818. doi: 10.2967/jnumed.117.195818.
    PubMed     Abstract available


  945. LAMICHHANE N, Dewkar GK, Gobalakrishnan S, Wang L, et al
    Fluorine-18 Labeled Carboplatin Derivative for PET Imaging of Platinum Drug Distribution.
    J Nucl Med. 2017 Jul 20. pii: jnumed.117.191965. doi: 10.2967/jnumed.117.191965.
    PubMed     Abstract available


  946. BRENDEL M, Focke C, Blume T, Peters F, et al
    Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life-Span of Wild-Type Mice: A PET Study.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.195107. doi: 10.2967/jnumed.117.195107.
    PubMed     Abstract available


  947. ANTUNES IF, Willemsen ATM, Sijbesma JWA, Boerema AS, et al
    In vivo quantification of ER-beta expression by pharmacokinetic modeling: Studies with 18F-FHNP PET.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.192666. doi: 10.2967/jnumed.117.192666.
    PubMed     Abstract available


  948. CHEAL SM, Fung EK, Patel MV, Punzalan B, et al
    Curative multi-cycle radioimmunotherapy monitored by quantitative SPECT/CT-based theranostics, using bispecific antibody pretargeting strategy in colorectal cancer.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.193250. doi: 10.2967/jnumed.117.193250.
    PubMed     Abstract available


  949. PANDIT-TASKAR N, Zanzonico PB, Staton KD, Carrasquillo JA, et al
    Biodistribution and dosimetry of 18F-Meta Fluorobenzyl Guanidine (MFBG): A first-in-human PET-CT imaging study of patients with neuroendocrine malignancies.
    J Nucl Med. 2017 Jul 13. pii: jnumed.117.193169. doi: 10.2967/jnumed.117.193169.
    PubMed     Abstract available


  950. JAMES ML, Hoehne A, Mayer AT, Lechtenberg K, et al
    Imaging B cells in a mouse model of multiple sclerosis using 64Cu-Rituximab-PET.
    J Nucl Med. 2017 Jul 7. pii: jnumed.117.189597. doi: 10.2967/jnumed.117.189597.
    PubMed     Abstract available


  951. FAHEY FH, Goodkind A, MacDougall RD, Oberg L, et al
    Operational and Dosimetric Aspects of Pediatric PET/CT.
    J Nucl Med. 2017 Jul 7. pii: jnumed.116.182899. doi: 10.2967/jnumed.116.182899.
    PubMed     Abstract available


  952. SCHWARZENBOCK SM, Rauscher I, Bluemel C, Fendler WP, et al
    PSMA Ligands for PET-Imaging of Prostate Cancer.
    J Nucl Med. 2017 Jul 7. pii: jnumed.117.191031. doi: 10.2967/jnumed.117.191031.
    PubMed     Abstract available


  953. VAN SCHAIK JPJ, Bennink RJ
    Integrated Residency in Radiology and Nuclear Medicine in The Netherlands.
    J Nucl Med. 2017;58:9N-11N.
    PubMed    


  954. CARNEY B, Kossatz S, Reiner T
    Molecular Imaging of PARP.
    J Nucl Med. 2017;58:1025-1030.
    PubMed     Abstract available


  955. HANKIR MK, Kranz M, Keipert S, Weiner J, et al
    Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1-Deficient Mice.
    J Nucl Med. 2017;58:1100-1103.
    PubMed     Abstract available


  956. JOLING M, Vriend C, van den Heuvel OA, Raijmakers PGHM, et al
    Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.
    J Nucl Med. 2017;58:1117-1123.
    PubMed     Abstract available


    June 2017
  957. LU Y, Patel DC, Sweiss N
    Utilizing and Interpreting FDG-PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil is in the Details.
    J Nucl Med. 2017 Jun 29. pii: jnumed.117.197004. doi: 10.2967/jnumed.117.197004.
    PubMed    


  958. BLAIRE T, Bailliez A, Ben Bouallegue F, Bellevre D, et al
    Determination of the heart-to-mediastinum ratio of 123I-MIBG uptake using dual-isotope (123I-MIBG/99mTc-tetrofosmin) multi-pinhole CZT SPECT in patients with heart failure.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.194373. doi: 10.2967/jnumed.117.194373.
    PubMed     Abstract available


  959. ROACH PJ, Francis R, Emmett L, Hsiao E, et al
    The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.197160. doi: 10.2967/jnumed.117.197160.
    PubMed     Abstract available


  960. BAUCKNEHT M, Ferrarazzo G, Fiz F, Morbelli S, et al
    Doxorubicin effect on myocardial metabolism as a pre-requisite for subsequent development of cardiac toxicity: a translational 18F-FDG PET/CT observation.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.191122. doi: 10.2967/jnumed.117.191122.
    PubMed     Abstract available


  961. MAGOTA K, Shiga T, Asano Y, Shinyama D, et al
    Scatter correction with combined single-scatter simulation and Monte Carlo simulation scaling improved the visual artifacts and quantification in 3D brain PET/CT imaging with 15O-gas inhalation.
    J Nucl Med. 2017 Jun 23. pii: jnumed.117.193060. doi: 10.2967/jnumed.117.193060.
    PubMed     Abstract available


  962. HOFMAN MS
    Accuracy in the eye of the beholder: can we improve agreement in prostate cancer diagnostics with PSMA PET/CT?
    J Nucl Med. 2017 Jun 21. pii: jnumed.117.192542. doi: 10.2967/jnumed.117.192542.
    PubMed    


  963. VINSENSIA M, Choyke PL, Hadaschik B, Holland-Letz T, et al
    68Ga-PSMA PET/CT and volumetric morphology of PET-positive lymph nodes stratified by tumor differentiation of prostate cancer.
    J Nucl Med. 2017 Jun 21. pii: jnumed.116.185033. doi: 10.2967/jnumed.116.185033.
    PubMed     Abstract available


  964. O'DONOGHUE JA, Lewis JS, Pandit-Taskar N, Fleming SE, et al
    Pharmacokinetics, biodistribution, and radiation dosimetry for 89Zr-trastuzumab in patients with esophagogastric cancer.
    J Nucl Med. 2017 Jun 21. pii: jnumed.117.194555. doi: 10.2967/jnumed.117.194555.
    PubMed     Abstract available


  965. KOERBER SA, Utzinger MT, Kratochwil C, Kesch C, et al
    68Ga-PSMA11-PET/CT in newly diagnosed carcinoma of the prostate: correlation of intraprostatic PSMA uptake with several clinical parameters.
    J Nucl Med. 2017 Jun 15. pii: jnumed.117.190314. doi: 10.2967/jnumed.117.190314.
    PubMed     Abstract available


  966. KRAMER GM, Hoekstra OS, Boellaard R
    Reply: Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures in NSCLC Patients: Dynamic versus Test-Retest Design.
    J Nucl Med. 2017 Jun 15. pii: jnumed.117.195461. doi: 10.2967/jnumed.117.195461.
    PubMed    


  967. WELLS RG, Marvin B, Poirier M, Renaud JM, et al
    Optimization of SPECT Measurement of Myocardial Blood Flow with Corrections for Attenuation, Motion, and Blood-Binding Compared to PET.
    J Nucl Med. 2017 Jun 13. pii: jnumed.117.191049. doi: 10.2967/jnumed.117.191049.
    PubMed     Abstract available


  968. DESOGERE P, Tapias LF, Rietz TA, Rotile N, et al
    Optimization of a collagen-targeted positron emission tomography probe for molecular imaging of pulmonary fibrosis.
    J Nucl Med. 2017 Jun 13. pii: jnumed.117.193532. doi: 10.2967/jnumed.117.193532.
    PubMed     Abstract available


  969. WOLFS E, Holvoet B, Ordovas L, Breuls N, et al
    Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nucleases-mediated genome editing.
    J Nucl Med. 2017 Jun 8. pii: jnumed.117.189779. doi: 10.2967/jnumed.117.189779.
    PubMed     Abstract available


  970. DERCLE L, Seban RD, Lazarovici J, Schwartz L, et al
    18F-FDG PET and CT-scan Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-PD1 Immune Checkpoint Inhibitor.
    J Nucl Med. 2017 Jun 8. pii: jnumed.117.193011. doi: 10.2967/jnumed.117.193011.
    PubMed     Abstract available


  971. FERREIRA DA PONTE K, Berro DH, Collet S, Constans JM, et al
    In vivo relationship between hypoxia and angiogenesis in human glioblastoma: a multimodal imaging study.
    J Nucl Med. 2017 Jun 8. pii: jnumed.116.188557. doi: 10.2967/jnumed.116.188557.
    PubMed     Abstract available


  972. GONZALEZ TROTTER DE, Meng X, McQuade P, Rubins D, et al
    In vivo Imaging of the Programmed Death Ligand 1 by 18F Positron Emission Tomography.
    J Nucl Med. 2017 Jun 6. pii: jnumed.117.191718. doi: 10.2967/jnumed.117.191718.
    PubMed     Abstract available


  973. NA KJ, Choi H
    Tumor metabolic features identified by FDG PET correlates with gene networks of immune cell microenvironment in head and neck cancer.
    J Nucl Med. 2017 Jun 6. pii: jnumed.117.194217. doi: 10.2967/jnumed.117.194217.
    PubMed     Abstract available


  974. ROHDE M, Nielsen AL, Johansen J, Sorensen JA, et al
    Head-to-head comparison of chest x-ray/head and neck MRI, chest CT/head and neck MRI, and 18F-FDG-PET/CT for detection of distant metastases and synchronous cancer in oral, pharyngeal, and laryngeal Cancer.
    J Nucl Med. 2017 Jun 1. pii: jnumed.117.189704. doi: 10.2967/jnumed.117.189704.
    PubMed     Abstract available


  975. OSMAN MM, Iravani A, Hofman MS, Hicks RJ, et al
    Detection of Synchronous Primary Malignancies with 68Ga-PSMA PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients.
    J Nucl Med. 2017 Jun 1. pii: jnumed.117.190215. doi: 10.2967/jnumed.117.190215.
    PubMed     Abstract available


  976. SCHWARZ SW
    SNMMI Leadership Update: An Exciting Time for Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2017;58:19N.
    PubMed    


  977. WRIGHT CL, Niederkohr RD, Knopp MU, Knopp MV, et al
    Online Social Media Practices in Nuclear Medicine and Molecular Imaging: A Concept to Incentivize Creation of Digital and Web-Based Content.
    J Nucl Med. 2017;58:12N-14N.
    PubMed    


  978. FENG L, Jensen P, Thomsen G, Dyssegaard A, et al
    The Variability of Translocator Protein Signal in Brain and Blood of Genotyped Healthy Humans Using In Vivo 123I-CLINDE SPECT Imaging: A Test-Retest Study.
    J Nucl Med. 2017;58:989-995.
    PubMed     Abstract available


  979. KRAMER GM, Frings V, Heijtel D, Smit EF, et al
    Parametric Method Performance for Dynamic 3'-Deoxy-3'-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Carcinoma Patients Before and During Therapy.
    J Nucl Med. 2017;58:920-925.
    PubMed     Abstract available


  980. PARK S, Ha S, Kwon HW, Kim WH, et al
    Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication.
    J Nucl Med. 2017;58:899-904.
    PubMed     Abstract available


  981. NEVES AA, Xie B, Fawcett S, Alam IS, et al
    Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I.
    J Nucl Med. 2017;58:881-887.
    PubMed     Abstract available


  982. VAN ELSSEN CHMJ, Rashidian M, Vrbanac V, Wucherpfennig KW, et al
    Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.
    J Nucl Med. 2017;58:1003-1008.
    PubMed     Abstract available


  983. GROOTENDORST MR, Cariati M, Pinder SE, Kothari A, et al
    Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study.
    J Nucl Med. 2017;58:891-898.
    PubMed     Abstract available


  984. BETTHAUSER TJ, Lao PJ, Murali D, Barnhart TE, et al
    In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317.
    J Nucl Med. 2017;58:996-1002.
    PubMed     Abstract available


    May 2017
  985. JACOBSON O, Chen H, Niu G, Kiesewetter DO, et al
    PET-guided evaluation and optimization of internalized antibody-drug conjugates targeting erythropoietin producing hepatoma A2 receptor.
    J Nucl Med. 2017 May 25. pii: jnumed.117.192245. doi: 10.2967/jnumed.117.192245.
    PubMed     Abstract available


  986. KOUIJZER I, Kampschreur L, Wever P, Hoekstra C, et al
    The value of 18F-FDG-PET/CT in diagnosis and during follow-up in 273 patients with chronic Q fever.
    J Nucl Med. 2017 May 25. pii: jnumed.117.192492. doi: 10.2967/jnumed.117.192492.
    PubMed     Abstract available


  987. LE D
    Radiopharmaceuticals for Therapy.
    J Nucl Med. 2017 May 25. pii: jnumed.117.196568. doi: 10.2967/jnumed.117.196568.
    PubMed    


  988. DORIS MK, Rubeaux M, Pawade T, Otaki Y, et al
    Motion-corrected imaging of the aortic valve with 18F-NaF PET/CT and PET/MR: a feasibility study.
    J Nucl Med. 2017 May 25. pii: jnumed.117.194597. doi: 10.2967/jnumed.117.194597.
    PubMed     Abstract available


  989. COLLARINO A, Garganese G, Valdes Olmos RA, Stefanelli A, et al
    Evaluation of Dual Time Point Imaging 18F-FDG PET/CT for Lymph Node Staging in Vulvar Cancer.
    J Nucl Med. 2017 May 25. pii: jnumed.117.194332. doi: 10.2967/jnumed.117.194332.
    PubMed     Abstract available


  990. BIETH M, Kronke M, Tauber R, Dahlbender M, et al
    Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumour Burden in Prostate Cancer using 68Ga-PSMA-PET/CT.
    J Nucl Med. 2017 May 25. pii: jnumed.116.189050. doi: 10.2967/jnumed.116.189050.
    PubMed     Abstract available


  991. FENDLER WP, Stuparu AD, Evans-Axelsson S, Luckerath K, et al
    Establishing 177Lu-PSMA-617 radioligand therapy in a syngeneic model of murine prostate cancer.
    J Nucl Med. 2017 May 25. pii: jnumed.117.193359. doi: 10.2967/jnumed.117.193359.
    PubMed     Abstract available


  992. XI M, Liao Z, Hofstetter WL, Komaki R, et al
    FDG-PET Response After Induction Chemotherapy Can Predict Who Will Benefit From Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.
    J Nucl Med. 2017 May 18. pii: jnumed.117.192591. doi: 10.2967/jnumed.117.192591.
    PubMed     Abstract available


  993. LAMMERTSMA AA
    Forward to the Past: the Case for Quantitative PET Imaging.
    J Nucl Med. 2017 May 18. pii: jnumed.116.188029. doi: 10.2967/jnumed.116.188029.
    PubMed     Abstract available


  994. KENNEDY-DIXON TG, Gossell-Williams M, Cooper M, Trabelsi M, et al
    Evaluation of radiopharmaceutical adverse reaction reports to the British Nuclear Medicine Society for the period 2007 to 2016.
    J Nucl Med. 2017 May 18. pii: jnumed.117.194092. doi: 10.2967/jnumed.117.194092.
    PubMed     Abstract available


  995. HOPE TA, Aggarwal R, Chee B, Tao D, et al
    Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2017 May 18. pii: jnumed.117.192476. doi: 10.2967/jnumed.117.192476.
    PubMed     Abstract available


  996. SCHMUCK S, von Klot CA, Henkenberens C, Sohns JM, et al
    Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer.
    J Nucl Med. 2017 May 18. pii: jnumed.117.193581. doi: 10.2967/jnumed.117.193581.
    PubMed     Abstract available


  997. FOSS CA, Liu L, Mease RC, Wang H, et al
    Imaging Macrophage Accumulation in a Murine Model of Chronic Pancreatitis with [125I]iodoDPA SPECT-CT.
    J Nucl Med. 2017 May 18. pii: jnumed.117.189571. doi: 10.2967/jnumed.117.189571.
    PubMed     Abstract available


  998. NEDROW JR, Josefsson A, Park S, Ranka S, et al
    Imaging of programmed death ligand-1 (PD-L1): impact of protein concentration on distribution of anti-PD-L1 SPECT agent in an immunocompetent melanoma murine model.
    J Nucl Med. 2017 May 18. pii: jnumed.117.193268. doi: 10.2967/jnumed.117.193268.
    PubMed     Abstract available


  999. GOWRISHANKAR G, Hardy J, Wardak M, Namavari M, et al
    Specific Imaging of Bacterial Infection using 6'' -18F-Fluoromaltotriose: A Second Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria.
    J Nucl Med. 2017 May 10. pii: jnumed.117.191452. doi: 10.2967/jnumed.117.191452.
    PubMed     Abstract available


  1000. FLEDELIUS J, Winther-Larsen A, Khalil AA, Bylov CM, et al
    18F-FDG-PET/CT for very early response evaluation predicts CT response in Erlotinib treated NSCLC patients - A comparison of assessment methods.
    J Nucl Med. 2017 May 10. pii: jnumed.117.193003. doi: 10.2967/jnumed.117.193003.
    PubMed     Abstract available


  1001. STEIGER S, Arvanitakis M, Sick B, Weder W, et al
    Analysis of prognostic values of various PET metrics in preoperative FDG PET for early stage bronchial carcinoma for progression free and overall survival: significantly increased glycolysis is a predictive factor.
    J Nucl Med. 2017 May 10. pii: jnumed.117.189894. doi: 10.2967/jnumed.117.189894.
    PubMed     Abstract available


  1002. VAN DER VOS CS, Arens AI, Hamill J J, Hofmann C, et al
    Metal artifact reduction of CT scans to improve PET/CT.
    J Nucl Med. 2017 May 10. pii: jnumed.117.191171. doi: 10.2967/jnumed.117.191171.
    PubMed     Abstract available


  1003. ALEXANDER PK, Lie Y, Jones G, Sivaratnam C, et al
    Management Impact of Imaging Brain Vesicular Monoamine Transporter type-2 (VMAT2) in Clinically Uncertain Parkinsonian Syndrome (CUPS) with 18F-AV133 and PET.
    J Nucl Med. 2017 May 10. pii: jnumed.116.189019. doi: 10.2967/jnumed.116.189019.
    PubMed     Abstract available


  1004. SIEGEL JA, Sacks B, Pennington CW, Welsh JS, et al
    Dose Optimization to Minimize Radiation Risk for Children Undergoing CT and Nuclear Medicine Imaging is Misguided and Detrimental.
    J Nucl Med. 2017 May 10. pii: jnumed.117.195263. doi: 10.2967/jnumed.117.195263.
    PubMed     Abstract available


  1005. SUBRAMANIAM RM, Jadvar H, Colletti PM, Guimaraes A, et al
    American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Body.
    J Nucl Med. 2017 May 4. pii: jnumed.117.193524. doi: 10.2967/jnumed.117.193524.
    PubMed     Abstract available


  1006. CALAIS J, Czernin J, Eiber M, Fendler WP, et al
    Most intended management changes after 68Ga-DOTATATE PET/CT are implemented.
    J Nucl Med. 2017 May 4. pii: jnumed.117.192450. doi: 10.2967/jnumed.117.192450.
    PubMed     Abstract available


  1007. HOFHEINZ F, Apostolova I, Oehme L, Kotzerke J, et al
    Test-retest variability of lesion SUV and lesion SUR in 18F-FDG PET: an analysis of data from two prospective multicenter trials.
    J Nucl Med. 2017 May 4. pii: jnumed.117.190736. doi: 10.2967/jnumed.117.190736.
    PubMed     Abstract available


  1008. BOOIJ J, Dubroff J, Pryma D, Yu JQ, et al
    Diagnostic performance of the visual reading of 123I-ioflupane SPECT images when assessed with or without quantification in patients with movement disorders or dementia.
    J Nucl Med. 2017 May 4. pii: jnumed.116.189266. doi: 10.2967/jnumed.116.189266.
    PubMed     Abstract available


  1009. KAGNA O, Kurash M, Ghanem-Zouabi N, Keidar Z, et al
    Does antibiotic treatment affect the diagnostic accuracy of FDG PET/CT studies in patients with suspected infectious processes?
    J Nucl Med. 2017 May 4. pii: jnumed.117.192062. doi: 10.2967/jnumed.117.192062.
    PubMed     Abstract available


  1010. KESCH C, Vinsensia M, Radtke JP, Schlemmer HP, et al
    Intra-individual comparison of 18F-PSMA-1007-PET/CT, multi-parametric MRI and radical prostatectomy specimen in patients with primary prostate cancer - a retrospective, proof of concept study.
    J Nucl Med. 2017 May 4. pii: jnumed.116.189233. doi: 10.2967/jnumed.116.189233.
    PubMed     Abstract available


  1011. YANG J, Wiesinger F, Kaushik S, Shanbhag D, et al
    Evaluation of sinus/edge corrected ZTE-based attenuation correction in brain PET/MRI.
    J Nucl Med. 2017 May 4. pii: jnumed.116.188268. doi: 10.2967/jnumed.116.188268.
    PubMed     Abstract available


  1012. CLARK PM, Ebiana VA, Gosa L, Cloughesy TF, et al
    Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine.
    J Nucl Med. 2017;58:689-696.
    PubMed     Abstract available


  1013. GARG PK, Nazih R, Wu Y, Singh R, et al
    4-11C-Methoxy N-(2-Diethylaminoethyl) Benzamide: A Novel Probe to Selectively Target Melanoma.
    J Nucl Med. 2017;58:827-832.
    PubMed     Abstract available


  1014. WAN MYS, Endozo R, Michopoulou S, Shortman R, et al
    PET/CT Imaging of Unstable Carotid Plaque with 68Ga-Labeled Somatostatin Receptor Ligand.
    J Nucl Med. 2017;58:774-780.
    PubMed     Abstract available


  1015. MUZIK O, Mangner TJ, Leonard WR, Kumar A, et al
    Sympathetic Innervation of Cold-Activated Brown and White Fat in Lean Young Adults.
    J Nucl Med. 2017;58:799-806.
    PubMed     Abstract available


  1016. SEGTNAN EA, Grupe P, Jarden JO, Gerke O, et al
    Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis.
    J Nucl Med. 2017;58:768-773.
    PubMed     Abstract available


  1017. ILAN E, Sandstrom M, Velikyan I, Sundin A, et al
    Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast.
    J Nucl Med. 2017;58:744-749.
    PubMed     Abstract available


    April 2017
  1018. WONDERGEM M, van der Zant F, Knol R, Lazarenko S, et al
    18F-DCFPyL PET/CT in the detection of prostate cancer at 60 and 120 minutes ; detection rate, image quality, activity kinetics and biodistribution.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.192658. doi: 10.2967/jnumed.117.192658.
    PubMed     Abstract available


  1019. WONG SQ, Tothill RW, Dawson SJ, Hicks RJ, et al
    Wet or Dry? Are Liquid Biopsy Techniques Competing or Complementary Technologies to PET for Disease Monitoring in Oncology?
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190116. doi: 10.2967/jnumed.117.190116.
    PubMed    


  1020. MORBELLI S, Alama A, Ferrarazzo G, Coco S, et al
    Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an 18F-FDG PET/CT study.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193201. doi: 10.2967/jnumed.117.193201.
    PubMed     Abstract available


  1021. HSU DF, Ilan E, Peterson WT, Uribe J, et al
    Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.189514. doi: 10.2967/jnumed.117.189514.
    PubMed     Abstract available


  1022. AHRENS BJ, Li L, Ciminera AK, Chea J, et al
    Diagnostic PET Imaging of Mammary Microcalcifications using 64Cu-DOTA-alendronate in a Rat Model of Breast Cancer.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190850. doi: 10.2967/jnumed.117.190850.
    PubMed     Abstract available


  1023. ENGBERS EM, Timmer JR, Mouden M, Knollema S, et al
    Prognostic value of myocardial perfusion imaging with CZT SPECT camera in patients suspected for coronary artery disease.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188516. doi: 10.2967/jnumed.116.188516.
    PubMed     Abstract available


  1024. KOGA K, Nagai Y, Hanyu M, Yoshinaga M, et al
    High-contrast PET imaging of vasopressin V1B receptors with a novel radioligand, 11C-TASP699.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188698. doi: 10.2967/jnumed.116.188698.
    PubMed     Abstract available


  1025. KASTE SC, Metzger M, Shulkin B
    Reply: Prudence required when using 18F-FDG PET as reference standard for lymphoma detection.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190652. doi: 10.2967/jnumed.117.190652.
    PubMed    


  1026. KUNZ WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, et al
    Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET-CT Compared to Contrast-Enhanced MRI.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.191932. doi: 10.2967/jnumed.117.191932.
    PubMed     Abstract available


  1027. DERLIN T, Gueler F, Brasen JH, Schmitz J, et al
    Integrating MRI and chemokine receptor CXCR4-targeted PET for detection of leukocyte infiltration in complicated urinary tract infections after kidney transplantation.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193037. doi: 10.2967/jnumed.117.193037.
    PubMed     Abstract available


  1028. OSBORN EA, Kessinger CW, Tawakol A, Jaffer FA, et al
    Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.182873. doi: 10.2967/jnumed.116.182873.
    PubMed     Abstract available


  1029. KELLY JM, Amor-Coarasa A, Nikolopoulou A, Wustemann T, et al
    Double Targeting Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188722. doi: 10.2967/jnumed.116.188722.
    PubMed     Abstract available


  1030. DALM SU, Haeck J, Doeswijk GN, de Blois E, et al
    SSTR-mediated Breast Cancer Imaging: Is There A Role For Radiolabeled SSTR Antagonists?
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.189035. doi: 10.2967/jnumed.116.189035.
    PubMed     Abstract available


  1031. YOUNG JD, Abbate V, Imberti C, Meszaros LK, et al
    68Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room temperature, one-step kit-based radiolabeling.
    J Nucl Med. 2017 Apr 13. pii: jnumed.117.191882. doi: 10.2967/jnumed.117.191882.
    PubMed     Abstract available


  1032. FENDLER WP, Calais J, Allen-Auerbach M, Bluemel C, et al
    68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study.
    J Nucl Med. 2017 Apr 13. pii: jnumed.117.190827. doi: 10.2967/jnumed.117.190827.
    PubMed     Abstract available


  1033. O' DOHERTY J, Jauregui-Osoro M, Brothwood T, Szyszko T, et al
    18F-tetrafluoroborate (18F-TFB), a PET probe for imaging sodium-iodide symporter expression: Whole-body biodistribution, safety and radiation dosimetry in thyroid cancer patients.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192252. doi: 10.2967/jnumed.117.192252.
    PubMed     Abstract available


  1034. GERSTNER E
    MRI and PET: noninvasive tools to probe diffuse intrinsic pontine glioma biology.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192526. doi: 10.2967/jnumed.117.192526.
    PubMed    


  1035. KOSTAKOGLU L
    Reply: Fact sheet about interim and end-of-treatment 18F-FDG PET/CT in lymphoma.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.190512. doi: 10.2967/jnumed.117.190512.
    PubMed    


  1036. MILLER MP, Kostakoglu L, Pryma D, Yu JQ, et al
    Reader training for the re-staging of biochemically recurrent prostate cancer using fluciclovine (18F) PET/CT.
    J Nucl Med. 2017 Apr 6. pii: jnumed.116.188375. doi: 10.2967/jnumed.116.188375.
    PubMed     Abstract available


  1037. COLLETTI PM
    2016 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2017;58:9N-12N.
    PubMed    


  1038. DONOHOE KJ, Cohen EJ, Giammarile F, Grady E, et al
    Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and Excerpts.
    J Nucl Med. 2017;58:14N-17N.
    PubMed    



  1039. SNMMI Begins Release of AUC for High-Value Nuclear Medicine Procedures.
    J Nucl Med. 2017;58:13N.
    PubMed    


  1040. ADAMS HJ, Kwee TC
    Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma.
    J Nucl Med. 2017;58:684-685.
    PubMed    


  1041. GROHEUX D
    18F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer.
    J Nucl Med. 2017;58:683.
    PubMed    


  1042. ZHU L, Ploessl K, Zhou R, Mankoff D, et al
    Metabolic Imaging of Glutamine in Cancer.
    J Nucl Med. 2017;58:533-537.
    PubMed     Abstract available


  1043. LEE HJ, Barback CV, Hoh CK, Qin Z, et al
    Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes.
    J Nucl Med. 2017;58:547-553.
    PubMed     Abstract available


  1044. MAYER AT, Natarajan A, Gordon SR, Maute RL, et al
    Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging.
    J Nucl Med. 2017;58:538-546.
    PubMed     Abstract available


  1045. CHEN H, Jacobson O, Niu G, Weiss ID, et al
    Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.
    J Nucl Med. 2017;58:590-597.
    PubMed     Abstract available


  1046. HAGGKVIST J, Toth M, Tari L, Varnas K, et al
    Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex.
    J Nucl Med. 2017;58:617-622.
    PubMed     Abstract available


  1047. HAHN A, Schain M, Erlandsson M, Sjolin P, et al
    Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology.
    J Nucl Med. 2017;58:623-631.
    PubMed     Abstract available


  1048. KLEINJAN GH, Hellingman D, van den Berg NS, van Oosterom MN, et al
    Hybrid Surgical Guidance: Does Hardware Integration of gamma- and Fluorescence Imaging Modalities Make Sense?
    J Nucl Med. 2017;58:646-650.
    PubMed     Abstract available


    March 2017
  1049. ZUKOTYNSKI K, Vajapeyam S, Fahey FH, Kocak M, et al
    Correlation of 18F-FDG PET and MR Apparent Diffusion Coefficient (ADC) Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.185389. doi: 10.2967/jnumed.116.185389.
    PubMed     Abstract available


  1050. O JH, Jacene HA, Luber B, Wang H, et al
    Quantitation of cancer treatment response by FDG PET/CT: multi-center assessment of measurement variability.
    J Nucl Med. 2017 Mar 30. pii: jnumed.117.189605. doi: 10.2967/jnumed.117.189605.
    PubMed     Abstract available


  1051. CHO SY, Lipson EJ, Im HJ, Rowe SP, et al
    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early Time-Point FDG-PET/CT Imaging in Patients with Advanced Melanoma.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.188839. doi: 10.2967/jnumed.116.188839.
    PubMed     Abstract available


  1052. WARNDERS FJ, Terwisscha van Scheltinga AG, Knuehl C, van Roy M, et al
    HER3 specific biodistribution and tumor uptake of 89Zr-MSB0010853 visualized by real-time and non-invasive PET imaging.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.181586. doi: 10.2967/jnumed.116.181586.
    PubMed     Abstract available


  1053. SEITH F, Schmidt H, Kunz J, Kuestner T, et al
    Simulation of tracer dose reduction in 18F-FDG-Positron emission tomography / magnetic resonance imaging (PET/MRI): Effects on oncologic reading, image quality and artifacts.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.184440. doi: 10.2967/jnumed.116.184440.
    PubMed     Abstract available


  1054. VERCELLINO L, Ouvrier MJ, Barre E, Cassinat B, et al
    Assessing bone marrow activity in patients with myelofibrosis: results of a pilot study of 18F-FLT PET.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.188508. doi: 10.2967/jnumed.116.188508.
    PubMed     Abstract available


  1055. BERREVOETS MA, Kouijzer IJ, Aarntzen EH, Janssen MJ, et al
    18F-FDG-PET/CT optimizes treatment in Staphylococcus aureus bacteremia and is associated with reduced mortality.
    J Nucl Med. 2017 Mar 23. pii: jnumed.117.191981. doi: 10.2967/jnumed.117.191981.
    PubMed     Abstract available


  1056. SUCKSDORFF M, Rissanen E, Tuisku J, Nuutinen S, et al
    Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.183020. doi: 10.2967/jnumed.116.183020.
    PubMed     Abstract available


  1057. TEUHO J, Saunavaara V, Tolvanen T, Tuokkola T, et al
    Quantitative evaluation of two scatter correction techniques for 18F-FDG brain PET/MR imaging in regard to MR-based attenuation correction.
    J Nucl Med. 2017 Mar 23. pii: jnumed.117.190231. doi: 10.2967/jnumed.117.190231.
    PubMed     Abstract available


  1058. OTTOY J, Verhaeghe J, Niemantsverdriet E, Wyffels L, et al
    Validation of the semi-quantitative static SUVR method for [18F]-AV45 PET by pharmacokinetic modeling with an arterial input function.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.184481. doi: 10.2967/jnumed.116.184481.
    PubMed     Abstract available


  1059. USMANIJ EA, Natroshvili T, Timmer-Bonte JN, Oyen WJ, et al
    The predictive value of early in-treatment FDG-PET/CT response to chemotherapy in combination with bevacizumab in advanced non-squamous non-small cell lung cancer.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.185314. doi: 10.2967/jnumed.116.185314.
    PubMed     Abstract available


  1060. PIERT M, Shao X, Raffel DM, Davenport MS, et al
    Preclinical evaluation of 11C-sarcosine as a substrate of proton-coupled amino acid transporters and first human application in prostate cancer.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.173179. doi: 10.2967/jnumed.116.173179.
    PubMed     Abstract available


  1061. KRISHNAN S, Otaki Y, Doris M, Slipczuk L, et al
    Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
    J Nucl Med. 2017;58:359-364.
    PubMed     Abstract available


  1062. TERRITO PR, Meyer JA, Peters JS, Riley AA, et al
    Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation.
    J Nucl Med. 2017;58:458-465.
    PubMed     Abstract available


    February 2017
  1063. STEGMAYR C, Oliveira D, Niemietz N, Willuweit A, et al
    Influence of bevacizumab on blood-brain barrier permeability and O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.
    J Nucl Med. 2017 Feb 2. pii: jnumed.116.187047. doi: 10.2967/jnumed.116.187047.
    PubMed     Abstract available


  1064. COTTEREAU AS, Hapdey S, Chartier L, Modzelewski R, et al
    Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.
    J Nucl Med. 2017;58:276-281.
    PubMed     Abstract available


  1065. WANG J, Arulanandam R, Wassenaar R, Falls T, et al
    Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.
    J Nucl Med. 2017;58:221-227.
    PubMed     Abstract available


  1066. BAKER SL, Lockhart SN, Price JC, He M, et al
    Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    J Nucl Med. 2017;58:332-338.
    PubMed     Abstract available


  1067. VAN DER MEER LT, Terry SY, van Ingen Schenau DS, Andree KC, et al
    In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow.
    J Nucl Med. 2017;58:214-220.
    PubMed     Abstract available


    January 2017
  1068. ZHU Y, Wu S, Hou H, Ji J, et al
    Glucose Metabolic Profile by Visual Assessment Combined with SPM Analysis in Pediatric Patients with Epilepsy.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.187492. doi: 10.2967/jnumed.116.187492.
    PubMed     Abstract available


  1069. LAFFON E, Thumerel M, Jougon J, Marthan R, et al
    Cumulated activity Comparison of 64Cu-/177Lu-labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.180521. doi: 10.2967/jnumed.116.180521.
    PubMed     Abstract available


  1070. MOGHBEL MC, Mittra E, Gallamini A, Niederkohr R, et al
    Response Assessment Criteria and Their Applications in Lymphoma: Part 2.
    J Nucl Med. 2017;58:13-22.
    PubMed     Abstract available


  1071. ORDONEZ AA, Weinstein EA, Bambarger LE, Saini V, et al
    A Systematic Approach for Developing Bacteria-Specific Imaging Tracers.
    J Nucl Med. 2017;58:144-150.
    PubMed     Abstract available


  1072. DETOUR J, Pierre A, Boisson F, Kreutter G, et al
    Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
    J Nucl Med. 2017;58:36-41.
    PubMed     Abstract available


  1073. ENGLAND CG, Ehlerding EB, Hernandez R, Rekoske BT, et al
    Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    J Nucl Med. 2017;58:162-168.
    PubMed     Abstract available


  1074. VAN DER GEEST T, Laverman P, Gerrits D, Walgreen B, et al
    Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
    J Nucl Med. 2017;58:151-155.
    PubMed     Abstract available


  1075. SIEGEL JA, Pennington CW, Sacks B
    Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur of Non-Trivial Proportion.
    J Nucl Med. 2017;58:1-6.
    PubMed     Abstract available


  1076. GOLESTANI R, Razavian M, Ye Y, Zhang J, et al
    Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.
    J Nucl Med. 2017;58:138-143.
    PubMed     Abstract available


  1077. LEURQUIN-STERK G, Celen S, Van Laere K, Koole M, et al
    What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
    J Nucl Med. 2017;58:110-116.
    PubMed     Abstract available


    November 2016
  1078. FOWLER AM, Linden HM
    Functional Estrogen Receptor Imaging Prior to Neoadjuvant therapy for Primary Breast Cancer.
    J Nucl Med. 2016 Nov 17. pii: jnumed.116.183533.
    PubMed    


    October 2016
  1079. CARDINALE J, Schafer M, Benesova M, Bauder-Wust U, et al
    Preclinical Evaluation of [18F]PSMA-1007: A New PSMA-Ligand for Prostate Cancer Imaging.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.181768.
    PubMed     Abstract available


  1080. YANG H, Jenni S, Colovic M, Merkens H, et al
    18F-5-fluoro-aminosuberic acid (FASu) as a potential tracer to gauge oxidative stress in breast cancer models.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.180661.
    PubMed     Abstract available


  1081. AFSHAR-OROMIEH A, Babich JW, Kratochwil C, Giesel FL, et al
    The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Abstract available


  1082. PANDIT-TASKAR N, Veach DR, Fox JJ, Scher HI, et al
    Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.
    J Nucl Med. 2016;57.
    PubMed     Abstract available


  1083. SCHUSTER DM, Nanni C, Fanti S
    Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs.
    J Nucl Med. 2016;57.
    PubMed     Abstract available


  1084. IAGARU AH, Mittra E, Colletti PM, Jadvar H, et al
    Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Abstract available


  1085. JADVAR H
    Radiotheranostics in Prostate Cancer: Introduction and Overview.
    J Nucl Med. 2016;57.
    PubMed    


    September 2016
  1086. YIP SS, Kim J, Coroller T, Parmar C, et al
    Associations between somatic mutations and metabolic imaging phenotypes in non-small cell lung cancer.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.181826.
    PubMed     Abstract available


  1087. OKAMOTO S, Thieme A, Allmann J, D'Alessandria C, et al
    Radiation dosimetry for 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: Absorbed dose in normal organs and tumor lesions.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.178483.
    PubMed     Abstract available


  1088. FINDLAY JM, Bradley KM, Wang LM, Franklin JM, et al
    PREDICTING PATHOLOGICAL RESPONSE OF ESOPHAGEAL CANCER TO NEOADJUVANT CHEMOTHERAPY: THE IMPLICATIONS OF METABOLIC NODAL RESPONSE FOR PERSONALISED THERAPY.
    J Nucl Med. 2016 Sep 15. pii: jnumed.116.176313.
    PubMed     Abstract available


  1089. PALESTRO CJ
    Radionuclide Imaging of Musculoskeletal Infection: A Review.
    J Nucl Med. 2016;57:1406-12.
    PubMed     Abstract available


  1090. HARMS HJ, Huisman MC, Rijnierse MT, Greuter H, et al
    Noninvasive Quantification of Myocardial 11C-Meta-Hydroxyephedrine Kinetics.
    J Nucl Med. 2016;57:1376-81.
    PubMed     Abstract available


  1091. BAILLIEZ A, Lairez O, Merlin C, Piriou N, et al
    Left Ventricular Function Assessment Using 2 Different Cadmium-Zinc-Telluride Cameras Compared with a gamma-Camera with Cardiofocal Collimators: Dynamic Cardiac Phantom Study and Clinical Validation.
    J Nucl Med. 2016;57:1370-5.
    PubMed     Abstract available


  1092. SINGH P, Gonzalez-Ramos S, Mojena M, Rosales-Mendoza CE, et al
    GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.
    J Nucl Med. 2016;57:1428-35.
    PubMed     Abstract available


    August 2016
  1093. ZHANG H, Desai P, Koike Y, Houghton J, et al
    Dual modality imaging of prostate cancer with a fluorescent and radiogallium-labeled GRP receptor antagonist.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.176099.
    PubMed     Abstract available


  1094. DUBASH SR, Keat N, Mapelli P, Twyman F, et al
    Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors.
    J Nucl Med. 2016;57:1207-13.
    PubMed     Abstract available


  1095. SANTINI C, Kuil J, Bunschoten A, Pool S, et al
    Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.
    J Nucl Med. 2016;57:1289-95.
    PubMed     Abstract available


  1096. DOUKKY R, Frogge N, Appis A, Hayes K, et al
    Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging.
    J Nucl Med. 2016;57:1251-7.
    PubMed     Abstract available


  1097. BAUER M, Blaickner M, Philippe C, Wadsak W, et al
    Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans.
    J Nucl Med. 2016;57:1265-8.
    PubMed     Abstract available


  1098. KOBASHI N, Matsumoto H, Zhao S, Meike S, et al
    The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine.
    J Nucl Med. 2016;57:1276-81.
    PubMed     Abstract available


  1099. MEDHORA M, Haworth S, Liu Y, Narayanan J, et al
    Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging.
    J Nucl Med. 2016;57:1296-301.
    PubMed     Abstract available


    July 2016
  1100. SENGUPTA D, Pratx G
    Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy.
    J Nucl Med. 2016;57:1136-40.
    PubMed     Abstract available


    May 2016
  1101. MCCONATHY J
    [F-18]Fluciclovine (FACBC) and its Potential Use for Breast Cancer Imaging.
    J Nucl Med. 2016 May 19. pii: jnumed.116.175489.
    PubMed    


    April 2016
  1102. PARK GM, Kim YH, Yun SC, Ahn JM, et al
    Anatomical or Functional Evaluation as an Initial Test for Stable Coronary Artery Disease: A Propensity Score Analysis.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.169318.
    PubMed     Abstract available


  1103. HUAILEI J, Bansal A, Pandey M, Peng KW, et al
    Synthesis of 18F-Tetrafluoroborate (18F-TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170894.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: